rdi-20200930x10q
false--12-31Q3202000007166340000716634us-gaap:TreasuryStockMember2020-09-300000716634us-gaap:TreasuryStockMember2020-06-300000716634us-gaap:TreasuryStockMember2020-03-310000716634us-gaap:TreasuryStockMember2019-12-310000716634us-gaap:TreasuryStockMember2019-09-300000716634us-gaap:TreasuryStockMember2019-06-300000716634us-gaap:TreasuryStockMember2019-03-310000716634us-gaap:TreasuryStockMember2018-12-310000716634rdi:TwentyFiveMillionStockRepurchaseProgramMemberus-gaap:NonvotingCommonStockMember2020-09-300000716634rdi:TwoThousandTwentySevenStockRepurchasePlanMember2020-09-300000716634rdi:TwoThousandTwentySevenStockRepurchasePlanMemberus-gaap:CommonClassAMember2020-03-100000716634rdi:TwoThousandTwentySevenStockRepurchasePlanMember2020-01-012020-09-300000716634rdi:TwoThousandTwentySevenStockRepurchasePlanMember2020-03-100000716634rdi:TwentyFiveMillionStockRepurchaseProgramMemberus-gaap:CommonClassAMember2017-03-020000716634rdi:TwentyFiveMillionStockRepurchaseProgramMemberus-gaap:NonvotingCommonStockMember2020-07-012020-09-300000716634rdi:TwentyFiveMillionStockRepurchaseProgramMemberus-gaap:NonvotingCommonStockMember2020-04-012020-06-300000716634rdi:TwentyFiveMillionStockRepurchaseProgramMemberus-gaap:NonvotingCommonStockMember2020-03-052020-03-050000716634rdi:TwentyFiveMillionStockRepurchaseProgramMemberus-gaap:NonvotingCommonStockMember2020-01-012020-09-300000716634rdi:TwentyFiveMillionStockRepurchasedTwoMemberus-gaap:NonvotingCommonStockMember2020-01-012020-03-310000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2020-07-012020-09-300000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2020-04-012020-06-300000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2019-01-012019-03-310000716634us-gaap:RetainedEarningsMember2020-09-300000716634us-gaap:ParentMember2020-09-300000716634us-gaap:NoncontrollingInterestMember2020-09-300000716634us-gaap:AdditionalPaidInCapitalMember2020-09-300000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300000716634us-gaap:RetainedEarningsMember2020-06-300000716634us-gaap:ParentMember2020-06-300000716634us-gaap:NoncontrollingInterestMember2020-06-300000716634us-gaap:AdditionalPaidInCapitalMember2020-06-300000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-3000007166342020-06-300000716634us-gaap:RetainedEarningsMember2020-03-310000716634us-gaap:ParentMember2020-03-310000716634us-gaap:NoncontrollingInterestMember2020-03-310000716634us-gaap:AdditionalPaidInCapitalMember2020-03-310000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-3100007166342020-03-310000716634us-gaap:RetainedEarningsMember2019-12-310000716634us-gaap:ParentMember2019-12-310000716634us-gaap:NoncontrollingInterestMember2019-12-310000716634us-gaap:AdditionalPaidInCapitalMember2019-12-310000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000716634srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Memberus-gaap:ParentMember2019-09-300000716634srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Memberus-gaap:NoncontrollingInterestMember2019-09-300000716634srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Memberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300000716634srt:ScenarioPreviouslyReportedMemberus-gaap:TaxYear2019Member2019-09-300000716634srt:RestatementAdjustmentMemberus-gaap:TaxYear2019Member2019-09-300000716634srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Member2019-09-300000716634us-gaap:TaxYear2019Member2019-09-300000716634us-gaap:RetainedEarningsMember2019-09-300000716634us-gaap:ParentMember2019-09-300000716634us-gaap:NoncontrollingInterestMember2019-09-300000716634us-gaap:AdditionalPaidInCapitalMember2019-09-300000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300000716634us-gaap:RetainedEarningsMember2019-06-300000716634us-gaap:ParentMember2019-06-300000716634us-gaap:NoncontrollingInterestMember2019-06-300000716634us-gaap:AdditionalPaidInCapitalMember2019-06-300000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-3000007166342019-06-300000716634srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Memberus-gaap:RetainedEarningsMember2019-03-310000716634srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Memberus-gaap:ParentMember2019-03-310000716634srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Memberus-gaap:NoncontrollingInterestMember2019-03-310000716634srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Member2019-03-310000716634us-gaap:RetainedEarningsMember2019-03-310000716634us-gaap:ParentMember2019-03-310000716634us-gaap:NoncontrollingInterestMember2019-03-310000716634us-gaap:AdditionalPaidInCapitalMember2019-03-310000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-3100007166342019-03-310000716634srt:ScenarioPreviouslyReportedMemberus-gaap:TaxYear2019Member2018-12-310000716634srt:RestatementAdjustmentMemberus-gaap:TaxYear2019Member2018-12-310000716634us-gaap:TaxYear2019Member2018-12-310000716634us-gaap:RetainedEarningsMember2018-12-310000716634us-gaap:ParentMember2018-12-310000716634us-gaap:NoncontrollingInterestMember2018-12-310000716634us-gaap:AdditionalPaidInCapitalMember2018-12-310000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310000716634us-gaap:CommonClassAMember2018-01-012018-12-310000716634us-gaap:CommonClassAMember2018-12-3100007166342020-03-102020-03-100000716634rdi:NonEmployeeDirectorMemberus-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300000716634us-gaap:CommonClassAMember2019-01-012019-12-310000716634us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-01-012020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2020-01-012020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-01-012020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheTenMember2020-01-012020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheSixMember2020-01-012020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheEightMember2020-01-012020-09-300000716634rdi:StateCinemaHobartTasmaniaAustraliaMember2020-01-012020-09-300000716634rdi:DevonportTasmaniaAustraliaMember2020-01-012020-09-300000716634us-gaap:AccountingStandardsUpdate201602Member2020-01-012020-09-300000716634us-gaap:IntersegmentEliminationMember2020-07-012020-09-300000716634us-gaap:IntersegmentEliminationMember2020-01-012020-09-300000716634rdi:CinemaMembersrt:ScenarioPreviouslyReportedMemberus-gaap:TaxYear2019Member2019-07-012019-09-300000716634rdi:CinemaMembersrt:RestatementAdjustmentMemberus-gaap:TaxYear2019Member2019-07-012019-09-300000716634rdi:CinemaMemberus-gaap:TaxYear2019Member2019-07-012019-09-300000716634us-gaap:IntersegmentEliminationMember2019-07-012019-09-300000716634rdi:CinemaMembersrt:ScenarioPreviouslyReportedMemberus-gaap:TaxYear2019Member2019-01-012019-09-300000716634rdi:CinemaMembersrt:RestatementAdjustmentMemberus-gaap:TaxYear2019Member2019-01-012019-09-300000716634rdi:CinemaMemberus-gaap:TaxYear2019Member2019-01-012019-09-300000716634us-gaap:IntersegmentEliminationMember2019-01-012019-09-300000716634rdi:TammanyMezzInvestorLlcMemberrdi:MezzanineLoanMember2019-08-082019-08-080000716634us-gaap:RetainedEarningsMember2020-07-012020-09-300000716634us-gaap:RetainedEarningsMember2020-04-012020-06-300000716634us-gaap:RetainedEarningsMember2020-01-012020-03-310000716634us-gaap:RetainedEarningsMember2019-07-012019-09-300000716634us-gaap:RetainedEarningsMember2019-04-012019-06-300000716634us-gaap:RetainedEarningsMember2019-01-012019-03-310000716634rdi:VillageEastCinemaManhattanMember2019-08-282019-08-280000716634rdi:PurchaseMoneyPromissoryNoteMemberus-gaap:CommonClassAMember2019-09-182019-09-180000716634us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-07-012020-09-300000716634us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000716634us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-07-012019-09-300000716634us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-09-300000716634us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-09-300000716634us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-09-300000716634us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-09-300000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000716634us-gaap:NoncontrollingInterestMember2020-04-012020-06-300000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300000716634us-gaap:NoncontrollingInterestMember2020-01-012020-03-310000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-06-300000716634us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-310000716634us-gaap:OperatingSegmentsMemberrdi:RealEstateSegmentMember2020-07-012020-09-300000716634us-gaap:OperatingSegmentsMemberrdi:CinemaExhibitionSegmentMember2020-07-012020-09-300000716634us-gaap:OperatingSegmentsMember2020-07-012020-09-300000716634us-gaap:OperatingSegmentsMemberrdi:RealEstateSegmentMember2020-01-012020-09-300000716634us-gaap:OperatingSegmentsMemberrdi:CinemaExhibitionSegmentMember2020-01-012020-09-300000716634us-gaap:OperatingSegmentsMember2020-01-012020-09-300000716634us-gaap:OperatingSegmentsMemberrdi:RealEstateSegmentMember2019-07-012019-09-300000716634us-gaap:OperatingSegmentsMemberrdi:CinemaExhibitionSegmentMember2019-07-012019-09-300000716634us-gaap:OperatingSegmentsMember2019-07-012019-09-300000716634us-gaap:OperatingSegmentsMemberrdi:RealEstateSegmentMember2019-01-012019-09-300000716634us-gaap:OperatingSegmentsMemberrdi:CinemaExhibitionSegmentMember2019-01-012019-09-300000716634us-gaap:OperatingSegmentsMember2019-01-012019-09-300000716634us-gaap:NoncontrollingInterestMember2020-07-012020-09-300000716634us-gaap:NoncontrollingInterestMember2019-07-012019-09-300000716634rdi:SuttonHillPropertiesMember2020-07-012020-09-300000716634rdi:ShadowViewLandAndFarmingLlcMember2020-07-012020-09-300000716634rdi:AustraliaCountryCinemasMember2020-07-012020-09-300000716634rdi:SuttonHillPropertiesMember2019-07-012019-09-300000716634rdi:ShadowViewLandAndFarmingLlcMember2019-07-012019-09-300000716634rdi:AustraliaCountryCinemasMember2019-07-012019-09-300000716634rdi:SuttonHillPropertiesMember2019-01-012019-09-300000716634rdi:ShadowViewLandAndFarmingLlcMember2019-01-012019-09-300000716634rdi:AustraliaCountryCinemasMember2019-01-012019-09-300000716634rdi:SuttonHillPropertiesMember2020-09-300000716634rdi:ShadowViewLandAndFarmingLlcMember2020-09-300000716634rdi:AustraliaCountryCinemasMember2020-09-300000716634us-gaap:NoncontrollingInterestMember2019-04-012019-06-300000716634us-gaap:NoncontrollingInterestMember2019-01-012019-03-310000716634rdi:EmploymentLitigationMember2020-01-012020-09-300000716634rdi:JamesJ.CotterJr.LitigationMattersMember2020-01-012020-09-300000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierTwoMember2019-12-310000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierOneMember2019-12-310000716634us-gaap:RevolvingCreditFacilityMemberrdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierThreeMember2019-03-150000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierThreeMemberrdi:CoreFacilityMember2019-03-150000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierThreeMemberrdi:BankGuaranteeMember2019-03-150000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierThreeMember2019-03-150000716634rdi:RealEstateRevenueMembersrt:MinimumMember2020-09-300000716634rdi:RealEstateRevenueMembersrt:MaximumMember2020-09-300000716634rdi:CinemaMembersrt:MinimumMember2020-09-300000716634rdi:CinemaMembersrt:MaximumMember2020-09-300000716634srt:MinimumMember2020-09-300000716634srt:MaximumMember2020-09-300000716634rdi:RialtoCinemasMember2020-07-012020-09-300000716634rdi:MtGravattCinemaMember2020-07-012020-09-300000716634rdi:RialtoCinemasMember2020-01-012020-09-300000716634rdi:MtGravattCinemaMember2020-01-012020-09-300000716634rdi:RialtoCinemasMember2019-07-012019-09-300000716634rdi:MtGravattCinemaMember2019-07-012019-09-300000716634rdi:RialtoCinemasMember2019-01-012019-09-300000716634rdi:MtGravattCinemaMember2019-01-012019-09-300000716634srt:RestatementAdjustmentMemberus-gaap:TaxYear2019Member2019-07-012019-09-300000716634rdi:BusinessSegmentCinemaMember2020-01-012020-09-300000716634rdi:BusinessSegmentRealEstateMember2020-09-300000716634rdi:BusinessSegmentCinemaMember2020-09-300000716634rdi:BusinessSegmentRealEstateMember2019-12-310000716634rdi:BusinessSegmentCinemaMember2019-12-310000716634us-gaap:TradeNamesMember2020-01-012020-09-300000716634us-gaap:TradeNamesMember2020-09-300000716634us-gaap:OtherIntangibleAssetsMember2020-09-300000716634rdi:BeneficialLeasesMember2020-09-300000716634us-gaap:TradeNamesMember2019-12-310000716634us-gaap:OtherIntangibleAssetsMember2019-12-310000716634rdi:BeneficialLeasesMember2019-12-310000716634us-gaap:FairValueMeasurementsRecurringMember2020-09-300000716634us-gaap:FairValueMeasurementsRecurringMember2019-12-310000716634us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2020-09-300000716634us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2020-09-300000716634us-gaap:FairValueMeasurementsNonrecurringMember2020-09-300000716634us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2019-12-310000716634us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2019-12-310000716634us-gaap:FairValueMeasurementsNonrecurringMember2019-12-310000716634rdi:RialtoCinemasMember2019-12-310000716634rdi:MtGravattCinemaMember2019-12-310000716634rdi:RialtoCinemasMember2020-09-300000716634rdi:MtGravattCinemaMember2020-09-300000716634us-gaap:StockOptionMember2020-09-300000716634srt:ScenarioPreviouslyReportedMemberus-gaap:TaxYear2019Member2019-07-012019-09-300000716634us-gaap:TaxYear2019Member2019-07-012019-09-300000716634us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000716634us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000716634us-gaap:OtherCurrentLiabilitiesMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000716634us-gaap:OtherCurrentLiabilitiesMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000716634us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2020-07-012020-09-300000716634us-gaap:DesignatedAsHedgingInstrumentMember2020-07-012020-09-300000716634us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2020-01-012020-09-300000716634us-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000716634us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2019-07-012019-09-300000716634us-gaap:DesignatedAsHedgingInstrumentMember2019-07-012019-09-300000716634us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2019-01-012019-09-300000716634us-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-09-300000716634us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2020-07-012020-09-300000716634us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2020-01-012020-09-300000716634us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2019-07-012019-09-300000716634us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2019-01-012019-09-300000716634us-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000716634us-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000716634us-gaap:CorporateNonSegmentMember2020-07-012020-09-300000716634us-gaap:CorporateNonSegmentMember2020-01-012020-09-300000716634us-gaap:CorporateNonSegmentMember2019-07-012019-09-300000716634us-gaap:CorporateNonSegmentMember2019-01-012019-09-3000007166342019-01-012020-06-300000716634us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2014-08-2900007166342014-08-290000716634srt:ScenarioPreviouslyReportedMemberus-gaap:TaxYear2019Member2019-01-012019-09-300000716634srt:RestatementAdjustmentMemberus-gaap:TaxYear2019Member2019-01-012019-09-300000716634rdi:MinettaAndOrpheumTheatresLoanMemberrdi:SantanderBankMember2020-01-012020-09-300000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierThreeMember2020-01-012020-09-300000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierOneMember2020-01-012020-09-300000716634rdi:NewZealandCorporateCreditFacilityMemberrdi:BankBillSwapBidRateMember2020-07-270000716634rdi:NewZealandCorporateCreditFacilityMember2020-07-270000716634rdi:UnitedStateCinemasOneTwoThreeTermLoanMember2020-03-130000716634srt:MinimumMemberrdi:UnitedStatesBankOfAmericaCreditFacilityMember2020-03-060000716634srt:MaximumMemberrdi:UnitedStatesBankOfAmericaCreditFacilityMember2020-03-060000716634rdi:PurchaseMoneyPromissoryNoteMember2019-09-180000716634rdi:NewZealandCorporateCreditFacilityTranchOneMemberrdi:BankBillSwapBidRateMember2018-12-200000716634rdi:NewZealandCorporateCreditFacilityMember2018-12-200000716634rdi:UnitedStateCorporateOfficeTermLoanMember2017-06-260000716634rdi:UnitedStateCorporateOfficeTermLoanMember2016-12-130000716634rdi:UnitedStatesBankOfAmericaLineOfCreditMember2019-12-310000716634srt:MinimumMemberrdi:UnitedStateCorporateOfficeTermLoanMember2020-01-012020-09-300000716634srt:MaximumMemberrdi:UnitedStateCorporateOfficeTermLoanMember2020-01-012020-09-300000716634srt:MinimumMemberrdi:UnitedStateCorporateOfficeTermLoanMember2019-01-012019-12-310000716634srt:MaximumMemberrdi:UnitedStateCorporateOfficeTermLoanMember2019-01-012019-12-310000716634rdi:UnitedStateCorporateOfficeTermLoanMember2017-06-262017-06-260000716634rdi:UnitedStatesBankOfAmericaCreditFacilityMemberus-gaap:EurodollarMember2020-08-072020-08-070000716634rdi:UnitedStatesBankOfAmericaLineOfCreditMember2020-08-072020-08-070000716634rdi:UnitedStatesBankOfAmericaCreditFacilityMember2020-08-072020-08-070000716634rdi:NabAustralianCorporateTermLoanAndRevolverMember2020-08-062020-08-060000716634srt:MinimumMemberrdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierThreeMember2019-03-152019-03-150000716634srt:MaximumMemberrdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierThreeMember2019-03-152019-03-150000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierThreeMemberrdi:BankGuaranteeMember2019-03-152019-03-150000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierTwoMember2018-12-172018-12-170000716634rdi:NationalAustraliaBankAustralianCorporateTermLoanAndRevolverTierOneMember2018-12-172018-12-170000716634rdi:RealEstateRevenueMember2020-07-012020-09-300000716634rdi:CinemaMember2020-07-012020-09-300000716634rdi:RealEstateRevenueMember2020-01-012020-09-300000716634rdi:CinemaMember2020-01-012020-09-300000716634rdi:RealEstateRevenueMember2019-07-012019-09-300000716634rdi:CinemaMember2019-07-012019-09-300000716634rdi:RealEstateRevenueMember2019-01-012019-09-300000716634rdi:CinemaMember2019-01-012019-09-300000716634rdi:OtherRealEstateProjectsMemberrdi:OperatingAndInvestingPropertiesMember2020-09-300000716634rdi:CourtenayCentralDevelopmentMemberrdi:OperatingAndInvestingPropertiesMember2020-09-300000716634rdi:CinemaDevelopmentsAndImprovementsMemberrdi:OperatingAndInvestingPropertiesMember2020-09-300000716634rdi:OperatingAndInvestingPropertiesMember2020-09-300000716634rdi:UnionSquareDevelopmentMemberrdi:OperatingAndInvestingPropertiesMember2019-12-310000716634rdi:OtherRealEstateProjectsMemberrdi:OperatingAndInvestingPropertiesMember2019-12-310000716634rdi:CourtenayCentralDevelopmentMemberrdi:OperatingAndInvestingPropertiesMember2019-12-310000716634rdi:CinemaDevelopmentsAndImprovementsMemberrdi:OperatingAndInvestingPropertiesMember2019-12-310000716634rdi:OperatingAndInvestingPropertiesMember2019-12-310000716634us-gaap:CommonClassBMemberrdi:CommonStockSharesOutstandingMember2020-09-300000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2020-09-300000716634us-gaap:CommonClassBMemberrdi:CommonStockSharesOutstandingMember2020-06-300000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2020-06-300000716634us-gaap:CommonClassBMemberrdi:CommonStockSharesOutstandingMember2020-03-310000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2020-03-310000716634us-gaap:CommonClassBMemberrdi:CommonStockSharesOutstandingMember2019-12-310000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2019-12-310000716634us-gaap:CommonClassBMemberrdi:CommonStockSharesOutstandingMember2019-09-300000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2019-09-300000716634us-gaap:CommonClassBMemberrdi:CommonStockSharesOutstandingMember2019-06-300000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2019-06-300000716634us-gaap:CommonClassBMemberrdi:CommonStockSharesOutstandingMember2019-03-310000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2019-03-310000716634us-gaap:CommonClassBMemberrdi:CommonStockSharesOutstandingMember2018-12-310000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2018-12-310000716634us-gaap:CommonClassBMember2020-09-300000716634us-gaap:CommonClassAMember2020-09-300000716634us-gaap:CommonClassBMember2019-12-310000716634us-gaap:CommonClassAMember2019-12-3100007166342019-09-3000007166342018-12-310000716634rdi:DevonportTasmaniaAustraliaMember2020-09-300000716634rdi:DevonportTasmaniaAustraliaMember2019-01-300000716634us-gaap:OtherIntangibleAssetsMember2020-07-012020-09-300000716634rdi:BeneficialLeaseMember2020-07-012020-09-300000716634us-gaap:OtherIntangibleAssetsMember2020-01-012020-09-300000716634rdi:BeneficialLeaseMember2020-01-012020-09-300000716634us-gaap:OtherIntangibleAssetsMember2019-07-012019-09-300000716634rdi:BeneficialLeaseMember2019-07-012019-09-300000716634us-gaap:OtherIntangibleAssetsMember2019-01-012019-09-300000716634rdi:BeneficialLeaseMember2019-01-012019-09-300000716634us-gaap:StockOptionMember2020-07-012020-09-300000716634us-gaap:RestrictedStockUnitsRSUMember2020-07-012020-09-300000716634us-gaap:StockOptionMember2020-01-012020-09-300000716634us-gaap:StockOptionMember2019-07-012019-09-300000716634us-gaap:RestrictedStockUnitsRSUMember2019-07-012019-09-300000716634us-gaap:RestrictedStockUnitsRSUMember2019-05-072019-05-070000716634us-gaap:StockOptionMember2019-01-012019-09-300000716634us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-09-300000716634us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300000716634us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300000716634us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310000716634us-gaap:TreasuryStockMember2019-07-012019-09-300000716634us-gaap:AdditionalPaidInCapitalMember2019-04-012019-06-300000716634us-gaap:AccumulatedTranslationAdjustmentMember2020-09-300000716634us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-09-300000716634us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-09-300000716634us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-300000716634us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310000716634us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310000716634us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-310000716634us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310000716634us-gaap:BuildingAndBuildingImprovementsMember2020-09-300000716634us-gaap:BuildingAndBuildingImprovementsMember2019-12-310000716634us-gaap:TreasuryStockMember2020-07-012020-09-300000716634us-gaap:ParentMember2020-07-012020-09-300000716634us-gaap:TreasuryStockMember2020-04-012020-06-300000716634us-gaap:ParentMember2020-04-012020-06-3000007166342020-04-012020-06-300000716634us-gaap:TreasuryStockMember2020-01-012020-03-310000716634us-gaap:ParentMember2020-01-012020-03-3100007166342020-01-012020-03-310000716634us-gaap:TreasuryStockMember2019-04-012019-06-300000716634us-gaap:ParentMember2019-04-012019-06-3000007166342019-04-012019-06-300000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2020-01-012020-03-310000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2019-04-012019-06-300000716634us-gaap:TreasuryStockMember2019-01-012019-03-310000716634rdi:PurchaseMoneyPromissoryNoteMember2019-09-182019-09-180000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheThirteenMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheTenMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheSixMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheSevenMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheFourMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheElevenMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheEightMember2020-09-300000716634srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2020-09-300000716634srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-09-300000716634srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheTwelveMember2020-09-300000716634srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheNineMember2020-09-300000716634srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheFiveMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheTwelveMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheThirteenMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheTenMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheSixMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheSevenMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheNineMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheFourMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheFiveMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheElevenMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMemberrdi:ShareBasedCompensationAwardTrancheEightMember2020-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMember2020-09-300000716634srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2020-09-300000716634us-gaap:RestrictedStockUnitsRSUMember2020-09-300000716634us-gaap:LandMember2020-09-300000716634rdi:ConstructionInProgressIncludingCapitalizedInterestMember2020-09-300000716634us-gaap:LandMember2019-12-310000716634us-gaap:BuildingMember2019-12-310000716634rdi:ConstructionInProgressIncludingCapitalizedInterestMember2019-12-310000716634us-gaap:TaxYear2019Member2019-01-012019-09-300000716634srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300000716634us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300000716634us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-09-300000716634rdi:FortyFourUnionSquareMemberrdi:BankOfOzarksMember2016-12-290000716634country:US2020-01-012020-09-300000716634country:NZ2020-01-012020-09-300000716634country:AU2020-01-012020-09-300000716634rdi:MelbourneVictoriaMember2020-08-052020-08-050000716634rdi:MelbourneVictoriaMember2020-07-082020-07-080000716634country:US2020-07-012020-09-300000716634country:US2020-09-300000716634rdi:SuttonHillPropertiesMember2020-01-012020-09-300000716634rdi:ShadowViewLandAndFarmingLlcMember2020-01-012020-09-300000716634rdi:AustraliaCountryCinemasMember2020-01-012020-09-300000716634rdi:SuttonHillPropertiesMember2019-01-012019-12-310000716634rdi:ShadowViewLandAndFarmingLlcMember2019-01-012019-12-310000716634rdi:AustraliaCountryCinemasMember2019-01-012019-12-310000716634rdi:UnitedStatesUnionSquareLineOfCreditMember2020-09-300000716634rdi:UnitedStatesBankOfAmericaLineOfCreditMember2020-09-300000716634rdi:UnitedStatesBankOfAmericaCreditFacilityMember2020-09-300000716634rdi:UnitedStateCorporateOfficeTermLoanMember2020-09-300000716634rdi:UnitedStateCinemasOneTwoThreeTermLoanMember2020-09-300000716634rdi:TrustPreferredSecuritiesMember2020-09-300000716634rdi:PurchaseMoneyPromissoryNoteMember2020-09-300000716634rdi:NewZealandCorporateCreditFacilityMember2020-09-300000716634rdi:NationalAustraliaBankAustralianCorporateLoanFacilityMember2020-09-300000716634rdi:MinettaAndOrpheumTheatresLoanMember2020-09-300000716634rdi:UnitedStatesUnionSquareLineOfCreditMember2019-12-310000716634rdi:UnitedStatesBankOfAmericaCreditFacilityMember2019-12-310000716634rdi:UnitedStateCorporateOfficeTermLoanMember2019-12-310000716634rdi:UnitedStateCinemasOneTwoThreeTermLoanMember2019-12-310000716634rdi:TrustPreferredSecuritiesMember2019-12-310000716634rdi:PurchaseMoneyPromissoryNoteMember2019-12-310000716634rdi:NewZealandCorporateCreditFacilityMember2019-12-310000716634rdi:NationalAustraliaBankAustralianCorporateLoanFacilityMember2019-12-310000716634rdi:MinettaAndOrpheumTheatresLoanMember2019-12-310000716634rdi:FortyFourUnionSquareMemberrdi:BankOfOzarksMember2020-01-012020-09-300000716634rdi:FortyFourUnionSquareMemberrdi:BankOfOzarksMember2020-01-242020-01-240000716634currency:NZDrdi:SpotRateMember2020-07-012020-09-300000716634currency:NZDrdi:AverageRateMember2020-07-012020-09-300000716634currency:AUDrdi:SpotRateMember2020-07-012020-09-300000716634currency:AUDrdi:AverageRateMember2020-07-012020-09-300000716634currency:NZDrdi:SpotRateMember2020-01-012020-09-300000716634currency:NZDrdi:AverageRateMember2020-01-012020-09-300000716634currency:AUDrdi:SpotRateMember2020-01-012020-09-300000716634currency:AUDrdi:AverageRateMember2020-01-012020-09-300000716634currency:NZDrdi:SpotRateMember2019-07-012019-09-300000716634currency:NZDrdi:AverageRateMember2019-07-012019-09-300000716634currency:AUDrdi:SpotRateMember2019-07-012019-09-300000716634currency:AUDrdi:AverageRateMember2019-07-012019-09-300000716634currency:NZDrdi:SpotRateMember2019-01-012019-12-310000716634currency:NZDrdi:AverageRateMember2019-01-012019-12-310000716634currency:AUDrdi:SpotRateMember2019-01-012019-12-310000716634currency:AUDrdi:AverageRateMember2019-01-012019-12-310000716634currency:NZDrdi:SpotRateMember2019-01-012019-09-300000716634currency:NZDrdi:AverageRateMember2019-01-012019-09-300000716634currency:AUDrdi:SpotRateMember2019-01-012019-09-300000716634currency:AUDrdi:AverageRateMember2019-01-012019-09-3000007166342020-07-012020-09-300000716634us-gaap:CommonClassAMemberrdi:CommonStockSharesOutstandingMember2019-07-012019-09-300000716634us-gaap:ParentMember2019-07-012019-09-300000716634us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-3000007166342019-07-012019-09-3000007166342018-02-012018-02-2800007166342014-08-292014-08-290000716634rdi:UnitedStateCinemasOneTwoThreeTermLoanMember2020-03-132020-03-130000716634rdi:UnitedStateCinemasOneTwoThreeTermLoanMember2020-03-122020-03-120000716634rdi:UnitedStatesBankOfAmericaLineOfCreditMember2020-03-062020-03-060000716634rdi:UnitedStatesBankOfAmericaCreditFacilityMember2020-03-062020-03-060000716634rdi:UnitedStatesUnionSquareLineOfCreditMember2020-01-012020-09-300000716634rdi:UnitedStatesBankOfAmericaLineOfCreditMember2020-01-012020-09-300000716634rdi:UnitedStatesBankOfAmericaCreditFacilityMember2020-01-012020-09-300000716634rdi:UnitedStateCorporateOfficeTermLoanMember2020-01-012020-09-300000716634rdi:UnitedStateCinemasOneTwoThreeTermLoanMember2020-01-012020-09-300000716634rdi:TrustPreferredSecuritiesMember2020-01-012020-09-300000716634rdi:PurchaseMoneyPromissoryNoteMember2020-01-012020-09-300000716634rdi:NewZealandCorporateCreditFacilityMember2020-01-012020-09-300000716634rdi:NationalAustraliaBankAustralianCorporateLoanFacilityMember2020-01-012020-09-300000716634rdi:MinettaAndOrpheumTheatresLoanMember2020-01-012020-09-300000716634rdi:UnitedStatesUnionSquareLineOfCreditMember2019-01-012019-12-310000716634rdi:UnitedStatesBankOfAmericaLineOfCreditMember2019-01-012019-12-310000716634rdi:UnitedStatesBankOfAmericaCreditFacilityMember2019-01-012019-12-310000716634rdi:UnitedStateCorporateOfficeTermLoanMember2019-01-012019-12-310000716634rdi:UnitedStateCinemasOneTwoThreeTermLoanMember2019-01-012019-12-310000716634rdi:TrustPreferredSecuritiesMember2019-01-012019-12-310000716634rdi:PurchaseMoneyPromissoryNoteMember2019-01-012019-12-310000716634rdi:NewZealandCorporateCreditFacilityMember2019-01-012019-12-310000716634rdi:NationalAustraliaBankAustralianCorporateLoanFacilityMember2019-01-012019-12-310000716634rdi:MinettaAndOrpheumTheatresLoanMember2019-01-012019-12-3100007166342019-01-012019-12-310000716634rdi:NewZealandCorporateCreditFacilityTranchTwoMember2018-12-202018-12-200000716634rdi:NewZealandCorporateCreditFacilityTranchOneMember2018-12-202018-12-200000716634rdi:NewZealandCorporateCreditFacilityTranchOneMember2018-12-192018-12-190000716634rdi:MinettaAndOrpheumTheatresLoanMemberrdi:SantanderBankMember2018-10-122018-10-120000716634rdi:MinettaAndOrpheumTheatresLoanMember2018-10-122018-10-120000716634rdi:FortyFourUnionSquareMemberrdi:TammanyMezzInvestorLlcMemberrdi:MezzanineLoanMember2016-12-292016-12-290000716634rdi:FortyFourUnionSquareMember2016-12-292016-12-290000716634rdi:UnitedStateCorporateOfficeTermLoanMember2016-12-132016-12-130000716634us-gaap:ParentMember2019-01-012019-03-310000716634us-gaap:AdditionalPaidInCapitalMember2019-01-012019-03-3100007166342019-01-012019-03-310000716634rdi:NewZealandCorporateCreditFacilityMember2020-07-010000716634rdi:StateCinemaHobartTasmaniaAustraliaMember2020-03-310000716634rdi:StateCinemaHobartTasmaniaAustraliaMember2019-12-030000716634rdi:StateCinemaHobartTasmaniaAustraliaMember2019-12-042020-03-310000716634rdi:DevonportTasmaniaAustraliaMember2020-01-312020-03-3100007166342019-01-012019-09-300000716634rdi:UnionSquareDevelopmentMemberrdi:OperatingAndInvestingPropertiesMember2020-01-012020-09-300000716634rdi:OtherRealEstateProjectsMemberrdi:OperatingAndInvestingPropertiesMember2020-01-012020-09-300000716634rdi:CourtenayCentralDevelopmentMemberrdi:OperatingAndInvestingPropertiesMember2020-01-012020-09-300000716634rdi:CinemaDevelopmentsAndImprovementsMemberrdi:OperatingAndInvestingPropertiesMember2020-01-012020-09-300000716634rdi:OperatingAndInvestingPropertiesMember2020-01-012020-09-3000007166342020-09-3000007166342019-12-310000716634us-gaap:CommonClassBMember2020-01-012020-09-300000716634us-gaap:CommonClassAMember2020-01-012020-09-300000716634us-gaap:CommonClassBMember2020-11-060000716634us-gaap:CommonClassAMember2020-11-0600007166342020-01-012020-09-30rdi:claimiso4217:AUDiso4217:USDxbrli:sharesrdi:loanrdi:itemxbrli:pureiso4217:NZDiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________________________________

FORM 10-Q

(Mark One)

þ

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2020

OR

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number 1-8625

C:\Users\matthew.elmshauser\Pictures\Reading International logo.jpg

READING INTERNATIONAL, INC.

(Exact name of Registrant as specified in its charter)

Nevada

State or other jurisdiction of incorporation or organization)

95-3885184

(IRS Employer Identification Number)

5995 Sepulveda Boulevard, Suite 300

Culver City, CA

(Address of principal executive offices)

 

90230

(Zip Code)

Registrant’s telephone number, including area code: (213) 235-2240

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Class A Nonvoting Common Stock, $0.01 par value

 

RDI

 

NASDAQ

Class B Voting Common Stock, $0.01 par value

RDIB

NASDAQ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ  No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ¨ Accelerated Filer þ Non-Accelerated Filer  ¨ Smaller Reporting Company  ¨ Emerging Growth Company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨  No  þ

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of November 6, 2020, there were 20,068,607 shares of Class A Nonvoting Common Stock, $0.01 par value per share and 1,680,590 shares of Class B Voting Common Stock, $0.01 par value per share outstanding.

 

1


READING INTERNATIONAL, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

Page

PART I - Financial Information

3

Item 1 – Financial Statements

3

Consolidated Balance Sheets (Unaudited)

3

Consolidated Statements of Income (Unaudited)

4

Consolidated Statements of Comprehensive Income (Unaudited)

5

Consolidated Statements of Cash Flows (Unaudited)

6

Notes to Consolidated Financial Statements (Unaudited)

7

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

36

Item 3 – Quantitative and Qualitative Disclosure about Market Risk

63

Item 4 – Controls and Procedures

64

PART II – Other Information

65

Item 1 – Legal Proceedings

65

Item 1A – Risk Factors

65

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

66

Item 3 – Defaults Upon Senior Securities

66

Item 4 – Mine Safety Disclosure

66

Item 5 – Other Information

66

Item 6 – Exhibits

67

SIGNATURES

68

Certifications

 


 

2


PART 1 – FINANCIAL INFORMATION

Item 1 - Financial Statements

READING INTERNATIONAL, INC.

CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands, except share information)

September 30,

December 31,

2020

2019

ASSETS

(unaudited)

Current Assets:

Cash and cash equivalents

$

27,775

$

12,135

Receivables

3,300

7,085

Inventory

1,020

1,674

Prepaid and other current assets

10,052

6,105

Total current assets

42,147

26,999

Operating property, net

340,167

258,138

Operating lease right-of-use assets

213,177

229,879

Investment and development property, net

29,839

114,024

Investment in unconsolidated joint ventures

4,807

5,069

Goodwill

26,599

26,448

Intangible assets, net

4,344

4,320

Deferred tax asset, net

5,131

3,444

Other assets

7,226

6,668

Total assets

$

673,437

$

674,989

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:

Accounts payable and accrued liabilities

$

31,241

$

29,436

Film rent payable

1,853

8,716

Debt - current portion

40,890

36,736

Subordinated debt - current portion

644

644

Derivative financial instruments - current portion

217

109

Taxes payable - current

2,087

140

Deferred revenue

9,182

11,324

Operating lease liabilities - current portion

21,411

20,379

Other current liabilities

9,470

3,653

Total current liabilities

116,995

111,137

Debt - long-term portion

201,399

140,602

Derivative financial instruments - non-current portion

266

233

Subordinated debt, net

28,690

29,030

Noncurrent tax liabilities

12,882

12,353

Operating lease liabilities - non-current portion

206,415

223,164

Other liabilities

16,583

18,854

Total liabilities

583,230

535,373

Commitments and contingencies (Note 14)

 

 

Stockholders’ equity:

Class A non-voting common stock, par value $0.01, 100,000,000 shares authorized,

33,004,717 issued and 20,068,607 outstanding at September 30, 2020 and

32,963,489 issued and 20,102,535 outstanding at December 31, 2019

231

231

Class B voting common stock, par value $0.01, 20,000,000 shares authorized and

1,680,590 issued and outstanding at September 30, 2020 and December 31, 2019

17

17

Nonvoting preferred stock, par value $0.01, 12,000 shares authorized and no issued

or outstanding shares at September 30, 2020 and December 31, 2019

Additional paid-in capital

149,620

148,602

Retained earnings/(deficits)

(27,159)

20,647

Treasury shares

(40,407)

(39,737)

Accumulated other comprehensive income

4,004

5,589

Total Reading International, Inc. stockholders’ equity

86,306

135,349

Noncontrolling interests

3,901

4,267

Total stockholders’ equity

90,207

139,616

Total liabilities and stockholders’ equity

$

673,437

$

674,989

See accompanying Notes to the Unaudited Consolidated Financial Statements.

 

3


READING INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited; U.S. dollars in thousands, except per share data)

Quarter Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Revenue

Cinema

$

7,339

$

66,663

$

54,866

$

196,885

Real estate

2,852

3,723

7,975

11,001

Total revenue

10,191

70,386

62,841

207,886

Costs and expenses

Cinema

(15,817)

(53,709)

(71,769)

(158,273)

Real estate

(1,909)

(2,225)

(6,258)

(7,108)

Depreciation and amortization

(5,612)

(5,704)

(16,149)

(16,870)

General and administrative

(4,228)

(5,908)

(15,275)

(18,426)

Total costs and expenses

(27,566)

(67,546)

(109,451)

(200,677)

Operating income (loss)

(17,375)

2,840

(46,610)

7,209

Interest expense, net

(2,379)

(1,871)

(6,176)

(5,924)

Gain (loss) on sale of assets

(1)

(1)

(1)

(1)

Other income (expense)

10

141

(186)

190

Income (loss) before income tax expense and equity earnings of unconsolidated joint ventures

(19,745)

1,109

(52,973)

1,474

Equity earnings of unconsolidated joint ventures

(97)

220

(292)

581

Income (loss) before income taxes

(19,842)

1,329

(53,265)

2,055

Income tax benefit (expense)

490

(528)

5,070

(1,101)

Net income (loss)

$

(19,352)

$

801

$

(48,195)

$

954

Less: net income (loss) attributable to noncontrolling interests

(124)

(50)

(389)

(103)

Net income (loss) attributable to Reading International, Inc. common shareholders

$

(19,228)

$

851

$

(47,806)

$

1,057

Basic earnings (loss) per share attributable to Reading International, Inc. shareholders

$

(0.88)

$

0.04

$

(2.20)

$

0.05

Diluted earnings (loss) per share attributable to Reading International, Inc. shareholders

$

(0.88)

$

0.04

$

(2.20)

$

0.05

Weighted average number of shares outstanding–basic

21,748,531

22,546,827

21,749,146

22,791,530

Weighted average number of shares outstanding–diluted

22,098,757

22,688,230

22,099,372

22,952,838

See accompanying Notes to the Unaudited Consolidated Financial Statements. 

 

4


READING INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited; U.S. dollars in thousands)

Quarter Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Net income (loss)

$

(19,352)

$

801

$

(48,195)

$

954

Foreign currency translation gain (loss)

3,478

(6,598)

(1,574)

(7,355)

Gain (loss) on cash flow hedges

63

(20)

(142)

(211)

Other

47

51

131

159

Comprehensive income (loss)

(15,764)

(5,766)

(49,780)

(6,453)

Less: net income (loss) attributable to noncontrolling interests

(124)

(50)

(389)

(103)

Less: comprehensive income (loss) attributable to noncontrolling interests

(2)

(2)

(7)

(2)

Comprehensive income (loss) attributable to Reading International, Inc.

$

(15,638)

(5,714)

$

(49,384)

$

(6,348)

See accompanying Notes to the Unaudited Consolidated Financial Statements

 

5


READING INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; U.S. dollars in thousands)

Nine Months Ended

September 30,

2020

2019

Operating Activities

Net income (loss)

$

(48,195)

$

954

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Equity earnings of unconsolidated joint ventures

292

(581)

Distributions of earnings from unconsolidated joint ventures

235

760

Loss on sale of assets

1

1

Amortization of operating leases

15,593

15,719

Amortization of finance leases

79

121

Change in operating lease liabilities

(14,659)

(15,209)

Interest on hedged derivatives

1

Change in net deferred tax assets

(1,515)

214

Depreciation and amortization

16,149

16,870

Other amortization

741

1,088

Stock based compensation expense

1,063

1,097

Net changes in operating assets and liabilities:

Receivables

3,757

3,393

Prepaid and other assets

(3,056)

(4,757)

Payments for accrued pension

(513)

(513)

Accounts payable and accrued expenses

4,349

(2,950)

Film rent payable

(6,767)

(2,129)

Taxes payable

1,916

(1,091)

Deferred revenue and other liabilities

2,522

(2,191)

Net cash provided by (used in) operating activities

(28,008)

10,797

Investing Activities

Insurance recoveries relating to property damage and demolition costs

168

Purchases of and additions to operating and investment properties

(16,310)

(33,205)

Acquisition of business combinations

(1,380)

Change in restricted cash

1,334

Contributions to unconsolidated joint ventures

(240)

Net cash provided by (used in) investing activities

(16,550)

(33,083)

Financing Activities

Repayment of long-term borrowings

(28,910)

(31,692)

Repayment of finance lease principal

(77)

(120)

Proceeds from borrowings

87,764

58,677

Capitalized borrowing costs

(275)

(502)

Repurchase of Class A Nonvoting Common Stock

(1,150)

(7,800)

(Cash paid) proceeds from the settlement of employee share transactions

(43)

(315)

Noncontrolling interest contributions

30

55

Noncontrolling interest distributions

(42)

Net cash provided by (used in) financing activities

57,339

18,261

Effect of exchange rate changes on cash and cash equivalents

2,859

(394)

Net increase (decrease) in cash and cash equivalents

15,640

(4,420)

Cash and cash equivalents at January 1

12,135

13,127

Cash and cash equivalents at September 30

$

27,775

$

8,707

Supplemental Disclosures

Interest paid

$

7,618

$

8,134

Income taxes (refunded) paid

(712)

5,669

Non-Cash Transactions

Additions to operating and investing properties through accrued expenses

2,595

5,768

See accompanying Notes to the Unaudited Consolidated Financial Statements. 

 

6


READING INTERNATIONAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

 

Note 1 – Description of Business and Segment Reporting

Our Company

Reading International, Inc., a Nevada corporation (“RDI” and collectively with our consolidated subsidiaries and corporate predecessors, the “Company,” “Reading,” and “we,” “us,” or “our”) was incorporated in 1999. Our businesses consist primarily of:

the development, ownership, and operation of cinemas in the United States, Australia, and New Zealand; and,

the development, ownership, operation and/or rental of retail, commercial and live venue real estate assets in the United States, Australia, and New Zealand.

Business Segments

Reported below are the operating segments of our Company for which separate financial information is available and evaluated regularly by the Chief Executive Officer, the chief operating decision-maker of our Company. As part of our real estate activities, we hold undeveloped land in urban and suburban centers in the United States, Australia, and New Zealand.

The table below summarizes the results of operations for each of our business segments for the quarter and nine months ended September 30, 2020 and 2019, respectively. Operating expense includes costs associated with the day-to-day operations of the cinemas and the management of rental properties, including our live theatre assets.

Quarter Ended

Nine Months Ended

September 30,

September 30,

(Dollars in thousands)

2020

2019

2020

2019

Revenue:

Cinema exhibition

$

7,339

$

66,663

$

54,866

$

196,885

Real estate

3,023

5,531

9,928

16,525

Inter-segment elimination

(171)

(1,808)

(1,953)

(5,524)

$

10,191

$

70,386

$

62,841

$

207,886

Segment operating income (loss):

Cinema exhibition

$

(13,410)

$

5,951

$

(33,318)

$

17,715

Real estate

(844)

1,485

(1,464)

3,987

$

(14,254)

$

7,436

$

(34,782)

$

21,702

A reconciliation of segment operating income to income before income taxes is as follows:

Quarter Ended

Nine Months Ended

September 30,

September 30,

(Dollars in thousands)

2020

2019

2020

2019

Segment operating income (loss)

$

(14,254)

$

7,436

$

(34,782)

$

21,702

Unallocated corporate expense

Depreciation and amortization expense

(215)

(103)

(634)

(288)

General and administrative expense

(2,906)

(4,493)

(11,194)

(14,205)

Interest expense, net

(2,379)

(1,871)

(6,176)

(5,924)

Equity earnings of unconsolidated joint ventures

(97)

220

(292)

581

Gain (loss) on sale of assets

(1)

(1)

(1)

(1)

Other income (expense)

10

141

(186)

190

Income (loss) before income tax expense

$

(19,842)

$

1,329

$

(53,265)

$

2,055

 

Note 2 – Summary of Significant Accounting Policies

Basis of Consolidation

The accompanying consolidated financial statements include the accounts of our Company’s wholly-owned subsidiaries as well as majority-owned subsidiaries that our Company controls, and should be read in conjunction with our Company’s Annual Report on Form 10-K as of and for the year ended December 31, 2019 (“2019 Form 10-K”). All significant intercompany balances and transactions have been eliminated on consolidation. These consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim reporting with the instructions for Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”). As such, they do not include

 

7


all information and footnotes required by U.S. GAAP for complete financial statements. We believe that we have included all normal and recurring adjustments necessary for a fair presentation of the results for the interim period.

Operating results for the quarter and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires Management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and footnotes thereto. Significant estimates include (i) projections we make regarding the recoverability and impairment of our assets (including goodwill and intangibles), (ii) valuations of our derivative instruments, (iii) recoverability of our deferred tax assets, (iv) estimation of breakage and redemption experience rates, which drive how we recognize breakage on our gift card and gift certificates, and revenue from our customer loyalty program, (v) allocation of insurance proceeds to various recoverable components, and (vi) estimation of our Incremental Borrowing Rate (“IBR”) as relates to the valuation of our right-of-use assets and lease liabilities. Actual results may differ from those estimates.

Recently Adopted and Issued Accounting Pronouncements

Adopted:

1)On April 8, 2020, the FASB released FASB Staff Q&A Topic 842 and Topic 840: Accounting for Lease Concessions Related to the Effects of the COVID-19 Pandemic. This provides optional relief when accounting for modifications to leases obtained as a result of COVID-19 which otherwise would have required full modification assessment under ASC 842. Where we have obtained rent concessions from our landlords, or provided concessions to our tenants, we have elected not to perform the standard Topic 842 modification evaluation where the concession does not result in the total consideration required by the contract being substantially less than the total consideration originally required by the contract. Under the guidance, where we have received or provided deferrals of rent, we have recorded the deferrals as receivables or payables, and where we have received or provided abatements, we have recorded these as variable rents in the consolidated statements of income.

2)In the second quarter of 2020, in order to account for certain wage subsidies received from the Australian and New Zealand governments, we adopted International Accounting Standard 20 - Accounting for Government Grants and Disclosure of Government Assistance (“IAS 20”). The aim of these Australian and New Zealand government subsidies is to protect as many jobs as possible during the COVID-19 Pandemic by subsidizing the wages of employees, using the administrative capabilities of employers to forward such subsidies to their employees. The subsidies are not loans to employees or employers. U.S. GAAP has no codified accounting guidance concerning the measurement and presentation of such government grants, and in lieu of such guidance, common practice is to refer to IAS 20. IAS 20 permits entities to account for government grants on a gross basis, showing grants receivable as income and the associated expense as costs, or on a net basis, by deducting the grant from the related expense. The nature of the wage subsidies is such that, without them, our Company would likely have reduced its wages and salaries expense through the termination of certain employees. In order to faithfully present the transaction, our Company has therefore elected to present wages and salaries expense net of government grants. The impacted wages and salaries costs are contained within ‘other operating expenses’ and ‘general and administrative expenses’ in our cinema and real estate segments. As of September 30, 2020, we have received subsidies totaling AU$8.9 million and NZ$1.9 million. There are no unfulfilled conditions or contingencies relating to these subsidies as at September 30, 2020.

3)On January 1, 2020, we adopted ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This new guidance removes the second step of the two-step impairment test for measuring goodwill and is to be applied on a prospective basis only. Adoption of this standard has no material effect on our consolidated financial statements.

4)On January 1, 2020, we adopted ASU 2016-13, Financial Instruments – Credit Losses (Topic 326). This new guidance replaces the incurred loss impairment methodology under prior GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. We have no history of significant bad debt losses and as such adoption of this standard has no material effect on our consolidated financial statements.

5)On January 1, 2019, we adopted ASU 2016-02 Leases (Topic 842) using the current period adjustment method. We recognized the cumulative effect of initially applying the new leasing standard as an adjustment to the opening balance of retained earnings. The comparative information was not restated. Adoption of this standard has no material effect on our opening equity balances, and on a net basis has had no material effect on our consolidated financial statements.

 

8


Issued:

ASUs Effective 2020 and Beyond

 

1)In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. ASC 2020-04 is effective as of March 12, 2020 through December 31, 2022. Our Company is currently evaluating the effect the new standard will have on its consolidated financial statements.

Prior period financial statement correction of immaterial errors

Sales Tax

During the fourth quarter of 2019, we identified immaterial errors related to the accounting for sales tax on certain products sold from cinemas dating back to 2017. These errors resulted in an overstatement of revenue for certain periods.

We assessed the materiality of these errors on our financial statements for prior periods in accordance with the SEC Staff Accounting Bulletin (“SAB”) No. 99, Materiality, codified in ASC 250, Presentation of Financial Statements, and concluded that they were not material to any prior annual or interim periods. However, the aggregate amount of $993,000 related to the prior period immaterial errors through September 30, 2019, would have been material to the full year Consolidated Statement of Operations to December 31, 2019, presented within the December 31, 2019, Form 10-K. Consequently, in accordance with ASC 250 (specifically SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements), we have corrected these errors for all prior periods presented by revising the consolidated financial statements and other financial information included herein.

The following is a summary of the previously issued financial statement line items for all periods and statements included in this Form 10-Q report affected by the correction.

Consolidated Statements of Operations:

Quarter Ended September 30, 2019

Nine Months Ended September 30, 2019

(Dollars in thousands)

As Reported

Adjustment

As Revised

As Reported

Adjustment

As Revised

Cinema revenue

$

66,733

(70)

66,663

$

197,101

(216)

196,885

Total revenue

70,456

(70)

70,386

208,102

(216)

207,886

Operating income (loss)

2,910

(70)

2,840

7,425

(216)

7,209

Income (loss) before income taxes

1,399

(70)

1,329

2,271

(216)

2,055

Income tax (expense) benefit

(547)

19

(528)

(1,159)

58

(1,101)

Net income (loss)

852

(51)

801

1,112

(158)

954

Net income (loss) attributable to Reading International, Inc. common shareholders

902

(51)

851

1,215

(158)

1,057

Basic earnings (loss) per share

$

0.04

0.04

$

0.05

0.05

Diluted earnings (loss) per share

0.04

0.04

0.05

0.05

Consolidated Balance Sheets:

Summary of Equity

(Dollars in thousands)

As Reported

Adjustment

As Revised

Equity at January 1, 2019

$

180,547

$

(568)

$

179,979

Net income (loss) attributable to Reading International, Inc. common shareholders

1,112

(158)

954

Equity at September 30, 2019

163,714

(726)

162,988


 

9


Consolidated Statements of Cash Flows:

Nine Months Ended September 30, 2019

(Dollars in thousands)

As Reported

Adjustment

As Revised

Net income (loss)

$

1,112

$

(158)

$

954

Change in net deferred tax assets

272

(58)

214

Accounts payable and accrued expenses

(3,166)

216

(2,950)

Net cash provided by operating activities

10,797

10,797

 

 

10


Note 3 – Impact of COVID-19 Pandemic and Liquidity

On March 11, 2020, the World Health Organization (“WHO”) declared the novel coronavirus, COVID-19, a global pandemic. Following the date of this declaration, a number of jurisdictions imposed various restrictions on “non-essential” activities. In the jurisdictions in which we operate, these restrictions typically included closure of all business deemed “non-essential” (including movie-theaters and most other indoor forms of entertainment), and that all “non-essential” workers, and all members of the public, remain in their homes. As a result, beginning in March 2020 and continuing through and beyond the end of the first quarter of 2020, we temporarily closed all of our live theatres and cinema operations in the U.S., Australia and New Zealand. Operating restrictions adopted in Australia and New Zealand also affected, and to varying degrees continue to affect, many of our tenants at our retail shopping centers. While most of these tenants have, to date, remained open for trading, we have in many cases agreed to rent abatements or deferrals.

In the second and third quarters of 2020, several jurisdictions began relaxing COVID-19 restrictions, but principally due to pressure on their economies, rather than material containment of COVID-19. Conversely, certain jurisdictions are to varying degrees reinstating their lockdowns due to the resurgence of COVID-19. Even where businesses have been allowed to reopen, operational limitations on density, hours of operation, and other operating factors, and public concern about interacting with third parties, have prevented a return to normal operations. These periodic closures and limitations on operating activities are expected to continue until the COVID-19 spread is considered materially contained. There is no reliable estimate as to when this will be.

Cinema Segment Impact

As of the date of this Report, we had reopened all of the cinemas in our New Zealand circuit except for our Reading Cinemas at Courtenay Central (which continues to be closed due to seismic concerns), with social distancing measures in place. Government imposed social distancing requirements were discontinued in New Zealand on June 8, 2020. In June and July, 2020, we reopened all of our Australia circuit with social distancing measures in place, but as the state of Victoria went from partial lockdown to full lockdown on July 8, 2020, six of our locations were required to close as of this date, with the seventh location subsequently required to close as of August 5, 2020. This situation in Australia is still in place, although there are indications that the lockdown in Victoria is easing. As of the date of this Report, 13 of our U.S. cinemas have reopened with social distancing measures in place and 11 U.S. cinemas remain temporarily closed. No reopening dates have been determined for these remaining cinemas.

COVID-19 has and continues to adversely impact our business not only as a result of government mandated closures, but also by reducing our seating capacities, increasing our costs of operation due to the need for the implementation of enhanced cleaning protocols, deterring potential customers from sharing entertainment spaces with third parties, and deterring film distributors from releasing their films to exhibitors. Even if legally permitted to reopen, our decisions to reopen particular theaters, and whether to have those theaters remain open, will be impacted by a variety of considerations including movie availability, customer demand, and safety considerations relative to our staff and customers.

Real Estate Segment Impact

Most of the rentable retail portions of our Courtenay Central location continue to be closed since January 2019 due to seismic concerns. All of our tenants in our New Zealand real estate business are currently open for trading. Substantially all of our tenants in our Australian real estate business are currently open for trading. We have, to varying degrees, supported certain tenants with rent abatements and deferrals, and may continue to do so until we believe that such tenants are in a position to fully perform their obligations despite COVID-19 impacts. In the U.S., the majority of our real estate income is generated by rental revenue from our live theatres which, as of the date of this Report, are closed to the public due to COVID-19.

Liquidity Impact

The repercussions of COVID-19 resulted in a significant decrease in our Company’s revenues and earnings in the first nine months of 2020. The closure of our global cinemas resulted in effectively no revenue in the second quarter of 2020. And, with respect to the third quarter of 2020, our Company has continued to experience significantly reduced Company revenues and as a result, operating losses due to (i) the continuing closure of certain cinemas due to government mandates as a result of COVID-19, (ii) the major studios postponing or removing their tentpole movies from the global 2020 release calendar as a direct result of COVID-19, (iii) increased operating costs due to COVID-19 safety protocols, and (iv) reduced attendance due to potential audience hesitance to engage socially with third parties and/or a lack of compelling movies scheduled at reopened theaters. These third quarter losses were partially offset by revenues related to our 9 New Zealand cinemas that were open (without social distancing restrictions), our 16 Australian cinemas that were open (with social distancing restrictions), which did not include those in Australia’s State of Victoria, and the 13 out of 24 U.S. cinemas that were open (with social distancing restrictions). As a result of the conditions described in (ii), (iii) and (iv) above, even in markets where we have been permitted to reopen, we have, in many cases, not been able to operate profitably at the theater level.

 

11


With regards to our real estate operations, while all of our New Zealand and Australian real estate tenants are currently trading (other than certain tenants who have closed for reasons unrelated to COVID-19), our real estate revenue and earnings may continue to be affected by any rent relief that we may deem necessary to provide to certain tenants experiencing impacts from COVID-19.

As of September 30, 2020, our Company had negative working capital of $74.8 million. In response to the issues associated with COVID-19, our Company has taken, and continues to take, significant proactive steps to preserve cash by:

(i)Completing arrangements with substantially all of our third-party landlords, which arrangements have resulted in both abatements and deferrals of our occupancy costs;

(ii)As the impacts of COVID-19 extend longer than anticipated, the Company is negotiating with such third-party landlords to further extend into the 2021 period and beyond such abatement and/or deferrals of occupancy costs and related repayment terms;

(iii)Terminating most hourly cinema employees in the U.S.;

(iv)Reducing the hours of certain other employees;

(v)Implementing a hiring freeze across our home offices in Culver City, New York City, Melbourne (Australia) and Wellington (New Zealand);

(vi)Eliminating non-essential operating costs;

(vii)Deferring, to the extent practicable, certain operating expenses, such as utility costs; and

(viii)Deferring, to the extent practicable, all non-essential capital expenditures.

Our Company secured access to government wage subsidy programs in Australia and New Zealand. The Australian wage subsidy program expires on December 31, 2020, after which a further application can be made for the first quarter of 2021. No assurances can be given that we will qualify for this scheme in the first quarter of 2021, or if our application will be successful. The New Zealand program expired on August 25, 2020. Our Company continues to review various programs offered by governmental agencies in the jurisdictions where it operates as those programs are further defined or revised, but there can be no assurances that our Company will qualify for any such programs or, even if it does qualify, the degree that it may be successful in its applications for such support.

In addition, during the third quarter of 2020, Management lodged an application to carry back certain operating losses under the recently enacted CARES Act. The CARES Act permits net operating losses generated from tax years 2018 through 2020 to be carried back five years. During the third quarter of 2020, the Company filed its 2019 federal income tax return and carried back the net operating losses generated in 2019 to offset taxable income from tax years 2015 and 2016. The CARES Act also permits corporate taxpayers to claim in full any previously unrefunded alternative minimum tax credit in the 2019 tax year. This claim was made with our Company’s 2019 federal income tax return. The carryback of the 2019 net operating loss and the refund claim for 100% of the remaining alternative minimum tax credit will result in a tax refund of approximately $5.1 million receivable at September 30, 2020.

To address the impacts of COVID-19 on our liquidity, we have renegotiated certain financial covenant modifications with our applicable lenders. These modifications permit us to classify the relevant debt instruments as long term and are further discussed below in Note 11 – Debt. As of March 31, 2020, Management had drawn down in full the operating debt facilities available to our Company. As of September 30, 2020, all of our Company’s facilities remain fully drawn with the exception of the Bank of America Credit Facility which has $5.8 million of capacity available, as detailed in Note 11 – Debt. Our Company’s use of these funds is in some ways limited due to limitations on the repatriation of funds from Australia and New Zealand to the United States and limitations on our use of the proceeds from our $55.0 million Bank of America Credit Facility for purposes unrelated to our U.S. cinema activities.

Management continues to explore and pursue additional sources of liquidity and means of preserving existing liquidity, including but not limited to,

Completing the refinancing of certain loans before the conclusion of 2020, to provide additional cash and extend maturity dates;

Raising of additional debt finance using certain unencumbered real estate assets;

Deferring capital expenditures;

Potential sale of certain non-core real estate assets, or sale of interests in such assets;

Further negotiations with landlords regarding rent abatements and payment deferrals;

The use of creative exhibition structures (such as auditorium rentals, private screenings for movies or gaming experiences) to bring people back to our auditoriums; and

Pursuit of additional benefits under various state and government COVID-19 relief legislation.

 

12


Management continues to evaluate the assertion required by ASC 205-40 Going Concern as it relates to our Company, including its operations in its various individual operating jurisdictions: U.S., Australia and New Zealand. Management’s evaluation is informed by current liquidity positions, cash flow estimates, known capital and other expenditure requirements and commitments and Management’s current business plan and strategies. Our Company’s business plan - two businesses (real estate and cinema) in three countries (Australia, New Zealand and the U.S.) - has served us well since the onset of COVID-19 and is key to Management’s overall evaluation of ASC 205-40 Going Concern.

Based on Management’s evaluation of ASC 205-40 Going Concern and the current conditions and events, considered in the aggregate, and Management’s various plans for enhancing its liquidity, Management has concluded that it is probable that our Company will be able to continue as a going concern for at least twelve months following the issuance of our financial statements.

Management’s forecasts and cash flow estimates are based on the current expectation that the global cinema industry will begin to recover in 2021, but this forecast relies upon, among other things, the elimination of governmental restrictions on the reopening of cinemas, the resumption of release of tentpole movies, and confidence of moviegoers in the safety protocols established by the global cinema industry. These named factors are both out of Management’s control and are material, individually and in the aggregate, to the realization of Management’s forecasts and expectations throughout the period of COVID-19. Management recognizes that in times of domestic or global economic turmoil, including COVID-19, our estimates and judgments with respect to these cash flow estimates are subject to greater uncertainty than in more stable periods. The forecasts are inherently uncertain and have required us to make estimates and judgements regarding the extent to which COVID-19 will continue to affect the cinema industry.

Management reviewed its significant cinema and real estate operations in Australia and New Zealand, two geographies that have experienced relatively more success in controlling COVID-19 than the U.S. As of September 30, 2020, substantially all of our cinema operations and real estate operations had resumed in Australia and New Zealand. However, the cash flow of our Australian and New Zealand cinemas has been diminished by the temporary determinations by the major studios to delay the global release of tentpole movies because key cinema markets in the U.S. (i.e. New York City and Los Angeles) remain closed. Our Australian real estate’s revenue generation abilities are less affected by COVID-19, and aside from the issuance of rental abatements and deferrals to certain tenants, our portfolio continues to generate near-to-expected cash flows. In addition, we hold in New Zealand unencumbered high value assets that, if required to, could be leveraged or sold to meet our expected obligations as they fall due.

In order to alleviate doubt that the Company will be able to generate sufficient cash flows within the twelve month period after the issuance of these financial statements to meet its obligations as they become due, Management has in place various specific plans to meet such obligations. Firstly, construction having been completed (except for punch list items) and a temporary certificate having been issued, Management is implementing our business plan to refinance the construction loan on our 44 Union Square building in New York City (the “Union Square Refinancing Plan”) to free up cash for other purposes. The Union Square Refinancing Plan has been a key part of the three-year real estate business strategy presented to our Board of Directors annually since 2018.  In August 2020, Management engaged and instructed an experienced New York based mortgage broker to source and complete such takeout financing. Although no assurances can be given, based on current facts and circumstances, including, without limitation, recent appraisals and consultation with our mortgage broker, Management is confident that this takeout financing will be completed before the end of the first quarter 2021, on satisfactory terms.

As a backup to the Union Square Financing Plan, Management’s contingency plans include discussions with the current construction lender for 44 Union Square, to exercise its second one-year option on the existing construction loan. Taking into account that we are experiencing domestic and global times of uncertainty due to COVID-19, Management will, additionally, if necessary, rely on backup plans to borrow against or sell certain unencumbered real estate assets. Based on (i) recent appraisals, (ii) expressions of interest received from unsolicited potential purchasers and (iii) our understanding of the potential time frames to complete potential financing or sale transactions, Management believes that, in the aggregate, these contingency plans further alleviate the uncertainty about our ability to meet our obligations as they come due, for at least twelve months from the date these financial statements are issued.

In conclusion, as of the date of issuance of these financial statements, based on Management’s evaluation of ASC 205-40 Going Concern and the current conditions and events, considered in the aggregate, and Management’s various plans for enhancing its liquidity, Management concludes that substantial doubt about our Company’s ability to continue as a going concern has been alleviated by Management’s plans.

Impairment Considerations

 

13


Our Company considers that the events and factors described above constitute impairment indicators under ASC 360 Property, Plant and Equipment. Our Company performed a quantitative recoverability test of the carrying values of all of its asset groups. Our Company estimated the undiscounted future cash flows expected to result from the use of these asset groups and determined that there was no impairment as of September 30, 2020. The cash flow estimates used in this review are consistent with budgetary revisions performed by Management in response to COVID-19 and the developing market conditions. The realization of these forecasts is dependent on a number of variables and conditions, many of which are subject to the uncertainties associated with COVID-19 and as a result, actual results may materially differ from Management’s estimates.

Our Company also considers that the events and factors described above constitute impairment indicators under ASC 350 Intangibles – Goodwill and Other. Our Company performed a quantitative goodwill impairment test and determined that its goodwill was not impaired as of September 30, 2020. The test was performed at a reporting unit level by comparing each reporting unit’s carrying value, including goodwill, to its fair value. The fair value of each reporting unit was assessed using a discounted cash flow model based on the budgetary revisions performed by Management in response to COVID-19 and the developing market conditions. The realization of these forecasts is dependent on a number of variables and conditions, many of which are subject to the uncertainties associated with COVID-19 and as a result, actual results may materially differ from Management’s estimates.

 

Note 4 – Operations in Foreign Currency

We have significant assets in Australia and New Zealand. Historically, we have conducted our Australian and New Zealand operations (collectively “foreign operations”) on a self-funding basis, where we use cash flows generated by our foreign operations to pay for the expenses of those foreign operations. Our Australian and New Zealand assets and liabilities are translated from their functional currencies of Australian dollar (“AU$”) and New Zealand dollar (“NZ$”), respectively, to the U.S. dollar based on the exchange rate as of September 30, 2020. The carrying value of the assets and liabilities of our foreign operations fluctuates as a result of changes in the exchange rates between the functional currencies of the foreign operations and the U.S. dollar. The translation adjustments are accumulated in the Accumulated Other Comprehensive Income in the Consolidated Balance Sheets.

Due to the natural-hedge nature of our funding policy, we have not historically used derivative financial instruments to hedge against the risk of foreign currency exposure. However, in certain circumstances, we move funds between jurisdictions where circumstances encouraged us to do so from an overall economic standpoint. When economies return to normal, post-COVID, and our banking arrangements allow, in light of recent tax law changes, we intend to take a more global view of our financial resources, and to be more flexible in making use of resources from one jurisdiction in other jurisdictions.

Presented in the table below are the currency exchange rates for Australia and New Zealand:

Foreign Currency / USD

As of and
for the
quarter
ended

As of and

for the

nine months ended

As of and
for the
twelve months
ended

As of and
for the
quarter
ended

As of and

for the

nine months ended

September 30, 2020

December 31, 2019

September 30, 2019

Spot Rate

Australian Dollar

0.7160

0.7030

0.6746

New Zealand Dollar

0.6608

0.6745

0.6262

Average Rate

Australian Dollar

0.7156

0.6770

0.6954

0.6856

0.6993

New Zealand Dollar

0.6619

0.6384

0.6593

0.6486

0.6643

 

Note 5 – Earnings Per Share

Basic earnings per share (“EPS”) is calculated by dividing the net income attributable to our Company’s common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS is calculated by dividing the net income attributable to our Company’s common stockholders by the weighted average number of common and common equivalent shares outstanding during the period and is calculated using the treasury stock method for equity-based compensation awards.

 

14


The following table sets forth the computation of basic and diluted EPS and a reconciliation of the weighted average number of common and common equivalent shares outstanding:

Quarter Ended

Nine Months Ended

September 30,

September 30,

(Dollars in thousands, except share data)

2020

2019

2020

2019

Numerator:

Net income (loss) attributable to RDI common stockholders

$

(19,228)

$

851

$

(47,806)

$

1,057

Denominator:

Weighted average number of common stock – basic

21,748,531

22,546,827

21,749,146

22,791,530

Weighted average dilutive impact of awards

350,226

141,403

350,226

161,308

Weighted average number of common stock – diluted

22,098,757

22,688,230

22,099,372

22,952,838

Basic earnings (loss) per share attributable to RDI common stockholders

$

(0.88)

$

0.04

$

(2.20)

$

0.05

Diluted earnings (loss) per share attributable to RDI common stockholders

$

(0.88)

$

0.04

$

(2.20)

$

0.05

Awards excluded from diluted earnings (loss) per share

674,676

516,010

674,676

516,010

Our weighted average number of common stock - basic decreased, primarily as a result of the repurchase of shares of Class A Non-Voting Common Stock pursuant to our current stock repurchase program offset by the vesting of restricted stock units. During the first nine months of 2020, we repurchased 75,157 shares of Class A Non-Voting Common Stock at an average price of $8.92 per share. All purchases occurred in the first quarter of 2020.

Certain shares issuable under stock options and restricted stock units were excluded from the computation of diluted net income (loss) per share in periods when their effect was anti-dilutive; either because our Company incurred a net loss for the period, or the exercise price of the options was greater than the average market price of the common stock during the period, or the effect was anti-dilutive as a result of applying the treasury stock method.

 

Note 6 – Property and Equipment

Operating Property, net

As of September 30, 2020, and December 31, 2019, property associated with our operating activities is summarized as follows:

September 30,

December 31,

(Dollars in thousands)

2020

2019

Land

$

76,435

$

75,663

Building and improvements

240,380

149,852

Leasehold improvements

57,649

56,912

Fixtures and equipment

189,235

186,949

Construction-in-progress

10,381

5,484

Total cost

574,080

474,860

Less: accumulated depreciation

(233,913)

(216,722)

Operating property, net

$

340,167

$

258,138

Depreciation expense for operating property was $5.4 million and $15.6 million for the quarter and nine months ended September 30, 2020 respectively and $5.5 million and $16.3 million for the quarter and nine months ended September 30, 2019.

Investment and Development Property, net

As of September 30, 2020, and December 31, 2019, our investment and development property is summarized below:

September 30,

December 31,

(Dollars in thousands)

2020

2019

Land

$

23,827

$

24,446

Building

1,900

Construction-in-progress (including capitalized interest)

6,012

87,678

Investment and development property

$

29,839

$

114,024

 

15


Construction-in-Progress – Operating and Investing Properties

Construction-in-Progress balances are included in both our operating and development properties. The balances of our major projects along with the movements for the nine months ended September 30, 2020 are shown below:

(Dollars in thousands)

Balance,

December 31,

2019

Additions during the period(1)

Completed
during the
period

Foreign
currency
translation

Balance,

September 30,

2020

Union Square development

$

81,934

$

6,201

$

(88,135)

$

$

Courtenay Central development

6,364

419

(110)

6,673

Cinema developments and improvements

3,032

5,723

(1,415)

94

7,434

Other real estate projects

1,832

1,306

(879)

27

2,286

Total

$

93,162

$

13,649

$

(90,429)

$

11

$

16,393

(1)Includes capitalized interest of $0.7 million and $2.4 million for the quarter and nine months ended September 30, 2020

Real Estate Transactions

Exercise of Option to Acquire Ground Lessee’s interest in Ground Lease and Improvements Constituting the Village East Cinema – On August 28, 2019, we exercised our option to acquire the ground lessee’s interest in the ground lease underlying and the real property assets constituting our Village East Cinema in Manhattan. The purchase price under the option is $5.9 million. It is anticipated that the transaction will close on or about May 31, 2021.

 

Note 7 – Investments in Unconsolidated Joint Ventures

Our investments in unconsolidated joint ventures are accounted for under the equity method of accounting.

The table below summarizes our active investment holdings in two (2) unconsolidated joint ventures as of September 30, 2020 and December 31, 2019:

September 30,

December 31,

(Dollars in thousands)

Interest

2020

2019

Rialto Cinemas

50.0%

$

1,043

$

1,175

Mt. Gravatt

33.3%

3,764

3,894

Total investments

$

4,807

$

5,069

For the quarter and nine months ended September 30, 2020 and 2019, the recognized share of equity earnings from our investments in unconsolidated joint ventures are as follows:

Quarter Ended

Nine Months Ended

September 30,

September 30,

(Dollars in thousands)

2020

2019

2020

2019

Rialto Cinemas

$

(24)

$

64

$

(132)

$

78

Mt. Gravatt

(73)

156

(160)

503

Total equity earnings

$

(97)

$

220

$

(292)

$

581

 

Note 8 – Goodwill and Intangible Assets

The table below summarizes goodwill by business segment as of September 30, 2020 and December 31, 2019.

(Dollars in thousands)

Cinema

Real Estate

Total

Balance at December 31, 2019

$

21,224

$

5,224

$

26,448

Change in goodwill due to a purchase of a business combination

120

120

Foreign currency translation adjustment

31

31

Balance at September 30, 2020

$

21,375

$

5,224

$

26,599

Our Company is required to test goodwill and other intangible assets for impairment on an annual basis and, if current events or circumstances require, on an interim basis. Our Company has performed an interim goodwill assessment as described in Note 3 – Impact of COVID-19 Pandemic and Liquidity. Our next annual evaluation of goodwill and other intangible assets is scheduled during the fourth quarter of 2020. To test the impairment of goodwill, our Company compares the fair value of each reporting unit to its carrying amount, including the goodwill, to determine if there is potential goodwill impairment. A reporting unit is generally one level

 

16


below the operating segment. As of September 30, 2020, we were not aware that any events indicating potential impairment of goodwill had occurred outside of those described at Note 3 – Impact of COVID-19 Pandemic and Liquidity.

The tables below summarize intangible assets other than goodwill, as of September 30, 2020 and December 31, 2019, respectively.

As of September 30, 2020

(Dollars in thousands)

Beneficial
Leases

Trade
Name

Other
Intangible
Assets

Total

Gross carrying amount

$

12,309

$

9,062

$

4,752

$

26,123

Less: Accumulated amortization

(10,237)

(7,301)

(4,241)

(21,779)

Net intangible assets other than goodwill

$

2,072

$

1,761

$

511

$

4,344

As of December 31, 2019

(Dollars in thousands)

Beneficial
Leases

Trade
Name

Other
Intangible
Assets

Total

Gross carrying amount

$

15,048

$

7,258

$

3,145

$

25,451

Less: Accumulated amortization

(14,496)

(5,449)

(1,186)

(21,131)

Net intangible assets other than goodwill

$

552

$

1,809

$

1,959

$

4,320

Beneficial leases obtained in business combinations where we are the landlord are amortized over the life of the relevant leases. Trade names are amortized based on the accelerated amortization method over their estimated useful life of 30 years, and other intangible assets are amortized over their estimated useful lives of up to 30 years (except for transferrable liquor licenses, which are indefinite-lived assets). The table below summarizes the amortization expense of intangible assets for the quarter and nine months ended September 30, 2020.

Quarter Ended

Nine Months Ended

September 30,

September 30,

(Dollars in thousands)

2020

2019

2020

2019

Beneficial lease amortization

$

27

$

60

$

77

$

224

Other amortization

279

106

483

311

Total intangible assets amortization

$

306

$

166

$

560

$

535

 

Note 9 – Prepaid and Other Assets

Prepaid and other assets are summarized as follows:

September 30,

December 31,

(Dollars in thousands)

2020

2019

Prepaid and other current assets

Prepaid expenses

$

1,692

$

2,163

Prepaid rent

95

1,093

Prepaid taxes

2,599

912

Income taxes receivable

5,391

1,669

Deposits

245

214

Investment in marketable securities

22

47

Restricted cash

8

7

Total prepaid and other current assets

$

10,052

$

6,105

Other non-current assets

Straight-line rent

5,245

4,689

Other non-cinema and non-rental real estate assets

1,134

1,134

Investment in Reading International Trust I

838

838

Long-term deposits

9

7

Total other non-current assets

$

7,226

$

6,668

 

Note 10 – Income Taxes

The U.S. Coronavirus Aid, Relief, and Economic Security Act (“The CARES Act”) was enacted on March 27, 2020 to provide, among other things, tax relief to companies impacted by the COVID-19 pandemic. The CARES Act includes, among other items, provisions for net operating loss carryback, modifications to the business interest expense deduction, a technical correction to tax

 

17


depreciation methods for qualified improvement property, and alternative minimum tax credit refunds. During the quarter ended March 31, 2020, we recorded a tax benefit arising from the carryback of the net operating loss generated in the taxable year ended December 31, 2019.

The interim provision for income taxes is different from the amount determined by applying the U.S. federal statutory rate to consolidated income or loss before taxes.  The differences are attributable to foreign tax rate differential, unrecognized tax benefits, and foreign tax credit. Our effective tax rate was 9.5% and 53.6% for the nine months ended September 30, 2020 and 2019, respectively.  The change between 2020 and 2019 is primarily related to tax benefits from the carryback of our Company’s 2019 net operating loss, as the result of The CARES Act, to 2015 and 2016 tax years where the federal tax rate was 35%, offset by increase in valuation allowance in 2020.  The forecasted effective tax rate is updated each quarter as new information becomes available.

Note 11 – Debt

Our Company’s borrowings at September 30, 2020 and December 31, 2019, net of deferred financing costs and including the impact of interest rate derivatives on effective interest rates, are summarized below:

As of September 30, 2020

(Dollars in thousands)

Maturity Date

Contractual
Facility

Balance,
Gross

Balance,
Net(1)

Stated
Interest Rate

Effective
Interest
Rate

Denominated in USD

Trust Preferred Securities (USA)

April 30, 2027

$

27,913 

$

27,913 

$

26,451

4.27%

4.27%

Bank of America Credit Facility (USA)

March 6, 2023

55,000 

49,200

48,965

3.15%

3.15%

Bank of America Line of Credit (USA)

March 6, 2023

5,000 

5,000 

5,000 

4.00%

4.00%

Cinemas 1, 2, 3 Term Loan (USA)

April 1, 2022

24,768

24,768

24,387

4.25%

4.25%

Minetta & Orpheum Theatres Loan (USA)(2)

November 1, 2023

8,000 

8,000 

7,908

2.21%

5.15%

U.S. Corporate Office Term Loan (USA)

January 1, 2027

9,246

9,246

9,151

4.64% / 4.44%

4.61%

Purchase Money Promissory Note (USA)

September 18, 2024

2,883

2,883

2,883

5.00%

5.00%

Union Square Construction Financing (USA)

December 29, 2020

50,000 

40,064

40,009

5.50%

5.50%

Denominated in foreign currency ("FC") (3)

NAB Corporate Term Loan (AU)

December 31, 2023

85,920

85,920

85,722

1.89%

1.89%

Westpac Bank Corporate (NZ)

December 31, 2023

21,146

21,146

21,147

2.95%

2.95%

$

289,876

$

274,140

$

271,623

(1)Net of deferred financing costs amounting to $2.5 million.

(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.

(3)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of September 30, 2020.

As of December 31, 2019

(Dollars in thousands)

Maturity Date

Contractual
Facility

Balance,
Gross

Balance,

Net(1)

Stated
Interest
Rate

Effective

Interest

Rate

Denominated in USD

Trust Preferred Securities (USA)

April 30, 2027

$

27,913 

$

27,913 

$

26,311

5.94%

5.94%

Bank of America Credit Facility (USA)

March 6, 2023

55,000 

33,500

33,445

4.80%

4.80%

Bank of America Line of Credit (USA)

March 6, 2023

5,000 

4.80%

4.80%

Cinemas 1, 2, 3 Term Loan (USA)

April 1, 2022

18,658

18,658

18,532

3.25%

3.25%

Minetta & Orpheum Theatres Loan (USA)(2)

November 1, 2023

8,000

8,000

7,887

3.74%

5.15%

U.S. Corporate Office Term Loan (USA)

January 1, 2027

9,260

9,260

9,153

4.64% / 4.44%

4.64%

Union Square Construction Financing (USA)

December 29, 2020

50,000

36,048

36,035

6.02%

6.02%

Purchase Money Promissory Note (USA)

September 18, 2024

3,363

3,363

3,363

5.00%

5.00%

Denominated in foreign currency ("FC") (3)

NAB Corporate Term Loan (AU)

December 31, 2023

84,360

65,731

65,541

1.77%

1.77%

Westpac Bank Corporate (NZ)

December 31, 2023

21,584

6,745

6,745

3.05%

3.05%

Total

$

283,138

$

209,218

$

207,012

(1)Net of deferred financing costs amounting to $2.2 million.

(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.

(3)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2019.

 

18


Our loan arrangements are presented, net of the deferred financing costs, on the face of our consolidated balance sheet as follows:

September 30,

December 31,

Balance Sheet Caption

2020

2019

Debt - current portion

$

40,890

$

36,736

Debt - long-term portion

201,399

140,602

Subordinated debt - current portion

644

644

Subordinated debt - long-term portion

28,690

29,030

Total borrowings

$

271,623

$

207,012

Impact of COVID-19

To address the impact of COVID-19 on our business, we sought and obtained certain modifications to our loan agreements with the Bank of America, National Australia Bank, and Westpac. These loan modifications included changes to some of the covenant compliance terms and waivers of certain covenant testing periods. We are currently in compliance with our loan covenants as so modified. To date it has not been necessary for us to seek modifications or waivers with respect to our other loan agreements, as we continue to be in compliance with the terms of such loan agreements without the need for any such modifications or waivers.

Bank of America Credit Facility

On March 6, 2020, we amended our $55.0 million credit facility with Bank of America extending the maturity date to March 6, 2023. The refinanced facility carries an interest rate of 2.5% - 3.0%, depending on certain financial ratios plus a variable rate based on the loan defined “Eurodollar” interest rate.

On August 7, 2020, we modified certain financial covenants within this credit facility and temporarily suspended the testing of certain other covenant tests through the measurement period ending September 30, 2021. The testing of the financial covenant resumes for the measurement period ending December 31, 2021. In addition to the covenant modifications, the interest rate on borrowings under this facility was fixed at 3.0% above the “Eurodollar” rate, which itself now has a floor of 1.0%. Such a modification was not considered to be substantial under U.S. GAAP.

Bank of America Line of Credit

On March 6, 2020, the term of our $5.0 million line of credit was extended to March 6, 2023. On August 7, 2020 we modified the interest rate on this line of credit, wherein the LIBOR portion of the rate now has a floor of 1.0%.

Minetta and Orpheum Theatres Loan

On October 12, 2018, we refinanced our $7.5 million loan with Santander Bank, which is secured by our Minetta and Orpheum Theatres, with a loan for a five year term of $8.0 million. Such modification was not considered to be substantial under U.S. GAAP.

44 Union Square Construction Financing

On December 29, 2016, we closed our construction finance facilities totaling $57.5 million to fund the non-equity portion of the anticipated construction costs of the redevelopment of our property at 44 Union Square in New York City. The combined facilities consisted of $50.0 million in aggregate loans (comprised of three loan tranches) from BankOZK (formerly the Bank of the Ozarks), and a $7.5 million mezzanine loan from Tammany Mezz Investor, LLC, an affiliate of Fisher Brothers. On August 8, 2019, we repaid in full the $7.5 million mezzanine loan. On January 24, 2020, we exercised one of our two extension options of the BankOZK extending the maturity to December 29, 2020.

U.S. Corporate Office Term Loan

On December 13, 2016, we obtained a ten year $8.4 million mortgage loan on our new Culver City Corporate Headquarters at a fixed annual interest rate of 4.64%. This loan provided for a second loan upon completion of certain improvements. On June 26, 2017, we obtained a further $1.5 million under this provision at a fixed annual interest rate of 4.44%.

Cinemas 1,2,3 Term Loan

On March 13, 2020, Sutton Hill Properties LLC (“SHP”), a 75% subsidiary of RDI, refinanced its $20.0 million term loan with Valley National Bank with a new term loan of $25.0 million, an interest rate of 4.25%, and maturity date of April 1, 2022 with two six month options to extend.

 

19


Purchase Money Promissory Note

On September 18, 2019, we purchased for $5.5 million 407,000 Company Class A shares in a privately negotiated transaction under our Share Repurchase Program. Of this amount, $3.5 million was paid by the issuance of a Purchase Money Promissory Note, which bears an interest rate of 5.0% per annum, payable in equal quarterly payments of principal plus accrued interest. The Purchase Money Promissory Note matures on September 18, 2024.

Westpac Bank Corporate Credit Facility (NZ)

On December 20, 2018, we restructured our Westpac Corporate Credit Facilities. The maturity of the 1st tranche (general/non-construction credit line) was extended to December 31, 2023, with the available facility being reduced from NZ$35.0 million to NZ$32.0 million. The facility bears an interest rate of 1.75% above the Bank Bill Bid Rate on the drawn down balance and a 1.1% line of credit charge on the entire facility. The 2nd tranche (construction line) with a facility of NZ$18.0 million was removed.

On June 29, 2020, Westpac pushed out the June 30, 2020 covenant testing date to July 31, 2020. On July 27, 2020, Westpac waived the requirement to test certain covenants as of July 31, 2020. This agreement also increased the interest rate and line of credit charge to 2.40% above the Bank Bill Bid Rate and 1.65% respectively. The maturity date was extended to January 1, 2024. Such modifications of this facility were not considered to be substantial under U.S. GAAP. At the request of Westpac, we have deposited $10.6 million (NZ$16.0 million) in a term deposit with Westpac, as we have no current operating need for such funds in New Zealand. On September 15, 2020, Westpac waived the requirement to test certain covenants as of September 30, 2020.

Australian NAB Corporate Term Loan (AU)

On March 15, 2019, we amended our Revolving Corporate Markets Loan Facility with National Australia Bank (“NAB”) from a facility comprised of (i) a AU$66.5 million loan facility with an interest rate of 0.95% above the Bank Bill Swap Bid Rate (“BBSY”) and a maturity date of June 30, 2019 and (ii) a bank guarantee of AU$5.0 million at a rate of 1.90% per annum into a (i) AU$120.0 million Corporate Loan facility at rates of 0.85%-1.30% above BBSY depending on certain ratios with a due date of December 31, 2023, of which AU$80.0 million is revolving and AU$40.0 million is core and (ii) a Bank Guarantee Facility of AU$5.0 million at a rate of 1.85% per annum. Such modifications of this particular term loan were not considered to be substantial under U.S. GAAP.

On August 6, 2020, we modified certain covenants within this Revolving Corporate Markets Loan Facility. These modifications apply until the quarter ended June 30, 2021. In addition, for the period in which these covenant modifications apply, the interest rate on amounts borrowed under the facility is 1.75%. Such a modification was not considered to be substantial under U.S. GAAP.

 

Note 12 – Other Liabilities

Other liabilities are summarized as follows:

September 30,

December 31,

(Dollars in thousands)

2020

2019

Current liabilities

Lease liability

$

5,900

$

Liability for demolition costs

2,689

2,745

Accrued pension

684

684

Security deposit payable

114

114

Finance lease liabilities

50

93

Other

33

17

Other current liabilities

$

9,470

$

3,653

Other liabilities

Lease make-good provision

6,932

6,667

Accrued pension

4,155

4,469

Deferred rent liability

3,720

Environmental reserve

1,656

1,656

Lease liability

5,900

Acquired leases

31

37

Finance lease liabilities

80

116

Other

9

9

Other liabilities

$

16,583

$

18,854

 

20


Pension Liability – Supplemental Executive Retirement Plan

On August 29, 2014, the Supplemental Executive Retirement Plan (“SERP”) that has been effective since March 1, 2007, was ended and replaced in accordance with the terms of a pension annuity. As a result of the termination of the SERP program, the accrued pension liability of $7.6 million was reversed and replaced with this pension annuity liability of $7.5 million. The valuation of the liability is based on the present value of $10.2 million discounted at a rate of 4.25% over a 15-year term, resulting in a monthly payment of $57,000. The discounted value of $2.7 million (which is the difference between the estimated payout of $10.2 million and the present value of $7.5 million) as of August 29, 2014 will be amortized and expensed based on the 15-year term. In addition, the accumulated actuarial loss of $3.1 million recorded, as part of other comprehensive income will also be amortized based on the 15-year term.

In February 2018, we made a payment of $2.4 million relating to the annuity representing payments for the 42 months outstanding at the time. Monthly ongoing payments of $57,000 are now being made.

As a result of the above, included in our current and non-current liabilities are accrued pension costs of $4.8 million at September 30, 2020. The benefits of our pension plan are fully vested and therefore no service costs were recognized for the quarter and nine months ended September 30, 2020 and 2019. Our pension plan is unfunded.

During the quarter and nine months ended September 30, 2020, the interest cost was $65,000 and $199,000, respectively, and the actuarial loss was $52,000 and $155,000, respectively. During the quarter and nine months ended September 30, 2019, the interest cost was $70,000 and $414,000, respectively, and the actuarial loss was $52,000 and $155,000, respectively.

 

Note 13 – Accumulated Other Comprehensive Income

The following table summarizes the changes in each component of accumulated other comprehensive income attributable to RDI:

(Dollars in thousands)

Foreign
Currency
Items

Unrealized
Gain (Losses)
on Available-
for-Sale
Investments

Accrued
Pension
Service Costs

Hedge
Accounting
Reserve

Total

Balance at January 1, 2020

$

8,118

$

10

$

(2,287)

$

(252)

$

5,589

Change related to derivatives

Total change in hedge fair value recorded in Other Comprehensive Income

(282)

(282)

Amounts reclassified from accumulated other comprehensive income

140

140

Net change related to derivatives

(142)

(142)

Net current-period other comprehensive income (loss)

(1,574)

(24)

155

(142)

(1,585)

Balance at September 30, 2020

$

6,544

$

(14)

$

(2,132)

$

(394)

$

4,004

Note 14 – Commitments and Contingencies

Litigation General

We are currently involved in certain legal proceedings and, as required, have accrued estimates of probable and estimable losses for the resolution of these claims, including legal costs.

Where we are a plaintiff, we accrue legal fees as incurred on an on-going basis and make no provision for any potential settlement amounts until received. In Australia, the prevailing party is usually entitled to recover its attorneys’ fees, which recoveries typically work out to be approximately 60% of the amounts actually spent where first-class legal counsel is engaged at customary rates. Where we are a plaintiff, we have likewise made no provision for the liability for the defendant’s attorneys' fees in the event we are determined not to be the prevailing party.

Where we are a defendant, we accrue for probable damages that insurance may not cover as they become known and can be reasonably estimated, as permitted under ASC 450-20 Loss Contingencies. In our opinion, any claims and litigation in which we are currently involved are not reasonably likely to have a material adverse effect on our business, results of operations,

 

21


financial position, or liquidity. It is possible, however, that future results of the operations for any particular quarterly or annual period could be materially affected by the ultimate outcome of the legal proceedings. From time-to-time, we are involved with claims and lawsuits arising in the ordinary course of our business that may include contractual obligations, insurance claims, tax claims, employment matters, and anti-trust issues, among other matters.

All of these matters require significant judgments based on the facts known to us. These judgments are inherently uncertain and can change significantly when additional facts become known. We provide accruals for matters that have probable likelihood of occurrence and can be properly estimated as to their expected negative outcome. We do not record expected gains until the proceeds are received by us. However, we typically make no accruals for potential costs of defense, as such amounts are inherently uncertain and dependent upon the scope, extent and aggressiveness of the activities of the applicable plaintiff.

Environmental and Asbestos Claims on Reading Legacy Operations

Certain of our subsidiaries were historically involved in railroad operations, coal mining, and manufacturing. Also, certain of these subsidiaries appear in the chain-of-title of properties that may suffer from pollution. Accordingly, certain of these subsidiaries have, from time-to-time, been named in and may in the future be named in various actions brought under applicable environmental laws. Also, we are in the real estate development business and may encounter from time-to-time unanticipated environmental conditions at properties that we have acquired for development. These environmental conditions can increase the cost of such projects and adversely affect the value and potential for profit of such projects. We do not currently believe that our exposure under applicable environmental laws is material in amount.

From time to time, there are claims brought against us relating to the exposure of former employees of our railroad operations to asbestos and coal dust. These are generally covered by an insurance settlement reached in September 1990 with our insurance providers. However, this insurance settlement does not cover litigation by people who were not our employees and who may claim second-hand exposure to asbestos, coal dust and/or other chemicals or elements now recognized as potentially causing cancer in humans. Our known exposure to these types of claims, asserted or probable of being asserted, is not material.

Cotter Jr. Derivative Litigation

This action was originally brought by James J. Cotter, Jr. (“Cotter Jr.”) in June 2015 in the Nevada District Court against all of the Directors of the Company and against the Company as a nominal defendant: James J. Cotter, Jr., individually and derivatively on behalf of Reading International, Inc. vs. Margaret Cotter, et al.” Case No: A-15-719860-V. Summary judgment was entered against Cotter, Jr., and in favor of all defendants and a $1.55 million cost judgment was entered against Cotter, Jr., and in favor of our Company. Cotter, Jr. appealed both judgements. On October 1, 2020, the Nevada Supreme Court ordered the Trial Court to dismiss that lawsuit, concluding that Mr. Cotter, Jr. was not an adequate representative of our Company’s stockholders. In arriving at this conclusion, the Nevada Supreme Court noted, among other things, that “because one of the main remedies Cotter Jr. is seeking is his reinstatement as CEO, his interests are divergent from the shareholders’ interests” and that “Cotter Jr.’s action appears to be vindictively sought in response to his termination as CEO. . .” Mr. Cotter, Jr.’s request for a rehearing was also denied by the Nevada Supreme Court. Our Company is now pursuing collection of the approximately $800,000 in costs from Mr. Cotter, Jr. approved by the Nevada Supreme Court, which amount is covered by a bond posted by Mr. Cotter, Jr., in connection with his appeal.

Employment Litigation

Our Company is currently involved in two California employment matters which include substantially overlapping wage and hour claims: Taylor Brown, individually, and on behalf of other members of the general public similarly situated vs. Reading Cinemas et al. Superior Court of the State of California for the County of Kern, Case No. BCV-19-1000390 (“Brown v. RC,” and the “Brown Class Action Complaint” respectively) and Peter M. Wagner, Jr., an individual, vs. Consolidated Entertainment, Inc. et al., Superior Court of the State of California for the County of San Diego, Case NO. 37-2019-00030695-CU-WT-CTL (“Wagner v. CEI,” and the “Wagner Individual Complaint” respectively). Brown v. RC was initially filed in December 2018, as an individual action and refiled as a putative class action in February 2019, but not served until June 24, 2019. These lawsuits seek damages, and attorneys’ fees, relating to alleged violations of California labor laws relating to meal periods, rest periods, reporting time pay, unpaid wages, timely pay upon termination and wage statements violations. Wagner v. CEI was filed as a discrimination and retaliation lawsuit in June 2019. The following month, in July 2019, a notice was served on us by separate counsel for Mr. Wagner under the California Private Attorney General Act of 2004 (Cal. Labor Code Section 2698, et seq) (the “Wagner PAGA Claim”) purportedly asserting in a representational capacity claims under the PAGA statute, overlapping, in substantial part, the allegations set forth in the Brown Class Action Complaint. On March 6, 2020, Wagner filed a purported class action in the Superior Court of California, County of San Diego, again covering basically the same allegations as set forth in the Brown Class Action Complaint, and titled Peter M. Wagner, an individual, on behalf of himself and all others similarly situated vs. Reading International, Inc., Consolidated Entertainment, Inc. and Does 1 through 25, Case No. 37-2020-000127-CU-OE-CTL (the “Wagner Class Action”). Neither plaintiff has specified the amount of damages sought.

 

22


Our Company is investigating and intends to vigorously defend the allegations of the Brown Class Action Complaint, the Wagner Individual Complaint, the Wagner PAGA Claim and the Wagner Class Action Complaint. In addition, we have denied that a PAGA representative action is appropriate. These matters are in their early stages, and the putative class actions have not been certified. As these cases are in early stages, our Company is unable to predict the outcome of the litigation or the range of potential loss, if any; however, our Company believes that its potential liability with respect to such matters is not material to its overall financial position, results of operations and cash flows. Accordingly, our Company has not established a reserve for loss in connection with these matters.


 

23


Note 15 – Non-controlling Interests

These are composed of the following enterprises:

Australia Country Cinemas Pty Ltd. - 25% noncontrolling interest owned by Panorama Group International Pty Ltd.:

Shadow View Land and Farming, LLC - 50% noncontrolling membership interest owned by the estate of Mr. James J. Cotter, Sr. (the “Cotter Estate”); and,

Sutton Hill Properties, LLC - 25% noncontrolling interest owned by Sutton Hill Capital, LLC (which in turn is 50% owned by the Cotter Estate).

The components of noncontrolling interests are as follows:

September 30,

December 31,

(Dollars in thousands)

2020

2019

Australian Country Cinemas, Pty Ltd

$

32

$

119

Shadow View Land and Farming, LLC

2,127

2,145

Sutton Hill Properties, LLC

1,742

2,003

Noncontrolling interests in consolidated subsidiaries

$

3,901

$

4,267

The components of income attributable to noncontrolling interests are as follows:

Quarter Ended

Nine Months Ended

September 30,

September 30,

(Dollars in thousands)

2020

2019

2020

2019

Australian Country Cinemas, Pty Ltd

$

(35)

$

32

$

(80)

$

69

Shadow View Land and Farming, LLC

(5)

(43)

(48)

(77)

Sutton Hill Properties, LLC

(84)

(39)

(261)

(95)

Net income (loss) attributable to noncontrolling interests

$

(124)

$

(50)

$

(389)

$

(103)

 

24


Summary of Controlling and Noncontrolling Stockholders’ Equity

A summary of the changes in controlling and noncontrolling stockholders’ equity is as follows:

Common Shares

Retained

Accumulated 

Reading

Class A 

Class A

Class B

Class B 

Additional

Earnings

 Other 

International Inc. 

Total

Non-Voting

 Par 

Voting

Par

Paid-In

(Accumulated 

Treasury

Comprehensive 

Stockholders’ 

Noncontrolling 

Stockholders’

(Dollars in thousands, except shares)

Shares

Value

 Shares

 Value

 Capital

Deficit)

 Shares

Income (Loss)

Equity

Interests

 Equity

At January 1, 2020

20,103

$

231

1,680

$

17

$

148,602

$

20,647

$

(39,737)

$

5,589

$

135,349

$

4,267

$

139,616

Net income (loss)

(5,875)

(5,875)

(81)

(5,956)

Other comprehensive income, net

(15,879)

(15,879)

(18)

(15,897)

Share-based compensation expense

336

336

336

Share repurchase plan

(75)

(670)

(670)

(671)

In-kind exchange of share for the exercise of options, net issued

Restricted Stock Units

19

(30)

(30)

(30)

Contributions from noncontrolling stockholders

Distributions to noncontrolling stockholders

At March 31, 2020

20,047

$

231

1,680

$

17

$

148,908

$

14,772

$

(40,407)

$

(10,290)

$

113,231

$

4,168

$

117,399

Net income

(22,703)

(22,703)

(185)

(22,888)

Other comprehensive income, net

10,707

10,707

9

10,716

Share-based compensation expense

369

369

369

Share repurchase plan

0

0

0

Class A common stock issued for share-based bonuses and options exercised

In-kind exchange of share for the exercise of options, net issued

Restricted Stock Units

21

(11)

(11)

(11)

Contributions from noncontrolling stockholders

Distributions to noncontrolling stockholders

At June 30, 2020

20,068

231

1,680

17

149,266

(7,931)

(40,407)

417

101,593

3,992

105,585

Net income

(19,228)

(19,228)

(124)

(19,352)

Other comprehensive income, net

3,587

3,587

3

3,590

Share-based compensation expense

358

358

358

Share repurchase plan

(0)

(0)

(0)

Class A common stock issued for share-based bonuses and options exercised

In-kind exchange of share for the exercise of options, net issued

Restricted Stock Units

1

(4)

(4)

(4)

Contributions from noncontrolling stockholders

30

30

Distributions to noncontrolling stockholders

At September 30, 2020

20,069

$

231

1,680

$

17

$

149,620

$

(27,159)

$

(40,407)

$

4,004

$

86,306

$

3,901

$

90,207


 

25


Common Shares

Retained

Accumulated 

Reading

Class A 

Class A

Class B

Class B 

Additional

Earnings

 Other 

International Inc. 

Total

Non-Voting

 Par 

Voting

Par

Paid-In

(Accumulated 

Treasury

Comprehensive 

Stockholders’ 

Noncontrolling 

Stockholders’

(Dollars in thousands, except shares)

Shares

Value

 Shares

 Value

 Capital

Deficit)

 Shares

Income (Loss)

Equity

Interests

 Equity

At January 1, 2019

21,195

$

232

1,680

$

17

$

147,452

$

47,048

$

(25,222)

$

6,115

$

175,642

$

4,337

$

179,979

Net income (loss)

(2,124)

(2,124)

(16)

(2,140)

Adjustments to opening retained earnings on adoption of ASC 842

28

28

(46)

(18)

Other comprehensive income, net

1,510

1,510

1

1,511

Share-based compensation expense

280

280

280

Share repurchase plan

(9)

(9)

(9)

Class A common stock issued for share-based bonuses and options exercised

(185)

(185)

(185)

Restricted Stock Units

40

1

(75)

(74)

(74)

Contributions from noncontrolling stockholders

18

18

Distributions to noncontrolling stockholders

(27)

(27)

At March 31, 2019

21,235

$

233

1,680

$

17

$

147,472

$

44,952

$

(25,231)

$

7,625

$

175,068

$

4,267

$

179,335

Net income

2,331

2,331

(37)

2,294

Other comprehensive income, net

(2,346)

(2,346)

(1)

(2,347)

Share-based compensation expense

400

400

400

Share repurchase plan

(197)

(2,622)

(2,622)

(2,622)

Class A common stock issued for share-based bonuses and options exercised

In-kind exchange of share for the exercise of options, net issued

Restricted Stock Units

33

(31)

(31)

(31)

Contributions from noncontrolling stockholders

9

9

Distributions to noncontrolling stockholders

(15)

(15)

At June 30, 2019

21,071

233

1,680

17

147,841

47,283

(27,853)

5,279

172,800

4,223

177,023

Net income

851

851

(50)

801

Adjustments to opening retained earnings on adoption of ASC 842

(6,567)

(6,567)

(2)

(6,569)

Other comprehensive income, net

417

417

417

Share-based compensation expense

(660)

(8,690)

(8,690)

(8,690)

Share repurchase plan

Class A common stock issued for share-based bonuses and options exercised

In-kind exchange of share for the exercise of options, net issued

(6)

(22)

(22)

(22)

Restricted Stock Units

(2)

2

Contributions from noncontrolling stockholders

28

28

Distributions to noncontrolling stockholders

At September 30, 2019

20,405

$

231

1,680

$

17

$

148,236

$

48,134

$

(36,541)

$

(1,288)

$

158,789

$

4,199

$

162,988


 

26


Note 16 – Stock-Based Compensation and Stock Repurchases

Employee and Director Stock Incentive Plan

Our 2010 Stock Incentive Plan under which our Company has granted stock options and other share-based payment awards of our Common Stock to eligible employees, directors, and consultants has expired. In total, 1,663,099 shares of Common Stock were issued or reserved for issuance pursuant to the previously granted options or restricted stock units under that plan.

Stock options were granted at exercise prices equal to the grant-date market prices and typically expire no later than five years from the grant date. In contrast to a stock option where the grantee buys our Company’s share at an exercise price determined on grant date, a restricted stock unit (“RSU”) entitles the grantee to receive one share for every RSU based on a vesting plan, typically between one and four years from grant. At the time the options are exercised or RSUs vest and are settled, at the discretion of management, we will issue treasury shares or make a new issuance of shares to the option or RSU holder.

Stock Options

We have estimated the grant-date fair value of our stock options using the Black-Scholes option-valuation model, which takes into account assumptions such as the dividend yield, the risk-free interest rate, the expected stock price volatility, and the expected life of the options. We expensed the estimated grant-date fair values of options over the vesting period on a straight-line basis. Based on our historical experience, the “deemed exercise” of expiring in-the-money options and the relative market price to strike price of the options, we have not estimated any forfeitures of vested or unvested options.

No stock options were issued in the nine months ended September 30, 2020. Stock options covering 219,408 shares were issued in the quarter and nine months ended September 30, 2019, all in the first quarter of 2019. The weighted average assumptions used in the option-valuation model were as follows:

Nine Months Ended

September 30,

2020

2019

Stock option exercise price

$

$

16.12

Risk-free interest rate

2.42%

Expected dividend yield

Expected option life in years

3.75

Expected volatility

23.32%

Weighted average fair value

$

$

3.50

For the quarters ended September 30, 2020 and 2019, we recorded compensation expense of $103,000 and $129,000, respectively with respect to our prior stock option grants. For the nine months ended September 30, 2020 and September 30, 2019, we recorded compensation expense of $343,000 and $329,000, respectively. At September 30, 2020, the total unrecognized estimated compensation expense related to non-vested stock options was $0.7 million, which we expect to recognize over a weighted average vesting period of 1.49 years. The intrinsic, unrealized value of all options outstanding vested and expected to vest, at September 30, 2020 was nil, as the closing price of our Common Stock on that date was $3.22.

The following table summarizes the number of options outstanding and exercisable as of September 30, 2020 and December 31, 2019:

Outstanding Stock Options - Class A Shares

Number
of Options

Weighted
Average
Exercise Price

Weighted
Average
Remaining
Years of
Contractual
Life

Aggregate
Intrinsic
Value

Class A

Class A

Class A

Class A

Balance - December 31, 2018

586,469

$

14.01

2.88

$

1,530,528

Granted

219,408

16.12

Exercised

(69,500)

13.42

185,175

Forfeited

(25,000)

13.42

Balance - December 31, 2019

711,377

$

14.74

2.79

$

136,350

Granted

Exercised

Forfeited

(36,701)

14.74

Balance - September 30, 2020

674,676

$

14.78

2.06

$

 

27


Restricted Stock Units

We estimate the grant-date fair values of our RSUs using our Company’s stock price at grant-date and record such fair values as compensation expense over the vesting period on a straight-line basis.  The following table summarizes the status of the RSUs granted to date as of September 30, 2020:

Outstanding Restricted Stock Units

RSU Grants (in units)

Vested,

Unvested,

Forfeited,

Grant Date

Directors

Management

Total
Grants

September 30,

2020

September 30,

2020

September 30,

2020

March 10, 2016

35,147

27,381

62,528

62,262

266

April 11, 2016

5,625

5,625

5,108

517

March 23, 2017

30,681

32,463

63,144

54,196

8,416

532

August 29, 2017

7,394

7,394

7,394

January 2, 2018

29,393

29,393

29,393

April 12, 2018

29,596

29,596

14,553

13,873

1,170

April 13, 2018

14,669

14,669

7,336

7,333

July 6, 2018

932

932

932

November 7, 2018

23,010

23,010

23,010

March 13, 2019

24,366

24,366

5,316

15,946

3,104

March 14, 2019

23,327

23,327

5,832

17,495

May 7, 2019

11,565

11,565

11,565

March 10, 2020

287,163

287,163

287,163

Total

129,796

452,916

582,712

225,965

350,226

6,521

RSU awards to Management vest 25% on the anniversary of the grant date over a period of four years. Beginning this year, a performance component has been added to certain of the RSUs granted to Management. On March 10, 2020, RSUs covering 287,163 shares were issued to members of executive Management and other employees of our Company.

Prior to November 7, 2018, RSU awards to non-employee directors vested 100% in January of the following year in which such RSUs were granted.  At the November 7, 2018 Board meeting, it was determined that it would be more appropriate for the vesting of RSUs to align with the director’s term of office. Accordingly, the RSUs granted on November 7, 2018, vested on the first to occur of (i) 5:00 pm, Los Angeles, CA time on the last business day prior to the one year anniversary of the grant date, or (ii) the date on which the recipient’s term as a director ended and the recipient or, as the case may be, the recipient’s successor was elected to the board of directors. Accordingly, the RSUs granted to directors on November 7, 2018 vested on May 7, 2019 annual meeting of stockholders. Due to the fact that our Company moved up our annual meeting of stockholders from November to May in 2019, the vesting period for the RSUs issued on November 7, 2018 was shorter than anticipated. In order to adjust for this factor, the award of RSUs to directors made immediately following the 2019 Annual Meeting of Stockholders was determined using a value of $35,000 or one half of the dollar amount of the prior year's annual grant. The RSUs issued to non-employee directors on May 7, 2019 vested on May 6, 2020. No RSUs have been issued to non-employee directors since May 7, 2019.

For the quarter ended September 30, 2020 and 2019, we recorded compensation expense of $237,000 and $288,000, respectively. For the nine months ended September 30, 2020 and 2019, we recorded compensation expense of $708,000 and $768,000, respectively. The total unrecognized compensation expense related to the non-vested RSUs was $2.3 million as of September 30, 2020, which we expect to recognize over a weighted average vesting period of 1.93 years.

Stock Repurchase Program

On March 2, 2017, our Company's Board of Directors authorized Management, at its discretion, to spend up to an aggregate of $25.0 million to acquire shares of Reading’s Class A Non-Voting Common Stock.  On March 14, 2019, the Board of Directors extended this stock buy-back program for two years, through March 2, 2021. On March 10, 2020, the Board increased the authorized amount by $25.0 million and extended it to March 2, 2022. At the present time, the amount available under the repurchase program authorization is $26.0 million.

The repurchase program allows Reading to repurchase its shares in accordance with the requirements of the SEC on the open market, in block trades and in privately negotiated transactions, depending on market conditions and other factors.  All purchases are subject to the availability of shares at prices that are acceptable to Reading, and accordingly, no assurances can be given as to the timing or number of shares that may ultimately be acquired pursuant to this authorization.

 

28


Under the stock repurchase program, as of September 30, 2020, our Company had reacquired a total of 1,792,819 shares of Class A Non-Voting Common Stock for $24.0 million at an average price of $13.39 per share (excluding transaction costs). 75,157 shares of Class A Non-Voting Common Stock were purchased during the quarter ended March 31, 2020 at an average price of $8.92 per share. No shares of Class A Non-Voting Common Stock were purchased during the quarters ended June 30, 2020 and September 30, 2020. This leaves $26.0 million available under the March 2, 2017 program, as extended, to March 2, 2022. The last share repurchase made by our Company was made on March 5, 2020, at which time 25,000 shares were purchased at an average cost per share of $7.30.

 

Note 17 - Leases

In all leases, whether we are the lessor or lessee, we define lease term as the non-cancellable term of the lease plus any renewals covered by renewal options that are reasonably certain of exercise based on our assessment of economic factors relevant to the lessee. The non-cancellable term of the lease commences on the date the lessor makes the underlying property in the lease available to the lessee, irrespective of when lease payments begin under the contract.

As Lessee

We have operating leases for certain cinemas and corporate offices, and finance leases for certain equipment assets. Our leases have remaining lease terms of 1 to 20 years, with certain leases having options to extend to up to a further 20 years.

Contracts are analyzed in accordance with the criteria set out in ASC 842 to determine if there is a lease present. For contracts that contain an operating lease, we account for the lease component and the non-lease component together as a single component. For contracts that contain a finance lease we account for the lease component and the non-lease component separately in accordance with ASC 842.

In leases where we are the lessee, we recognize a right of use asset and lease liability at lease commencement, which is measured by discounting lease payments using an incremental borrowing rate applicable to the relevant country and lease term of the lease as the discount rate. Subsequent amortization of the right of use asset and accretion of the lease liability for an operating lease is recognized as a single lease cost, on a straight-line basis, over the term of the lease. A finance lease right-of-use asset is depreciated on a straight-line basis over the lesser of the useful life of the leased asset or the lease term. Interest on each finance lease liability is determined as the amount that results in a constant periodic discount rate on the remaining balance of the liability. Property taxes and other non-lease costs are accounted for on an accrual basis.

Lease payments for our cinema operating leases consist of fixed base rent, and for certain leases, variable lease payments consisting of contracted percentages of revenue, changes in the relevant CPI, and/or other contracted financial metrics.

As a result of the impacts of COVID-19, we have obtained certain concessions from our landlords. We have elected to account for these concessions as if there have been no changes to the underlying contracts, thereby recognizing abatements secured as variable lease expenses, and increasing payables for lease payment deferrals.

The components of lease expense are as follows:

Quarter Ended

Nine Months Ended

September 30,

September 30,

(Dollars in thousands)

2020

2019

2020

2019

Lease cost

Finance lease cost:

Amortization of right-of-use assets

$

15

$

40

$

79

$

121

Interest on lease liabilities

2

3

6

10

Operating lease cost

8,136

7,773

24,447

23,339

Variable lease cost

(1,747)

320

(2,428)

1,174

Total lease cost

$

6,406

$

8,136

$

22,105

$

24,644

 

29


Supplemental cash flow information related to leases is as follows:

Nine Months Ended

September 30,

(Dollars in thousands)

2020

2019

Cash flows relating to lease cost

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows for finance leases

$

86

$

128

Operating cash flows for operating leases

10,190

22,988

Right-of-use assets obtained in exchange for new finance lease liabilities

Right-of-use assets obtained in exchange for new operating lease liabilities

179

5,760

Supplemental balance sheet information related to leases is as follows:

September 30,

December 31,

(Dollars in thousands)

2020

2019

Operating leases

Operating lease right-of-use assets

$

213,177

$

229,879

Operating lease liabilities - current portion

21,411

20,379

Operating lease liabilities - non-current portion

206,415

223,164

Total operating lease liabilities

$

227,826

$

243,543

Finance leases

Property plant and equipment, gross

371

370

Accumulated depreciation

(246)

(165)

Property plant and equipment, net

$

125

$

205

Other current liabilities

50

93

Other long-term liabilities

80

116

Total finance lease liabilities

$

130

$

209

Other information

Weighted-average remaining lease term - finance leases

3

3

Weighted-average remaining lease term - operating leases

11

11

Weighted-average discount rate - finance leases

5.26%

5.13%

Weighted-average discount rate - operating leases

4.78%

4.86%

The maturities of our leases were as follows:

(Dollars in thousands)

Operating
leases

Finance
leases

2020

$

7,945

$

15

2021

31,963

53

2022

31,961

43

2023

31,210

28

2024

29,368

Thereafter

162,035

Total lease payments

$

294,482

$

139

Less imputed interest

(66,656)

(9)

Total

$

227,826

$

130

As of September 30, 2020, we have additional operating leases, primarily for cinemas, that have not yet commenced operations of approximately $36.0 million. It is anticipated that these operating leases will commence between fiscal year 2020 and fiscal year 2021 with lease terms of 15 to 20 years.

 

30


As Lessor

We have entered into various leases as a lessor for our owned real estate properties. These leases vary in length between 1 and 20 years, with certain leases containing options to extend at the behest of the applicable tenants. Lease components consist of fixed base rent, and for certain leases, variable lease payments consisting of contracted percentages of revenue, changes in the relevant CPI, and/or other contracted financial metrics. None of our leases grant any right to the tenant to purchase the underlying asset.

We recognize lease payments for operating leases as property revenue on a straight-line basis over the lease term. Lease incentive payments we make to lessees are amortized as a reduction in property revenue over the lease term.

As a result of the impacts of COVID-19, we have provided certain concessions to specific tenants. We have elected to account for these concessions as if there have been no changes to the underlying contracts, thereby recognizing abatements granted as variable lease payments through revenue and increasing receivables for lease payment deferrals.

Lease income relating to operating lease payments was as follows:

Quarter Ended

Nine Months Ended

September 30,

September 30,

(Dollars in thousands)

2020

2019

2020

2019

Components of lease income

Lease payments

$

2,400

$

2,246

$

6,972

$

6,819

Variable lease payments

97

302

(114)

898

Total lease income

$

2,497

$

2,548

$

6,858

$

7,717

The book value of underlying assets under operating leases from owned assets was as follows:

September 30,

December 31,

(Dollars in thousands)

2020

2019

Building and improvements

Gross balance

$

68,630

$

67,766

Accumulated depreciation

(21,874)

(20,220)

Net Book Value

$

46,756

$

47,546

The Maturity of our leases were as follows:

 

(Dollars in thousands)

Operating
leases

2020

$

2,097

2021

8,202

2022

7,366

2023

6,563

2024

5,610

Thereafter

8,283

Total

$

38,121

Note 18 – Hedge Accounting

As of September 30, 2020, and December 31, 2019, our Company held interest rate derivatives in the total notional amount of $8.0 million and $8.0 million, respectively.

 

31


The derivatives are recorded on the balance sheet at fair value and are included in the following line items:

Liability Derivatives

September 30,

December 31,

2020

2019

(Dollars in thousands)

Balance sheet location

Fair value

Balance sheet location

Fair value

Interest rate contracts

Derivative financial instruments - current portion

$

217

Derivative financial instruments - current portion

$

109

Derivative financial instruments - non-current portion

266

Derivative financial instruments - non-current portion

233

Total derivatives designated as hedging instruments

$

483

$

342

Total derivatives

$

483

$

342

We have no derivatives designated as hedging instruments which are in asset positions.

The changes in fair value are recorded in Other Comprehensive Income and released into interest expense in the same period(s) in which the hedged transactions affect earnings. In the quarter and nine months ended to September 30, 2020 and September 30, 2019, respectively, the derivative instruments affected Comprehensive Income as follows:

(Dollars in thousands)

Location of Loss Recognized in Income on Derivatives

Amount of Loss Recognized in Income on Derivatives

Quarter Ended September 30, 2020

Nine Months Ended September 30, 2020

2020

2019

2020

2019

Interest rate contracts

Interest expense

$

60

$

18

$

140

$

42

Total

$

60

$

18

$

140

$

42

Loss Recognized in OCI on Derivatives (Effective Portion)

(Dollars in thousands)

Amount

Amount

Quarter Ended September 30

Nine Months Ended September 30

2020

2019

2020

2019

Interest rate contracts

$

60

$

38

$

282

$

253

Total

$

60

$

38

$

282

$

253

Loss Reclassified from OCI into Income (Effective Portion)

Line Item

Amount

Amount

Quarter Ended September 30

Nine Months Ended September 30

2020

2019

2020

2019

Interest expense

$

60

$

18

$

141

$

42

Total

$

60

$

18

$

141

$

42

 The derivative has no ineffective portion, and consequently no losses have been recognized directly in income.

 

Note 19 – Fair Value Measurements

ASC 820, Fair Value Measurement establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The statement requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities;

Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and,

Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

As of September 30, 2020, and December 31, 2019 we had derivative financial liabilities carried and measured at fair value on a recurring basis of $483,000 and $342,000 respectively.

 

32


The following tables summarize our financial liabilities that are carried at cost and measured at fair value on a non-recurring basis as of September 30, 2020 and December 31, 2019, by level within the fair value hierarchy.

Fair Value Measurement at September 30, 2020

(Dollars in thousands)

Carrying
Value(1)

Level 1

Level 2

Level 3

Total

Notes payable

$

243,344

$

$

$

247,617

$

247,617

Subordinated debt

30,796

20,258

20,258

$

274,140

$

$

$

267,875

$

267,875

Fair Value Measurement at December 31, 2019

(Dollars in thousands)

Carrying
Value(1)

Level 1

Level 2

Level 3

Total

Notes payable

$

177,942

$

$

$

181,916

$

181,916

Subordinated debt

31,276

22,132

22,132

$

209,218

$

$

$

204,048

$

204,048

(1)These balances are presented before any deduction for deferred financing costs.

Following is a description of the valuation methodologies used to estimate the fair value of our financial assets and liabilities. There have been no changes in the methodologies used at September 30, 2020 and December 31, 2019.

Level 1 investments in marketable securities primarily consist of investments associated with the ownership of marketable securities in U.S. and New Zealand. These investments are valued based on observable market quotes on the last trading date of the reporting period.

Level 2 derivative financial instruments are valued based on discounted cash flow models that incorporate observable inputs such as interest rates and yield curves from the derivative counterparties. The credit valuation adjustments associated with our non-performance risk and counterparty credit risk are incorporated in the fair value estimates of our derivatives. As of September 30, 2020, and December 31, 2019, we concluded that the credit valuation adjustments were not significant to the overall valuation of our derivatives.

Level 3 borrowings include our secured and unsecured notes payable, trust preferred securities and other debt instruments. The borrowings are valued based on discounted cash flow models that incorporate appropriate market discount rates. We calculated the market discount rate by obtaining period-end treasury rates for fixed-rate debt, or LIBOR for variable-rate debt, for maturities that correspond to the maturities of our debt, adding appropriate credit spreads derived from information obtained from third-party financial institutions. These credit spreads take into account factors such as our credit rate, debt maturity, types of borrowings, and the loan-to-value ratios of the debt.

Our Company’s financial instruments also include cash, cash equivalents, receivables and accounts payable. The carrying values of these financial instruments approximate the fair values due to their short maturities. Additionally, there were no transfers of assets and liabilities between levels 1, 2, or 3 during the quarter and nine months ended September 30, 2020 and September 30, 2019.


 

33


Note 20 – Business Combinations

Devonport, Tasmania, Australia

On January 30, 2019, we purchased the tenant’s interest and other operating assets of an established four-screen cinema in Devonport, Tasmania, Australia, for $1.4 million. We commenced trading from this cinema site on January 30, 2019.

The total purchase price was allocated to the identifiable assets acquired based on our estimates of their fair values on the acquisition date. The identified assets included fixtures and equipment and immaterial working capital balances. There were immaterial liabilities assumed.

Our final purchase price allocation is as follows:

(Dollars in thousands)

Preliminary Purchase Price Allocation(1)

Measurement Period Adjustments(2)

Final Purchase Price Allocation(1)

Tangible Assets

Operating property:

Fixtures and equipment

$

153

$

$

153

Intangible Assets

Goodwill

1,248

(23)

1,225

Total assets acquired

1,401

(23)

1,378

Net assets acquired

$

1,401

$

(23)

$

1,378

(1)The balances were translated into U.S. Dollars based on the applicable exchange rate as of the date of acquisition, January 30, 2019.

(2)The measurement period adjustments relate to finalization of immaterial employee obligations.

State Cinema Hobart, Tasmania, Australia

On December 3, 2019, we purchased the tenant’s interest and other operating assets of an established ten-screen cinema in Hobart, Tasmania, Australia, for $6.2 million. We commenced trading from this cinema site on December 5, 2019.

 

34


Our Company finalized its purchase price allocation in the first quarter of 2020. The total purchase price was allocated to the identifiable assets acquired based on our estimates of their fair values on the acquisition date. The identified assets include fixtures and equipment, the State Cinema brand, inventory and immaterial working capital balances. The determination of the fair values of the acquired assets (and the related determination of their estimated lives where depreciation is permitted) requires significant judgment. There were immaterial liabilities assumed, including certain gift card obligations.

Our final purchase price allocation is as follows:

(Dollars in thousands)

Preliminary Purchase Price Allocation(1)

Measurement Period Adjustments

Final Purchase Price Allocation(1)

Tangible Assets

Operating property:

Fixtures and equipment

$

481

(119)

$

362

Deferred tax

5

5

Current assets:

Inventory

333

333

Intangible Assets

Brand name

250

250

Liquor license

1

1

Goodwill

5,617

(132)

5,485

Total assets acquired

6,436

6,436

Liabilities

Employee liabilities

(20)

(20)

Deferred revenue balances

(236)

(236)

Total liabilities acquired

(256)

(256)

Net assets acquired

$

6,180

$

6,180

 

(1)The balances were translated into U.S. Dollars based on the applicable exchange rate as of the date of acquisition, December 5, 2019.

Note 21 – Subsequent Events

As of the issue date, no material subsequent events were identified.


 

35


This MD&A should be read in conjunction with the accompanying unaudited consolidated financial statements included in Part I, Item 1 (Financial Statements). The foregoing discussions and analyses contain certain forward-looking statements. Please refer to the “Forward-Looking Statements” included at the conclusion of this section and our “Risk Factors” set forth in our 2019 Form 10-K, Part 1, Item 1A and the Risk Factors set out below.

Item 2 – Management’s Discussion and Analysis (“MD&A”) of Financial Condition and Results of Operations

Adapting to the Impact of COVID-19

In the third quarter of 2020, several international and domestic jurisdictions continue, to varying degrees, reinstate their lockdowns due to the re-emergence of COVID-19, while others removed or loosened restrictions. These differing approaches, and the local and global affects that these may have, create an uncertainty that is expected to continue until the COVID-19 spread is considered materially contained or there is an approved vaccine.

Re-Starting Operations

Our Company has reopened the majority of its cinema operations as follows:

i.In Australia, by July 1, 2020, the majority of our cinemas had reopened with governmentally imposed physical distancing requirements and a number of new safety protocols. Our seven cinemas in Victoria opened briefly but were closed by government order due to a spike in COVID-19 cases in that State. The Victorian government recently announced that cinemas would be able to reopen due to a decrease in COVID-19 cases. We expect to reopen our remaining cinemas on November 11, 2020, with social distancing restrictions in place.

ii.In New Zealand, as of August 30, 2020, all of our cinemas had reopened, with the exception of our Reading Cinemas at Courtenay Central (which is temporarily closed due to seismic concerns), with no physical distancing requirements. We have implemented a variety of new safety protocols at these cinemas.

iii.In the United States, as of the date of this Report, 13 of our 24 theaters have reopened with an elevated set of cleaning protocols and new operating strategies, including physical distancing through reduced seat counts. We expect to announce opening dates for our other cinemas in the U.S. once local government authorities remove restrictions and new and compelling movies are available.

Our real estate business has been less impacted by the impact of the COVID-19 pandemic than our cinema business. In Australia, our Entertainment-Themed Centers (“ETCs”) at Newmarket Village (Brisbane area, QLD), Cannon Park (Townsville, QLD), The Belmont Common (Perth area, WA), and Auburn Redyard (Sydney area, NSW) continue to be open for business through the third quarter of 2020. In the U.S., we began receiving rental revenue from our Culver City tenant in October 2020, and we also received some rental revenue related to our live theatre business in the third quarter of 2020. However, while our real estate assets comprise a significant portion of our asset value, they have historically been responsible for only approximately 9% of our revenues and 25% of our overall operating income.

Results Continue to be Impacted by COVID-19

In the third quarter of 2020, we continued to work with our landlords to extend rent abatements or deferrals. In most cases, we have been able to achieve abatements or deferrals from April to September of 2020, and in some cases, were able to negotiate further extensions, typically with no repayments until 2021, which will help preserve our Company’s liquidity. While no assurances can be given on future abatements or deferrals, with delays in movie releases and, consequently, theater reopenings, we will continue to negotiate additional occupancy relief. Our landlords understand that this is not a situation of our making and have generally been sympathetic to our situation. We believe that our relationships with our various landlords continue to be good.

As we have seen in the third quarter of 2020, the repercussions of the COVID-19 pandemic continue to drastically decrease our Company’s revenues and earnings. The lack of new product due to movie release schedule delays, the ongoing temporary closures of some of our cinemas, and our social distancing measures continued to materially adversely impact our third quarter 2020 cinema attendance. Naturally, during the period in which our cinemas remain closed and until new and compelling movies are available to draw customer back to cinemas, we will continue to experience a significant loss of revenue and negative operating income.

Our Company may continue to be significantly impacted by the COVID-19 pandemic even after all of our cinemas have reopened and film distributors resume distribution of new and compelling movies to theaters. The global economic impact of the COVID-19 pandemic has led to higher levels of unemployment in our operating jurisdictions and may lead to lower consumer spending in the near term. Physical distancing and increased cleaning protocols may also delay our ability to produce financial results at pre-COVID-19 pandemic levels.

 

36


Counter balancing to some extent the challenges posed by the COVID-19 pandemic on a moving-forward basis, is what we believe to be the ongoing desire of people to enjoy entertainment outside of their homes. While no assurance can be given, we believe that, as our society reopens, we will see cinemas once again return to their historic position as a principal source of outside-the-home entertainment, both in the U.S. and abroad.

BUSINESS OVERVIEW

We are an internationally diversified company principally focused on the development, ownership, and operation of entertainment and real estate assets in the United States, Australia, and New Zealand. Currently, we operate in two business segments:

Cinema exhibition, through our 60 cinemas.

Real estate, including real estate development and the rental of retail, commercial, and live theatre assets.

For the last several years, we have consistently stated our belief that these two business segments complement one another, as we have used the comparatively consistent cash flows generated by our cinema operations to fund the front-end cash demands of our real estate development business. Now, we are relying upon income from our real estate assets, and the imbedded value in those assets, to support our Company through the COVID-19 crisis. As we continue to navigate the uncertainty and challenges posed by the global COVID-19 pandemic, we are steadfast in our belief that this two-pronged, diversified international business strategy has supported the strength and long-term viability of our Company. We believe that our strong real estate base provides us with flexibility and asset strength not available to those of our competitors who only have cinema leasehold assets.

Key Performance Indicators

Two key performance indicators utilized by Management are EBITDA and food and beverage spend per patron (“SPP”). Due to the COVID-19 pandemic and the temporary closure of all of our cinema and live theatre operations in the U.S., Australia, and New Zealand for a substantial portion of the nine month period ended September 30, 2020, and due to the lower attendances resulting from social distancing requirements, the lack of new and compelling film product and the reticence of customers to participate in social gatherings with third parties, Management does not currently believe that a discussion of Reading’s key performance indicators will serve as a useful metric for stockholders. Management intends to resume providing a discussion of our key performance indicators in future filings.


 

37


Cinema Exhibition Overview

We operate our worldwide cinema exhibition businesses under various brands:

in the U.S., under the Reading Cinemas, Angelika Film Centers, Consolidated Theatres, and City Cinemas brands.

in Australia, under the Reading Cinemas, the State Cinema, and the unconsolidated joint venture Event Cinemas brands.

in New Zealand, under the Reading Cinemas and the unconsolidated joint ventures Rialto Cinemas brands.

Shown in the following table are the number of locations and screens in our theater circuit in each country, by state/territory/region, our cinema brands, and our interest in the underlying assets as of September 30, 2020.

State / Territory /

Location

Screen

Interest in Asset
Underlying the Cinema

Country

Region

Count

Count

Leased

Owned

Operating Brands

United States

Hawaii

9

98

9

Consolidated Theatres

California

7

88

7

Reading Cinemas, Angelika Film Center

New York

3

16

2

1

Angelika Film Center, City Cinemas

Texas

2

13

2

Angelika Film Center

New Jersey

1

12

1

Reading Cinemas

Virginia

1

8

1

Angelika Film Center

Washington, D.C.

1

3

1

Angelika Film Center

U.S. Total

24

238

23

1

Australia

Victoria

7

51

7

Reading Cinemas

New South Wales

6

44

4

2

Reading Cinemas

Queensland

5

50

2

3

Reading Cinemas, Event Cinemas(1)

Western Australia

2

16

1

1

Reading Cinemas

South Australia

2

15

2

Reading Cinemas

Tasmania

2

14

2

Reading Cinemas, State Cinema

Australia Total

24

190

18

6

New Zealand

Wellington

3

18

2

1

Reading Cinemas

Otago

3

15

2

1

Reading Cinemas, Rialto Cinemas(2)

Auckland

2

15

2

Reading Cinemas, Rialto Cinemas(2)

Canterbury

1

8

1

Reading Cinemas

Southland

1

5

1

Reading Cinemas

Bay of Plenty

1

5

1

Reading Cinemas

Hawke's Bay

1

4

1

Reading Cinemas

New Zealand Total

12

70

7

5

GRAND TOTAL

60

498

48

12

(1)Our Company has a 33.3% unincorporated joint venture interest in a 16-screen cinema located in Mt. Gravatt, Queensland managed by Event Cinemas.

(2)Our Company is a 50% joint venture partner in two New Zealand Rialto Cinemas, with a total of 13-screens. We are responsible for the booking of these cinemas and our joint venture partner, Event Cinemas, manages their day-to-day operations.

Real Estate Overview

We engage in the real estate business through the development and our ownership and rental or licensing to third parties of retail, commercial and live theatre assets. We own the fee interests in all of our live theatres and in 12 of our cinemas (as presented in the preceding table). Our real estate business creates long-term value for our stockholders through the continuous improvement and development of our investment and operating properties, including our ETCs.

Our real estate activities have historically consisted principally of:

the ownership of fee or long-term leasehold interests in properties used in our cinema exhibition activities or which were acquired for the development of cinemas or cinema-based real estate development projects;

the acquisition of fee interests in land for general real estate development;

the licensing to production companies of the use of our live theatres; and,

the redevelopment of our existing fee-owned cinema or live theatre sites to their highest and best use.

 

38


Cinema Exhibition

Our cinema revenue consists primarily of admissions, Food & Beverage (“F&B”), advertising, gift card purchases, theater rentals, and online convenience fee revenue generated by the sale of our cinema tickets through our websites and mobile apps. Cinema operating expense consists of the costs directly attributable to the operation of the cinemas, including film rent expense, operating costs, and occupancy costs. Cinema revenues and expenses fluctuate with the availability of quality first run films and the numbers of weeks such first run films stay in the market. For a breakdown of our current cinema assets that we own and/or manage, please see Part I, Item 1 – Our Business of our 2019 Form 10-K.

While our capital projects in recent years have been focused on growing our real estate segment, we have also maintained our focus on improving and enhancing our cinema exhibition portfolio, as discussed below:

Cinema Additions and Enhancements

The latest additions and enhancements to our cinema portfolio are as follows:

Acquisition of a well-established Cinema in Devonport, Tasmania, Australia: On January 30, 2019, we purchased the tenant’s interest and other operating assets of a well-established four-screen cinema in Devonport, Tasmania, Australia, for $1.4 million (AU$1.95 million). We commenced trading from this new cinema site on January 30, 2019.

Leased a Cinema space in Lower Hutt, adjacent to Wellington, New Zealand: To mitigate the ongoing temporary closure of Reading Cinemas at Courtenay Central, we opened a three-screen cinema that trades as The Hutt Pop Up by Reading Cinemas in late June 2019.

Acquisition of a Dynamic Arthouse Cinema in Hobart, Tasmania, Australia: On December 4, 2019, we acquired the leasehold interest and other operating assets of the iconic State Cinema for $6.2 million (AU$9.0 million). This leasehold interest features 10 screens, a roof top cinema and bar, a large café, and a bookstore.

Opened a new state-of-the-art six-screen Cinema in Melbourne, Australia: On December 5, 2019, we opened a six-screen Reading Cinemas in the Burwood Brickworks shopping center offering a TITAN LUXE with DOLBY ATMOS immersive sound, enhanced food and beverage offerings, and full recliner seating in all auditoriums.

U.S. Refurbishments: In 2019 and 2020, we continued to invest in the refurbishment and enhancements of our existing cinemas, as contemplated by our strategic plan. During this period, three locations had significant refurbishment work performed: (i) our Consolidated Theatre in Mililani was renovated “top-to-bottom”, (ii) we converted an auditorium at our Reading Cinemas in Rohnert Park, California, to TITAN XC, and (iii) our Consolidated Theatre at the Kahala Mall in Hawaii had work commence in late 2019 on a top-to-bottom renovation, however, this renovation work continues to be suspended due to the COVID-19 shutdown.

AU and NZ Refurbishments: In 2019 and 2020, we improved eight theaters. In Australia, we improved Chirnside Park, Dandenong, Harbour Town, Maitland, Rhodes, Waurn Ponds, and West Lakes. In New Zealand, we improved The Palms.


 

39


Cinema Pipeline

At the start of 2020, we continued with the renovation of our Consolidated Theatres at the Kahala Mall in Honolulu in the U.S. However, this renovation has been halted due to the governmental restrictions imposed due to the COVID pandemic. We do not have a definitive schedule for recommencing this renovation.

In Australia, we previously announced the construction of four new Reading Cinemas pursuant to Agreements to Lease: (i) Altona, VIC, (ii) Traralgon, VIC, (iii) Jindalee, QLD, and (iv) South City Square in Brisbane, QLD. We have an agreement with our Altona landlord in the State of Victoria to extend that cinema fit-out handover date. Based on our agreement, the potential opening date of that new cinema will likely be delayed until mid-2021. With respect to our Traralgon cinema in the State of Victoria, the landlord has been delayed in turning over the space for cinema fit-out and discussions about the tenancy and scheduling are ongoing. We do not anticipate that the cinema in Traralgon will open in 2020.

We also will be proceeding with the fit-out of a newly constructed Reading Cinemas in Jindalee (QLD), and expect that new cinema will open by the end of 2020.

We expect hand-over from the landlord of South City Square during 2021 with a 2022 opening.

Our focus with respect to new cinemas includes state-of-the-art projection and sound, luxury recliner seating, enhanced F&B (typically including alcohol service), and typically at least one major TITAN-type presentation screen. Our focus is on providing best-in-class services and amenities that will differentiate us from in-home and mobile viewing options. We believe that a night at the movies should be a special and premium experience and, indeed, that it must be able to compete with the variety of options being offered to consumers through other platforms.

We continue to focus on the rollout and enhancement of our proprietary online ticketing capabilities and social media interfaces. These are intended to enhance the convenience of our offerings and to promote guest affinity with the experience and product that we are offering. We will also be focusing on post-COVID-19 technology improvements to facilitate improved social distancing and contactless experiences. Further, expanding our online capabilities, in the third quarter of 2020, we launched the online ordering of a limited F&B menu for our Angelika brand in the U.S. and will expand to other brands during the fourth quarter.

Cinema Closures

As of the end of the first quarter of 2020, all of our cinemas in the United States, Australia, and New Zealand were temporarily closed in accordance with the directions and recommendations of the relevant local, state, and federal authorities relating to the COVID-19 pandemic. As the COVID-19 pandemic outbreak has been largely contained in most areas in Australia and New Zealand, and the restrictions have been reduced by local government authorities, we have begun reopening. As of July 1, 2020, we had reopened our Australian cinema circuit, however, as of August 5, 2020, due to a spike in new COVID-19 cases, we had shut down all seven of our theaters in the state of Victoria. We expect to reopen our cinemas in the State of Victoria in Australia on November 11, 2020. As of August 30, 2020, we had reopened our New Zealand circuit except for our Reading Cinemas at Courtenay Central, which continues to be closed due to seismic concerns. In the U.S., as of the date of this Report, we had reopened 13 of our 24 theaters. We expect to announce reopening dates for our other cinemas in the U.S. once local government restrictions permit the opening of movie theaters and new film product is available.

In January 2019, we temporarily closed our Courtenay Central cinema in Wellington, New Zealand. This temporary closure is related to seismic concerns and is currently ongoing. While we have continued, during the COVID-19 pandemic, to advance our planning for the center, and have continued conversations with consultants, potential tenants, and city representatives, given the uncertainty surrounding the COVID-19 pandemic, we have no fixed time frame for the commencement of the redevelopment of this property.

During the second quarter of 2019, our Company’s management agreement for the operation of the 86th Street Cinema in New York City terminated due to the expiration of the underlying lease. Additionally, during the third quarter of 2019, the leases underlying our historically profitable Paris Theatre and Beekman Theatre in New York City both expired. We were unable to obtain extensions or new leases for these cinemas on commercially reasonable terms.

 

In December 2019, we temporarily closed our Consolidated Theatres at the Kahala Mall in Honolulu for a top-to-bottom renovation, a closure that is currently ongoing. The renovation has not yet been completed, and our construction has been effectively halted by the governmental restrictions imposed on us in reaction to the COVID-19 pandemic. When reopened, the theatre will feature recliner seating throughout along with a state-of-the-art kitchen and an elevated F&B menu.

Some of our cinemas have encountered new competition, and we believe that others will benefit from planned refurbishment and upgrading. The scope, extent, and timing of such refurbishment and upgrading will be necessarily impacted by our need to preserve capital and liquidity while we work through the various challenges posed by the ongoing COVID-19 pandemic.

 

40


Upgrades to our Film Exhibition Technology and Theater Amenities

As previously discussed, we continue to focus on areas of the well-established cinema business where we believe we have growth potential and ultimately, provide long-term value to our stockholders. In order to meet our changing role in the entertainment industry, we have invested both in the upgrading of our existing cinemas and the development of new cinemas to provide our customers with premium offerings, including state-of-the-art presentation (including sound, lounges, and bar service), and luxury recliner seating. As of September 30, 2020, all of the upgrades to our theater circuits’ film exhibition technology and amenities over the years are as summarized in the following table:

Location
Count

Screen
Count

Screen Format

Digital (all cinemas in our theater circuit)

60

498

IMAX

1

1

TITAN XC and LUXE

24

29

Dine-in Service

Gold Lounge (AU/NZ)(1)

9

24

Premium (AU/NZ)(2)

14

33

Spotlight (U.S.)(3)

1

6

Upgraded Food & Beverage menu (U.S.)(4)

16

n/a

Premium Seating (features recliner seating)

26

161

Liquor Licenses (5)

35

n/a

(1)Gold Lounge: This is our "First Class Full Dine-in Service" in our Australian and New Zealand cinemas, which includes an upgraded F&B menu (with alcoholic beverages), luxury recliner seating features (intimate 25-50 seat cinemas) and waiter service.

(2)Premium Service: This is our "Business Class Dine-in Service" in our Australian and New Zealand cinemas, which typically includes upgraded F&B menu (some with alcoholic beverages) and may include luxury recliner seating features (less intimate 80-seat cinemas), but no waiter service.

(3)Spotlight Service: Our first dine-in cinema concept in the U.S. at Reading Cinemas in Murrieta, California. Six of our 17 auditoriums at this theater feature waiter service before the movie begins with a full F&B menu, luxury recliner seating, and laser focus on customer service.

(4)Upgraded Food & Beverage Menu: Features an elevated F&B menu including a menu of locally inspired and freshly prepared items that go beyond traditional concessions, which we have worked with former Food Network executives to create. The elevated menu also includes beer, wine and/or spirits at most of our locations.

(5)Liquor Licenses: Licenses are applicable at each cinema location, rather than each theater auditorium. For accounting purposes, we capitalize the cost of successfully purchasing or applying for liquor licenses meeting certain thresholds as an intangible asset due to long-term economic benefits derived on future sales of alcoholic beverages. As of September 30, 2020, we have pending applications for additional liquor licenses for six theaters in the U.S., two in New Zealand, and one in Australia.

Real Estate

As of September 30, 2020, our operating properties consisted of the following:

Newmarket Village (Brisbane area, QLD), Cannon Park (Townsville, QLD), The Belmont Common (Perth area, WA), Auburn Redyard (Sydney area, NSW), and Courtenay Central (Wellington area, NZ);

two single-auditorium live theatres in Manhattan (Minetta Lane and Orpheum) and a four-auditorium live theatre complex (including the accompanying ancillary retail and commercial tenants) in Chicago (The Royal George);

our worldwide headquarters’ building in Culver City, California and our Australian corporate office building in Melbourne, Australia; and

the ancillary retail and commercial tenants at some of our non-ETC cinema properties.

 

At the start of the spread of the COVID-19 pandemic, varied trading restrictions, some enforced by the government, affected many of our tenants at our properties, including Newmarket Village (Brisbane area, QLD), Cannon Park (Townsville, QLD), The Belmont Common (Perth area, WA), Auburn Redyard (Sydney area, NSW), and Courtenay Central (Wellington area, NZ). Although there were varied trading restrictions, most of these properties remained open for business through the COVID-19 crisis. As of the date of this Report, the majority of our tenants are currently open for business at our Australian and New Zealand properties with new health and safety measure in place. Most of the rentable retail portions of our Courtenay Central location in New Zealand continue to be closed since January 2019 due to seismic concerns.

In addition, we have various parcels of unimproved real estate held for development in Australia and New Zealand and certain unimproved land in the U.S., including some that were used in our legacy activities.

 

41


Our key real estate transactions in recent years are as follows:

Strategic Acquisitions

Purchase of Property in Auburn, Australia – On June 29, 2018, we added 20,870 square feet of land, improved with a 16,830 square foot office building, to our Auburn Redyard ETC. The property was acquired at auction for $3.5 million (AU$4.5 million) and is bordered by our existing ETC on three sides. The property is leased to Telstra through July 2022. This lease will allow us time to plan for the efficient integration of the property into our ETC. With this acquisition, Auburn Redyard now represents approximately 519,358 square feet of land, with approximately 1,641 feet of uninterrupted frontage to Parramatta Road, a major Sydney arterial motorway.

Exercise of Option to Acquire Ground Lessee’s interest in Ground Lease and Improvements Constituting the Village East CinemaOn August 28, 2019, we exercised our option to acquire the ground lessee’s interest in the ground lease underlying and the real property assets constituting our Village East Cinema in Manhattan. The purchase price under the option is $5.9 million. It is now anticipated that the transaction will close on or about May 31, 2021. On March 12, 2020, we amended the original agreement to (i) extend the term of the lease to January 31, 2022 and (ii) at the request of Sutton Hill Capital L.L.C. (“SHC”), in connection with our deferral of the closing date for our acquisition of SHC’s interest in the Village East Cinema, our Company reinstated and extended until December 4, 2021 SHC’s right to put that interest to us. That put right had previously expired on December 4, 2019. We are advised by SHC that it wanted this reinstatement and extension in order to assure itself that, in the event of the non-performance by us of our current contractual obligation to close our purchase of the interest in the ground lease on or about the extended date of May 31, 2021, that it could (as, in effect, an additional remedy) exercise this reinstated and extended put right. As the transaction is a related party transaction, it was reviewed and approved by our Board’s Audit and Conflicts Committee and supported by a third-party valuation, which showed substantial value in the option and, upon closing, will result in an annual rent savings of $590,000.

Value-creating Opportunities

The implementation of most of our real estate development plans have been delayed due to COVID-19 and the need to conserve capital. However, we continue to believe that our Company’s strong real estate base will provide (i) increased financial security through the potential sale of certain non-core real estate assets or (ii) provide collateral for strategic re-financing, in each case to meet liquidity demands. We intend to continue to emphasize the prudent development of our real estate assets.

United States:

Sepulveda Office Building (Culver City, U.S.) On May 27, 2020, we leased on a multi-year basis the entire second floor of our headquarter building in Culver City, California (approximately 11,000 usable square feet) to WWP (wwpinc.com), a global company with over 35 years of experience providing the cosmetics and personal care industries with a range of packaging needs. On the date of the lease, possession of the space was turned over to WWP, which is responsible for building out its space. In October 2020, we began receiving rental income from the tenant.

44 Union Square (New York City, U.S.) – Historically known as Tammany Hall, this building with approximately 73,113 square feet of net rentable area overlooks Manhattan’s Union Square. During the COVID-19 pandemic, New York City shutdown non-essential construction and business, including construction work at our site. However, the construction of the improvements necessary to obtain a core and shell temporary certificate of occupancy were substantially completed prior to the shutdown. On July 1, 2020, the site reopened for construction activities, and on August 31, 2020, we received a temporary certificate of occupancy for the core and shell of the building.

Our leasing team is now actively pursuing potential tenants and increasing leasing efforts. This building, hailed as a dramatic pièce de résistance with its first in the city, over 800-piece glass dome, brings the future to New York’s fabled past and was awarded in 2020 the ENR New York’s Best Projects awards for Renovation/Restoration and for Safety. We believe 44 Union Square is attractive to potential tenants interested in both (i) operating in New York City and (ii) seeking to have greater control over the size and design of their spaces in a post-COVID-19 environment. It is one of a very limited number of “brandable” sites available for lease in New York City and can be delivered immediately upon the execution of leases.

Minetta Lane Theatre (New York City, U.S.) – We have completed an initial feasibility study regarding the potential redevelopment of this property. Prior to COVID-19, our theatre was used by Audible, a subsidiary of Amazon, to present plays featuring a limited cast of one or two characters and special live performance engagements, which it recorded and made available to the public through the Audible streaming service. Due to COVID-19, no shows have been presented since March 2020 and the theatre remains closed to the public until further instruction from local government authorities.

 

 

 

42


Cinemas 1,2,3 Redevelopment (New York City, U.S.) – As previously disclosed, our endeavors to negotiate a joint development deal with our adjoining neighbors have not borne fruit. Given the closure of our two cinemas in New York City’s Upper East Side, we have determined to continue to operate this location as a cinema for at least the near term. We are pursuing a rezoning of this property so as to allow us to continue our cinema use as a part of any such redevelopment. However, all other redevelopment activity related to this location has been suspended, until we are able to develop a better understanding of the ongoing effects of COVID-19 on our assets and the market.

New Zealand:

Manukau/Wiri Land Rezoning (Auckland, New Zealand) – We continued to progress the infrastructure plans for our 64.0-acre property, which we previously re-zoned from agricultural to light industrial uses, and the remaining 6.4-acre property, zoned for heavy industrial use, each located in the highly sought after industrial market of Manukau/Wiri near the Auckland Airport.

In June 2020, the Auckland Council granted to us and the adjoining landowner, subject to certain conditions, certain consents required to construct certain infrastructure needed to take advantage of the new light industrial zoning.

Notwithstanding that the Auckland Airport recently announced that the COVID-19 pandemic may lead to an indefinite suspension of certain expansion plans, including the “Park and Ride” facility near our property, we continue to view the industrial property sector as being one of the most resilient in the current economic climate. We believe that the work completed to date has contributed to the overall value of our industrial land in Manukau/Wiri.

Courtenay Central Redevelopment (Wellington, New Zealand) – Located in the heart of Wellington – New Zealand’s capital city – our Courtenay Central property covers 161,071 square feet of land situated proximate to (i) the Te Papa Tongarewa Museum (attracting over 1.5 million visitors annually, pre-COVID), and (ii) across the street from the site of the future Wellington Convention and Exhibition Centre (wcec.co.nz), the capital’s first premium conference and exhibition space, which is due to be completed in 2023. Despite the COVID-19 pandemic, construction for this major public project has resumed and plans include the creation of a public concourse linking through to Wakefield Street, which is across the street from our Courtenay Central project.

As previously reported, damage from the 2016 Kaikoura earthquake necessitated demolition of our nine-story parking garage at the site, and unrelated seismic issues caused us to close major portions of the existing cinema and retail structure in early 2019. Prior to the COVID-19 pandemic, the real estate team had developed a comprehensive plan featuring a variety of uses to complement and build upon the “destination quality” of the Courtenay Central location. Notwithstanding the COVID-19 pandemic, our real estate team is continuing to work with our consultants, potential tenants, and city representatives to advance our redevelopment plans for this property.

Corporate Matters

Stock Repurchase ProgramOn March 10, 2020, our Board of Directors authorized a $25.0 million increase to our 2017 stock repurchase program, bringing our total authorized repurchase amount remaining to $26.0 million, and extending the program to March 2, 2022. Through September 30, 2020, we have repurchased 1,792,819 shares of Class A Non-Voting Common Stock at an average price of $13.39 per share (excluding transaction costs). Of these, 75,157 shares were purchased during the nine months ended September 30, 2020, at an average price of $8.92 per share.

Due to the COVID-19 pandemic and its impact on our overall liquidity, our stock repurchase program has and will likely continue to take a lower capital allocation priority for the foreseeable future.

Board Compensation and Stock Options Committee – Our Compensation and Stock Options Committee, in early 2020, determined to pay out no cash bonuses, with respect to 2019, to any Reading senior executives, including our CEO. As of today, no non-employee director RSUs or stock options have been issued in 2020. Our 2010 Stock Incentive Plan has now expired.

 


 

43


Our Financing Strategy

Prior to the interruptions to our revenues caused by the COVID-19 pandemic, we have used cash generated from operations and other excess cash, to the extent not needed to fund capital investments contemplated by our business plan, to pay down our loans and credit facilities. This has provided us with availability under our available loan facilities for future use and thereby, reduced interest charges. On a periodic basis, we have reviewed the maturities of our borrowing arrangements and negotiated renewals and extensions where necessary in the current circumstances. We completed amending and extending various financing arrangements less than two weeks prior to the COVID-19 government mandated shutdowns, which we believe has helped provide necessary liquidity to see us through the COVID-19 crisis.

In response to the COVID-19 pandemic, the closure of our theaters, and the trading restrictions placed on many of our real estate tenants at our ETCs, we had fully drawn-down on all our available operating lines-of-credit to provide future liquidity by the end of the first quarter of 2020. During Q3 2020, we paid down $5.8 million on our U.S. Credit Facility and have the ability to redraw these funds if Management deems necessary.

In order to address the impact of COVID-19, we have obtained certain modifications to our loan agreements with Bank of America, N.A., National Australia Bank, and Westpac New Zealand Limited to ensure future liquidity in light of the COVID-19 pandemic. These loan modifications included changes to some of the covenant compliance terms and waivers to certain covenant testing periods. We currently have no covenant breaches to which loan modifications or waivers to the covenant testing periods have not been obtained. To date it has not been necessary for us to seek modifications or waivers with respect to our other loan agreements, as we continue to be in compliance with the terms of such loan agreements without the need for any such modifications or waivers.

Bank of America Loan

On March 6, 2020, we (i) entered into an amendment for our $55.0 million credit facility with Bank of America, which supports our U.S. Cinema operations, extending the maturity date to March 6, 2023 and implementing an interest rate of 2.5% - 3.0% dependent on certain financial ratios plus a variable rate and (ii) extended the term of our $5.0 million line of credit with Bank of America to March 6, 2023.

On August 7, 2020, we entered into a Waiver and Second Amendment to the Second Amended and Restated Credit Agreement (“Amendment”) modifying certain financial covenants within this credit facility and temporarily suspended the testing of certain other covenant tests through measurement period ending September 30, 2021. The testing of the financial covenant resumes for measurement period ending December 31, 2021. The modifications also include new covenants related to maintenance of certain liquidity levels. Under the Amendment, cash balances in excess of $3.0 million will be used to paydown the facility debt. However, this is not a reduction in that credit facility and, subject to the satisfaction of draw down requirements, will be available for re-borrowing. In addition to the covenant modifications, the interest rate on borrowings under this facility was fixed at 3.0% above the “Eurodollar” rate, which itself now has a floor of 1.0%. As of September 30, 2020, we had $5.8 million available under this credit facility. In regard to the line of credit, we also modified the interest rate, wherein the LIBOR portion of the rate now has a floor of 1.0%. Such modifications were not considered to be substantial under U.S. GAAP.

Cinemas 1,2,3 Term Loan

On March 13, 2020, Sutton Hill Properties LLC, our 75% subsidiary, increased its term loan with Valley National Bank to $25.0 million from $20.0 million, with an interest rate based on the greater of (i) the two year U.S. Treasury Rate plus 2.5% or (ii) 4.25%. The current interest rate used for the Valley National loan is 4.25%.

NAB Corporate Term Loan (AU)

Prior to COVID-19, in March 2019, we amended our Revolving Corporate Markets Loan Facility with NAB from a facility comprised of (i) a AU$66.5 million loan facility with an interest rate of 0.95% above the BBSY and a maturity date of June 30, 2019 and (ii) a bank guarantee of AU$5.0 million at a rate of 1.90% per annum into (i) a AU$120.0 million Corporate Loan facility at a rate of 0.85% - 1.3% above BBSY, depending on certain ratios, with a due date of December 31, 2023, of which AU$80.0 million is revolving and AU$40.0 million is core and (ii) a Bank Guarantee Facility of AU$5.0 million at a rate of 1.85% per annum. Such debt modifications of this particular term loan were not considered to be substantial under U.S. GAAP.

On August 6, 2020, we modified certain covenants within this Revolving Corporate Markets Loan Facility with NAB (the “NAB Amendment”). These modifications apply until the quarter ended June 30, 2021. In addition, for the period in which these covenant modifications apply, the interest rate on amounts borrowed under the facility is 1.75%. The NAB Amendment modifies the Fixed Charge Cover Ratio testing for the quarters through June 30, 2021 so that ratio testing is calculated on each respective

 

44


quarter’s trading performance, as opposed to annually and waives the leverage ratio testing through the quarter ended June 30, 2021. Such a modification was not considered to be substantial under U.S. GAAP.

Westpac Bank Corporate Credit Facility (NZ)

On December 20, 2018, we restructured our Westpac Corporate Credit Facilities. The maturity of the 1st tranche (general/non-construction credit line) was extended to December 31, 2023, with the available facility being reduced from NZ$35.0 million to NZ$32.0 million. The facility bears an interest rate of 1.75% above the Bank Bill Bid Rate on the drawn down balance and a 1.1% line of credit charge on the entire facility.

On June 29, 2020, Westpac pushed out the June 30, 2020 covenant testing date to July 31, 2020. On July 27, 2020, Westpac waived the requirement to test certain covenants as of July 31, 2020. This agreement also increased the interest rate and line of credit charge to 2.40% above the Bank Bill Bid Rate and 1.65%, respectively. The maturity date was extended to January 1, 2024. Such modifications of this facility were not considered to be substantial under U.S. GAAP. On September 15, 2020, Westpac waived the requirement to test certain covenants as of September 30, 2020.

Union Square Financing

44 Union Square, our property in Manhattan with 73,113 net rentable square foot of retail and office space, is in the lease-up phase with construction being complete (except for minor punch list items). Total debt against the property aggregates to $40.1 million. We are currently seeking take out financing for that property and, while no assurances can be given, we are optimistic that a refinancing freeing up substantial capital can be finalized this year.

Refer to Note 11 – Debt for additional information.


 

45


Please refer to our 2019 Form 10-K for more details on our cinema and real estate segments.

RESULTS OF OPERATIONS

The table below summarizes the results of operations for each of our principal business segments along with the non-segment information for the quarter and nine months ended September 30, 2020 and September 30, 2019, respectively:

Quarter Ended

% Change

Nine Months Ended

% Change

(Dollars in thousands)

September 30,
2020

September 30,
2019

Fav/
(Unfav)

September 30,
2020

September 30,
2019

Fav/
(Unfav)

SEGMENT RESULTS

Revenue

Cinema exhibition

$

7,339 

66,663 

(89)

%

$

54,866 

$

196,885 

(72)

%

Real estate

3,023 

5,531 

(45)

%

9,928 

16,525 

(40)

%

Inter-segment elimination

(171)

(1,808)

91 

%

(1,953)

(5,524)

65 

%

Total revenue

10,191 

70,386 

(86)

%

62,841 

207,886 

(70)

%

Operating expense

Cinema exhibition

(15,988)

(55,517)

71 

%

(73,722)

(163,797)

55 

%

Real estate

(1,909)

(2,225)

14 

%

(6,258)

(7,108)

12 

%

Inter-segment elimination

171 

1,808 

(91)

%

1,953 

5,524 

65 

%

Total operating expense

(17,726)

(55,934)

68 

%

(78,027)

(165,381)

53 

%

Depreciation and amortization

Cinema exhibition

(3,845)

(4,271)

10 

%

(11,388)

(12,519)

%

Real estate

(1,552)

(1,330)

(17)

%

(4,127)

(4,061)

(2)

%

Total depreciation and amortization

(5,397)

(5,601)

%

(15,515)

(16,580)

%

General and administrative expense

Cinema exhibition

(916)

(924)

%

(3,074)

(2,854)

(8)

%

Real estate

(406)

(491)

17 

%

(1,007)

(1,369)

26 

%

Total general and administrative expense

(1,322)

(1,415)

%

(4,081)

(4,223)

%

Segment operating income

Cinema exhibition

(13,410)

5,951 

(>100)

%

(33,318)

17,715 

(>100)

%

Real estate

(844)

1,485 

(>100)

%

(1,464)

3,987 

(>100)

%

Total segment operating income

$

(14,254)

$

7,436 

(>100)

%

$

(34,782)

$

21,702 

(>100)

%

NON-SEGMENT RESULTS

Depreciation and amortization expense

(215)

(103)

(>100)

%

(634)

(288)

(>100)

%

General and administrative expense

(2,906)

(4,493)

35 

%

(11,194)

(14,205)

21 

%

Interest expense, net

(2,379)

(1,871)

(27)

%

(6,176)

(5,924)

(4)

%

Equity earnings of unconsolidated joint ventures

(97)

220 

(>100)

%

(292)

581 

(>100)

%

Gain (loss) on sale of assets

(1)

(1)

nm

(1)

(1)

-

%

Other income (expense)

10 

141 

(93)

%

(186)

190 

(>100)

%

Income before income taxes

(19,842)

1,329 

(>100)

%

(53,265)

2,055 

(>100)

%

Income tax benefit (expense)

490 

(528)

>100

%

5,070 

(1,101)

>100

%

Net income (loss)

(19,352)

801 

(>100)

%

(48,195)

954 

(>100)

%

Less: net income (loss) attributable to noncontrolling interests

(124)

(50)

(>100)

%

(389)

(103)

(>100)

%

Net income (loss) attributable to RDI common stockholders

$

(19,228)

$

851 

(>100)

%

$

(47,806)

$

1,057 

(>100)

%

Basic earnings (loss) per share

$

(0.88)

$

0.04 

(>100)

%

$

(2.20)

$

0.05 

(>100)

%

 

Consolidated and Non-Segment Results:

Third Quarter and Nine Months Net Results

Net income attributable to RDI common stockholders for the quarter ended September 30, 2020 decreased by $20.1 million, to a loss of $19.2 million, when compared to the same period in the prior year, and basic EPS decreased by $0.92, to a loss of $0.88 for the quarter ended September 30, 2020 compared to the quarter ended September 30, 2019. Revenue for the quarter ended September 30, 2020 decreased by 86%, or $60.2 million, to $10.2 million compared to the same period prior year. These decreases are mainly attributable to the ongoing temporary closure of a portion of our cinemas since the first quarter of 2020 as a result of COVID-19.

 

46


For the nine months ended September 30, 2020, net income attributable to RDI common stockholders decreased by $48.9 million, to a loss of $47.8 million, compared to the same period prior year. Basic EPS for the nine months ended September 30, 2020 decreased by $2.25, to a loss of $2.20 compared to the nine months ended September 30, 2019. Revenue for the nine months ended September 30, 2020 decreased by 70%, or $145.0 million, to $62.8 million compared to the same period prior year. These shifts are largely due to the temporary closure of our cinemas in the United States, Australia, and New Zealand as a result of COVID-19 in March of 2020.

In our Real Estate segment, occupancy across our centers was over 90% in Australia and 77% in New Zealand for our third-party tenants as of September 30, 2020. Most tenants are trading with no further restrictions as a result of the stringent actions taken early on by the Australian and New Zealand governments in response to the pandemic.

With respect to the third quarter, net loss attributable to RDI common stockholders was compounded by the strengthening value of the U.S. dollar when compared to the Australian and New Zealand dollars to the same periods for the prior year.

Non-Segment General & Administrative Expenses

Non-segment general and administrative expense for the quarter ended September 30, 2020 decreased by 35%, or $1.6 million, to $2.9 million compared to the same period in the prior year. This decrease is mainly attributable to the affirmation on appeal by the Nevada Supreme Court of a $0.8 million costs judgment entered in favor of our Company in the James Jr. Cotter derivative litigation. The decrease was further impacted by (i) savings in payroll costs as a result of the wage subsidy programs and reduction in corporate staff, (ii) reduced costs related to corporate airfare and travel as a result of COVID-19 travel restrictions, and (iii) a decrease in professional and legal services.

For the nine months ended September 30, 2020, non-segment general and administrative expense decreased by 21%, or $3.0 million, to $11.2 million compared to the nine months ended September 30, 2019 due to the affirmation on appeal by the Nevada Supreme Court of a $0.8 million costs judgment entered in favor of our Company in the James Jr. Cotter derivative litigation. Further, in Australia and New Zealand, we have enjoyed the benefits of wage subsidies provided by their respective government, which continue to cover a proportion of the costs of our corporate staff in Australia and which also covered a proportion of the corporate staff’s costs in New Zealand. While the wage subsidy program in New Zealand ended on August 25, 2020, the wage subsidy program in Australia has been extended to March 27, 2021.

Income Tax Benefit

Income tax benefit for the quarter and nine months ended September 30, 2020 increased by $1.0 million and $6.2 million, respectively, compared to the equivalent prior year period. The change between 2020 and 2019 is primarily related to tax benefits from the carryback of our Company’s 2019 net operating loss, as the result of The CARES Act, to 2015 and 2016 tax years where the federal tax rate was 35%, offset by an increase in valuation allowance in 2020. The carryback of the 2019 net operating loss and the refund claim for 100% of the remaining alternative minimum tax credit will result in a tax refund of approximately $5.1 million receivable at September 30, 2020.

 

47


Business Segment Results

As of September 30, 2020, we leased or owned and operated 60 cinemas with 498 screens, which includes our interests in certain unconsolidated joint ventures that total three cinemas with 29 screens. As of September 30, 2020, we also:

have expanded into Tasmania acquiring a four-screen cinema in Devonport in the first quarter of 2019 and a ten-screen cinema (the State Cinema) in Hobart in the fourth quarter of 2019;

have opened a three-screen pop-up in Lower Hutt located in the greater region of Wellington, New Zealand at the end of June 2019;

have ended our management agreement related to the 86th Street Cinema in New York City due to the expiration of the underlying lease and closed our historically profitable Paris and Beekman theatres in New York City due to lease expirations;

have launched our six-screen Reading Cinemas in Burwood, a suburb of Melbourne, Australia, in December 2019;

owned and operated five ETCs located in Newmarket Village (a suburb of Brisbane), Belmont (a suburb of Perth), Auburn Redyard (a suburb of Sydney), and Cannon Park (in Townsville) in Australia, and Courtenay Central (in Wellington) in New Zealand;

owned and operated our headquarters’ office building in Culver City (an emerging high-tech and communications hub in Los Angeles County) and, during the second quarter 2020, entered a multi-year lease with a corporate tenant for the entire second floor. We are currently in the tenant improvement phase and began receiving rental payments in October 2020;

owned and operated our headquarters’ office building in Melbourne, Australia;

owned and operated the fee interests in three developed commercial properties in Manhattan and Chicago improved with live theatres comprising six stages and ancillary retail and commercial space;

owned a 75% managing member interest in a limited liability company which in turn owns the fee interest in Cinemas 1,2,3;

owned our Union Square development property with approximately 73,113 square feet of net leasable area comprised of retail and office space. The 44 Union Square is currently in the leasing phase, and we have received a temporary certificate of occupancy with respect to the core and shell work on August 31, 2020.

held for development approximately 70.4-acres of developable industrial land located next to the Auckland Airport in New Zealand;

owned a 50% managing member interest in a limited liability company, which in turn owns a 202-acre property in Coachella, California that is zoned approximately 150-acres for single-family residential use (maximum 550 homes) and approximately 50-acres for high density mixed use in the U.S., that is held for development, and;

owned 197-acres principally in Pennsylvania from our legacy railroad business, including the Reading Viaduct in downtown Philadelphia.

Our Company transacts business in Australia and New Zealand and is subject to risks associated with fluctuations in foreign currency exchange rates. During the third quarter of 2020, compared to the same period prior year, the Australian dollar and New Zealand dollar strengthened against the U.S. dollar by 4.4% and 2.1%, respectively.

 

48


Cinema Exhibition

The following table details our cinema exhibition segment operating results for the quarter and nine months ended September 30, 2020 and September 30, 2019, respectively:

% Change

Quarter Ended

Nine Months Ended

Fav/(Unfav)

(Dollars in thousands)

September 30,

2020

% of Revenue

September 30,

2019

% of Revenue

September 30,

2020

% of Revenue

September 30,

2019

% of Revenue

Quarter
Ended

Nine Months Ended

REVENUE

United States

Admissions revenue

$

329

4%

$

22,470

34%

$

14,244

26%

$

66,957

34%

(99)

%

(79)

%

Food & beverage revenue

264

4%

11,606

17%

7,322

13%

34,304

17%

(98)

%

(79)

%

Advertising and other revenue

214

3%

2,604

4%

3,016

6%

8,266

5%

(92)

%

(64)

%

$

807

11%

$

36,680

55%

$

24,582

45%

$

109,527

56%

(98)

%

(78)

%

Australia

Admissions revenue

$

2,877

39%

$

15,603

23%

$

15,625

28%

$

46,219

23%

(82)

%

(66)

%

Food & beverage revenue

1,530

20%

7,014

11%

7,286

13%

20,482

10%

(78)

%

(64)

%

Advertising and other revenue

447

7%

1,662

2%

2,031

4%

4,617

3%

(73)

%

(56)

%

$

4,854

66%

$

24,279

36%

$

24,942

45%

$

71,318

36%

(80)

%

(65)

%

New Zealand

Admissions revenue

$

1,053

14%

$

3,862

6%

$

3,455

6%

$

10,734

5%

(73)

%

(68)

%

Food & beverage revenue

512

7%

1,618

2%

1,563

3%

4,549

2%

(68)

%

(66)

%

Advertising and other revenue

113

2%

224

1%

324

1%

757

1%

(50)

%

(57)

%

$

1,678

23%

$

5,704

9%

$

5,342

10%

$

16,040

8%

(71)

%

(67)

%

Total revenue

$

7,339

100%

$

66,663

100%

$

54,866

100%

$

196,885

100%

(89)

%

(72)

%

OPERATING EXPENSE

United States

Film rent and advertising cost

$

(189)

3%

$

(12,215)

18%

$

(7,456)

14%

$

(35,989)

18%

98

%

79

%

Food & beverage cost

(173)

2%

(2,642)

4%

(2,180)

4%

(7,952)

4%

93

%

73

%

Occupancy expense

(6,834)

93%

(6,655)

10%

(20,211)

37%

(20,487)

11%

(3)

%

1

%

Other operating expense

(3,068)

42%

(11,674)

18%

(15,197)

27%

(33,237)

17%

74

%

54

%

$

(10,264)

140%

$

(33,186)

50%

$

(45,044)

82%

$

(97,665)

50%

69

%

54

%

Australia

Film rent and advertising cost

$

(1,121)

14%

$

(7,456)

11%

$

(6,728)

12%

$

(21,764)

11%

85

%

69

%

Food & beverage cost

(413)

6%

(1,326)

2%

(1,675)

3%

(3,847)

2%

69

%

56

%

Occupancy expense

(932)

13%

(3,948)

6%

(6,619)

12%

(11,882)

6%

76

%

44

%

Other operating expense

(1,742)

24%

(5,267)

8%

(8,269)

15%

(16,048)

8%

67

%

48

%

$

(4,208)

57%

$

(17,997)

27%

$

(23,291)

42%

$

(53,541)

27%

77

%

56

%

New Zealand

Film rent and advertising cost

$

(427)

6%

$

(1,835)

3%

$

(1,528)

3%

$

(5,065)

3%

77

%

70

%

Food & beverage cost

(108)

2%

(328)

0%

(328)

1%

(945)

0%

67

%

65

%

Occupancy expense

(362)

5%

(891)

1%

(1,436)

2%

(2,602)

1%

59

%

45

%

Other operating expense

(619)

8%

(1,280)

2%

(2,094)

4%

(3,979)

2%

52

%

47

%

$

(1,516)

21%

$

(4,334)

6%

$

(5,386)

10%

$

(12,591)

6%

65

%

57

%

Total operating expense

$

(15,988)

218%

$

(55,517)

83%

$

(73,721)

134%

$

(163,797)

83%

71

%

55

%

DEPRECIATION, AMORTIZATION, GENERAL AND ADMINISTRATIVE EXPENSE

United States

Depreciation and amortization

$

(1,941)

26%

$

(2,647)

4%

$

(5,950)

11%

$

(7,789)

4%

27

%

24

%

General and administrative expense

(661)

9%

(480)

1%

(2,228)

4%

(1,516)

1%

(38)

%

(47)

%

$

(2,602)

35%

$

(3,127)

5%

$

(8,178)

15%

$

(9,305)

5%

17

%

12

%

Australia

Depreciation and amortization

$

(1,535)

21%

$

(1,227)

1%

$

(4,349)

8%

$

(3,630)

2%

(25)

%

(20)

%

General and administrative expense

(254)

3%

(384)

1%

(854)

1%

(1,238)

(0)%

34

%

31

%

$

(1,789)

24%

$

(1,611)

2%

$

(5,203)

9%

$

(4,868)

2%

(11)

%

(7)

%

New Zealand

Depreciation and amortization

$

(369)

5%

$

(396)

1%

$

(1,090)

2%

$

(1,099)

1%

7

%

1

%

General and administrative expense

(1)

1%

(61)

0%

8

(0)%

(100)

0%

98

%

>100

%

$

(370)

6%

$

(457)

1%

$

(1,082)

2%

$

(1,199)

1%

19

%

10

%

Total depreciation, amortization, general and administrative expense

$

(4,761)

65%

$

(5,195)

8%

$

(14,463)

26%

$

(15,372)

8%

8

%

6

%

OPERATING INCOME (LOSS) – CINEMA

United States

$

(12,059)

(164)%

$

367

1%

$

(28,640)

(52)%

$

2,556

1%

(>100)

%

(>100)

%

Australia

(1,143)

(16)%

4,671

7%

(3,552)

(6)%

12,909

7%

(>100)

%

(>100)

%

New Zealand

(208)

(3)%

913

1%

(1,126)

(2)%

2,250

1%

(>100)

%

(>100)

%

Total Cinema operating income (loss)

$

(13,410)

(183)%

$

5,951

9%

$

(33,318)

(60)%

$

17,715

9%

(>100)

%

(>100)

%

Third Quarter Results

Cinema Segment operating income

Cinema segment operating income for the third quarter 2020 decreased by $19.4 million, to a loss of $13.4 million when compared to the same period in 2019. This large shift is due to the continued temporary closure of a portion of our cinemas due to the COVID-19 pandemic and the lack of film product. This decrease was reduced by the absence of internal rent expense from some of our fee-interest cinemas due to the COVID-19 shutdowns and the rent abatements from a number of our landlords.

 

49


Revenue

Cinema revenue decreased by 89%, or $59.3 million, to $7.3 million for the third quarter 2020, compared to the same period in 2019.

Below are the changes in our cinema revenue by market:

U.S. Cinemas

Cinema revenue decreased by 98%, or $35.9 million, to $0.8 million for the third quarter 2020, due to a 98% decrease in attendance related to the ongoing temporary closures of some of our U.S Cinemas since March of 2020, the postponement or removal from the release schedule of major motion pictures, each due to COVID-19, along with the temporary closure of our Consolidated Theatre at the Kahala Mall in Honolulu since December of 2019 for a top-to-bottom renovation. However, during the third quarter of 2020, results improved slightly as we reopened 11 of our 24 U.S. cinemas: four in Hawaii, five in California, one in Texas, and another in New Jersey.

Australia Cinemas

Cinema revenue decreased by 80%, or $19.4 million, to $4.9 million for the third quarter 2020, due to an 84% decrease in attendance related to the COVID-19 shutdowns, social distancing measures and a lack of motion pictures being released during this COVID-19 period by the major studios. Fortunately, due to proactive measures conducted by the Australian government, we have since reopened 16 of our 23 cinemas: six in New South Wales, four in Queensland, two in Western Australia, two in South Australia, and two in Tasmania. These decreases were offset by a favorable foreign currency exchange rate in the Australian dollar.

New Zealand Cinemas

Cinema revenue decreased by 71%, or $4.0 million, to $1.7 million for the third quarter 2020, due to a 72% decrease in attendance related to the COVID-19 shutdowns and a lack of a slate of motion pictures from the major studios. The New Zealand government has been the acclaimed world leader in suppressing the spread of COVID-19, and as such, has paved the way for our Company to reopen operations for our New Zealand circuit with the exception of Courtenay Central, which closed due to seismic concerns. These decreases were offset by a favorable foreign currency exchange rate in the New Zealand dollar.

Operating expense

Operating expense for the third quarter 2020, decreased by 71%, or $39.5 million, to $16.0 million, principally due to the ongoing temporary closures of some of our cinemas as a result of the COVID-19 pandemic. We have enjoyed the benefits of wage subsidies from the Australian and New Zealand governments. These benefits cover most of our cinema level personnel costs in Australia and virtually all of the costs of our cinema level personnel in New Zealand. While the wage subsidy program in New Zealand ended on August 25, 2020, the wage subsidy program in Australia has been extended to March 27, 2021. This operating expense decrease was also due to savings in internal and external rent abatements received in the third quarter of 2020 as a result of the COVID-19 pandemic.

Depreciation, amortization, general and administrative expense

Depreciation, amortization, general and administrative expense for the third quarter 2020, decreased by 8%, or $0.4 million, to $4.8 million, compared to the same period in 2019. This decrease is attributable to a reduction in depreciation expense for our U.S. cinemas digital projectors, which has been substantially depreciated by the end of 2019. These decreases have been offset by increases in depreciation expense related to the completion of our capital improvements placed into service along with the strengthening foreign currency exchange rates in the Australian and New Zealand dollars.

Nine Months Results

Cinema Segment operating income

Cinema segment operating income for the nine months ended September 30, 2020 decreased by $51.0 million, to a loss of $33.3 million when compared to the same period in 2019. This decrease is due to the ongoing temporary closure of some of our cinemas, reduced seating occupancy as a result of social distancing measures, and the changes to the release schedule by film distributors, which collectively led to a significant attendance drop since March 2020. This decrease was partially alleviated by (i) the reopening of a portion of our cinemas worldwide during the second and third quarters of 2020, (i) the absence of internal rent expense from some of our fee-interest cinemas due to the COVID-19 pandemic, and (iii) rent abatements received from a number of our landlords.

 

50


Revenue

Cinema revenue decreased by 72%, or $142.0 million, to $54.9 million for the nine months ended September 30, 2020 compared to the same period in 2019.

Below are the changes in our cinema revenue by market:

U.S. Cinemas

Cinema revenue decreased by 78%, or $84.9 million, to $24.6 million for the nine months ended September 30, 2020, due to a 79% decrease in attendance. These decreases were significantly due to the ongoing temporary closure of some of our U.S. Cinemas since March 2020 and the social distancing measures put in place as a result of the COVID-19 pandemic, the lack of a consistent and compelling movie slate from the major studios, the temporary closure of our Consolidated Theatre at the Kahala Mall in Honolulu since December of 2019 for renovations, and the closures of our 86th Street, Paris, and Beekman Theatres since mid-2019. These decreases were partially offset by the reopening of 11 of our 24 U.S. cinemas during the third quarter of 2020.

Australia

Cinema revenue decreased by 65%, or $46.4 million, to $24.9 million for the nine months ended September 30, 2020, due to a 68% decrease in attendance. These decreases were significantly due to the ongoing temporary closures of some of our cinemas in Australia as a result of the COVID-19 pandemic and the lack of a consistent and compelling movie slate from the major, partially offset by the reopening of 16 of our 23 Australian cinemas in the second and third quarters of 2020. These results were further impacted by strengthening of the U.S. dollar when compared to the Australian dollar.

New Zealand

Cinema revenue decreased by 67%, or $10.7 million, to $5.3 million for the nine months ended September 30, 2020, due to a 67% decrease in attendance. These decreases were significantly due to the temporary closures of our cinemas in New Zealand as a result of the COVID-19 pandemic and the lack of a consistent and compelling movie slate from the major, partially offset by the reopening of our cinemas in New Zealand in June of 2020, excluding Courtenay Central, which remains closed due to seismic concerns. These results were further impacted by strengthening of the U.S. dollar when compared to the New Zealand dollar.

Operating expense

Operating expense for the nine months ended September 30, 2020, decreased by 55%, or $90.1 million, to $73.7 million. The temporary closures of our cinemas ultimately led to employee terminations in late March in the U.S. resulting in a reduction in labor costs. Conversely, in Australia and New Zealand, we did not need to terminate employees as we have enjoyed the benefits of wage subsidies provided by their respective governments, which have covered, and in Australia continue to cover, virtually all of the costs of our cinema level personnel. While the wage subsidy program in New Zealand ended on August 25, 2020, the wage subsidy program in Australia has been extended to March 27, 2021. This decline was also due to savings in internal and external rent abatements received in the second and third quarters of 2020 as a result of the COVID-19 pandemic.

Depreciation, amortization, general and administrative expense

Depreciation, amortization, general and administrative expense for the nine months ended September 30, 2020, decreased by 6%, or $0.9 million, to $14.5 million, compared to the same period in 2019. This decrease is attributable to a reduction in depreciation expense for our U.S. cinemas digital projectors, which has been substantially depreciated by the end of 2019. The decrease was partially offset by the foreign exchange movements in Australia and New Zealand.

 

 

51


Real Estate

The following table details our real estate segment operating results for the quarter and nine months ended September 30, 2020 and September 30, 2019, respectively:

% Change

Quarter Ended

Nine Months Ended

Fav/(Unfav)

(Dollars in thousands)

September 30,

2020

% of
Revenue

September 30,

2019

% of
Revenue

September 30,

2020

% of
Revenue

September 30,

2019

% of
Revenue

Quarter Ended

Nine Months Ended

REVENUE

United States

Live theatre rental and ancillary income

$

106

4%

$

955

17%

$

888

9%

$

2,721

16%

(89)

%

(67)

%

Property rental income

125

4%

51

1%

277

3%

152

1%

>100

%

82

%

231

8%

1,006

18%

1,165

12%

2,873

17%

(77)

%

(59)

%

Australia

Property rental income

2,562

84%

3,905

71%

8,050

81%

11,873

72%

(34)

%

(32)

%

New Zealand

Property rental income

230

8%

620

11%

713

7%

1,779

11%

(63)

%

(60)

%

Total revenue

$

3,023

100%

$

5,531

100%

$

9,928

100%

$

16,525

100%

(45)

%

(40)

%

OPERATING EXPENSE

United States

Live theatre cost

$

(140)

5%

$

(323)

6%

$

(612)

6%

$

(920)

6%

57

%

33

%

Property cost

(127)

4%

(147)

3%

(944)

10%

(461)

3%

14

%

(>100)

%

Occupancy expense

(240)

8%

(74)

1%

(561)

5%

(353)

1%

(>100)

%

(59)

%

(507)

17%

(544)

10%

(2,117)

21%

(1,734)

10%

7

%

(22)

%

Australia

Property cost

(653)

22%

(619)

11%

(1,733)

17%

(2,107)

13%

(5)

%

18

%

Occupancy expense

(400)

13%

(669)

12%

(1,353)

14%

(2,024)

12%

40

%

33

%

(1,053)

35%

(1,288)

23%

(3,086)

31%

(4,131)

25%

18

%

25

%

New Zealand

Property cost

(239)

8%

(284)

5%

(738)

7%

(849)

5%

16

%

13

%

Occupancy expense

(111)

3%

(109)

2%

(317)

4%

(394)

3%

(2)

%

20

%

(350)

11%

(393)

7%

(1,055)

11%

(1,243)

8%

11

%

15

%

Total operating expense

$

(1,910)

63%

$

(2,225)

40%

$

(6,258)

63%

$

(7,108)

43%

14

%

12

%

DEPRECIATION, AMORTIZATION, GENERAL AND ADMINISTRATIVE EXPENSE

United States

Depreciation and amortization

$

(385)

13%

$

(196)

4%

$

(791)

8%

$

(584)

4%

(96)

%

(35)

%

General and administrative expense

(211)

7%

(54)

1%

(601)

6%

(392)

2%

(>100)

%

(53)

%

(596)

20%

(250)

5%

(1,392)

14%

(976)

6%

(>100)

%

(43)

%

Australia

Depreciation and amortization

$

(925)

31%

$

(892)

16%

$

(2,633)

27%

$

(2,729)

17%

(4)

%

4

%

General and administrative expense

(187)

6%

(320)

6%

(429)

4%

(860)

5%

42

%

50

%

(1,112)

37%

(1,212)

22%

(3,062)

31%

(3,589)

22%

8

%

15

%

New Zealand

Depreciation and amortization

(242)

8%

(243)

4%

(703)

7%

(748)

4%

-

%

6

%

General and administrative expense

(7)

0%

(116)

2%

23

(0)%

(117)

1%

94

%

>100

%

(249)

8%

(359)

6%

(680)

7%

(865)

5%

31

%

21

%

Total depreciation, amortization, general and administrative expense

$

(1,957)

65%

$

(1,821)

33%

$

(5,134)

52%

$

(5,430)

33%

(7)

%

5

%

OPERATING INCOME (LOSS) - REAL ESTATE

United States

$

(872)

(29)%

$

212

4%

$

(2,344)

(24)%

$

163

1%

(>100)

%

(>100)

%

Australia

397

13%

1,405

25%

1,902

19%

4,153

25%

(72)

%

(54)

%

New Zealand

(369)

(12)%

(132)

(2)%

(1,022)

(10)%

(329)

(2)%

(>100)

%

(>100)

%

Total real estate operating income (loss)

$

(844)

(28)%

$

1,485

27%

$

(1,464)

(15)%

$

3,987

24%

(>100)

%

(>100)

%

Third Quarter Results

Real Estate Segment Income

Real estate segment operating income decreased by $2.3 million, to a loss of $0.8 million for the quarter ended September 30, 2020 compared to September 30, 2019, due to lower intercompany rent revenue from our fee-interest cinemas and rent abatements provided to tenants as a result of the COVID-19 pandemic. Moreover, because the government prohibited live stage presentations in indoor venues in the U.S., our live theatre rental income declined. However, these results were offset by a favorable foreign currency movement in Australia.

Revenue

Real estate revenue for the third quarter of 2020 decreased by 45%, or $2.5 million, to $3.0 million compared to the third quarter of 2019, primarily due to the ongoing pandemic which resulted in the temporary closure of our U.S. Live Theatres and the issuance of rent abatements to certain third party Australian tenants. The decrease was further caused by the vacating of a tenant at our Courtenay Central site in March 2020 and the decision by our Real Estate division to abate intercompany rent payable by Reading Cinemas as anchor tenants at our ETCs in response to the closures and revenue reductions caused by COVID-19. The results were partially offset by the strengthening foreign currency exchange rate in the Australian and New Zealand dollars.

Referring to our Australian real estate revenue, a federal government Code of Conduct was prepared at the end of the first quarter of 2020 intended to function as guidance for landlords and tenants when negotiating rent relief. Initially this Code of Conduct was taken to be ‘best practice’, but during the second quarter of 2020, state governments signed into law their own rent relief legislation which, to varying degrees, drew upon the Code of Conduct as well as incorporated other legislative requirements at a state’s own discretion. Consistent across the Australian states is legislation regarding the measurement of rent relief by way of abatement and/or deferral and is measured against declines in sales volumes over the period in which a tenant is impacted by COVID-19.

 

52


Operating Expense

Operating expense for the quarter ended September 30, 2020 decreased by 14%, or $0.3 million, to $1.9 million, compared to the third quarter ended September 30, 2019, due to the ongoing temporary closures of our Live Theatre business unit and rent abatements from our landlord in Australia. Throughout the third quarter of 2020, all capital costs and many operating expenses were significantly reduced, and various projects and maintenance works were postponed. In addition, our operating expenses were reduced as we brought in-house certain property management functions that were earlier outsourced. In Australia, various State Revenue Offices (SRO) implemented support measures for commercial landlords whereby land tax relief was provided, and continues to provide, by way of a percentage of land tax waiver. This decrease was further impacted by the strengthening U.S. dollar when compared to the Australian and New Zealand dollars.

Depreciation, Amortization, General and Administrative Expense

Depreciation, amortization, general and administrative expense for the quarter ended September 30, 2020 increased 7%, or $0.1 million, to $2.0 million compared to the third quarter ended September 30, 2019 due to increases in depreciation expense related to the completion of our capital improvements placed into service.

Nine Month Results

Real Estate Segment Income

Real estate segment operating income decreased by $5.5 million, to a loss of $1.5 million for the nine months ended September 30, 2020, compared to the same period in 2019. This decrease is attributable to the ongoing temporary closures of our U.S. Live Theatres, lower internal rent revenue from our fee-interest cinemas, and the rent abatements provided to our third-party tenants as a result of the COVID-19 pandemic.

Revenue

Real estate revenue for the nine months ended September 30, 2020 decreased by 40%, or $6.6 million, to $9.9 million, due to (i) internal and external rent abatements, (ii) rent abatements provided to our third party tenants, (iii) the ongoing temporary closure of our Live Theatres, and (iv) the vacating of a tenant at our Courtenay Central property in March of 2020. This decrease was further impacted by the strengthening U.S. dollar when compared to both the Australia and New Zealand dollars.

Operating Expense

Operating expense for the nine months ended September 30, 2020 decreased by 12%, or $0.9 million, to $6.3 million, due to (i) the ongoing temporary closures of our Live Theatre business unit, and (ii) a decrease in occupancy expense in our Australia and New Zealand segments, primarily caused by foreign-owner surcharge forgiveness in Queensland, Australia for the twelve months ended June 30, 2020 as part of the Australian government’s COVID-19 relief program. This decrease was offset by the strengthening U.S. dollar when compared to the Australian and New Zealand dollars.

Depreciation, Amortization, General and Administrative Expense

Depreciation, amortization, general and administrative expense for the nine months ended September 30, 2020 decreased by 5%, or $0.3 million, to $5.1 million, driven by general and administrative expense reductions in Australia, while depreciation remained relatively flat.

 


 

53


LIQUIDITY AND CAPITAL RESOURCES

The coronavirus outbreak has materially adversely affected the economies (and cinema exhibition in particular) of the United States, Australia, and New Zealand. Outbreaks of COVID-19 caused cinemas and other public assembly venues to close in March of 2020. Certain major studios have announced the delayed release of major motion pictures into 2021 and beyond. Consequently, the delayed releases of major motion pictures will push revenues into later quarters, thereby reducing our full year revenues, and may accelerate our decisions to consider more permanent reductions of operational levels at our cinemas. However, even if such film product is forthcoming, operating revenues may continue to be adversely impacted by ongoing governmental restrictions, social distancing requirements, the adoption and implementation of new sanitization protocols, and potential hesitancy of patrons to return to public indoor venues.

With respect to our home office employees, our Company’s home offices in Culver City, CA, New York City, NY, and Melbourne, Australia are closed as of the date of filing of this Report, with employees working from home. In regard to our office in Wellington, New Zealand, our temporary office space lease has expired and our staff are currently working from home.

In response to uncertainties associated with the outbreak of the COVID-19 pandemic and its impact on our Company’s business, Management had drawn down the available operating borrowing capacity in the first quarter of 2020 and continued to maintain those borrowing levels through the second quarter. As part of our expense reduction, in this case interest expense, we paid down $5.8 million on the Bank of America revolving credit facility during the third quarter of 2020. These funds are, however, now available to be drawn under this facility. Total outstanding borrowings were $274.1 million at September 30, 2020. Our Company’s use of these funds is in some ways limited due to limitations on the expatriation of funds from Australia and New Zealand to the United States and limitations on our use of the proceeds from our $55.0 million Bank of America Credit Facility for purposes unrelated to our U.S. cinema activities.

The impact of the COVID-19 pandemic on our business has reduced our liquidity and our Management, consequently, has postponed, or reprioritized capital expenditures based on assessments of conditions and liquidity requirements.

Our bank loans with the Bank of America, NAB, and Westpac require that our Company comply with certain covenants. The longer the COVID-19 pandemic and the associated limitations (both legal and practical) on our business exist, the more likely it becomes, in the absence of other actions by our Company, that we will be unable to continue to comply with these covenants. However, in such an event, our Company expects (but no assurances can be given) to be able to obtain an amendment or waiver from its lenders. We believe that our lenders understand that the current situation is not of our making, that we are doing everything that can reasonably be done, and that our relationship with our lenders is good. In the absence of such waivers, it is our current intention to look to our real estate assets to provide needed liquidity. Our 44 Union Square property in Manhattan with 73,113 net rentable square foot retail and office space, is in the lease-up phase following completion of construction (except for minor punch list items). Total debt against that property aggregates to $40.1 million. We are currently seeking takeout financing for that property and, while no assurances can be given, are optimistic that the Union Square Refinancing Plan will free up substantial capital and can be finalized this year. Our 202-acre Coachella property is unencumbered. That property is currently zoned for residential and mixed-use purposes. Our 70+ acre Manukau/Wiri industrial property (next to the Auckland Airport) is likewise unencumbered. Unlike pure cinema exhibition companies, we own the fee interest under all of our Live Theatres and underlying 12 of our cinemas.

Prior to the COVID-19 pandemic, our cinema exhibition business plan had been to enhance our current cinemas where it was financially reasonable to do so; develop our specialty cinemas in select markets; expand our F&B offering, and continue on an opportunistic basis, to identify, develop, and acquire cinema properties that allow us to leverage our cinema expertise over a larger operating base. This continues to be our plan once we are able to fully reopen, subject to liquidity constraints.

We continue to advance most of our real estate initiatives as these are, generally speaking, still in the planning stage and, as a result, less impacted than projects in their construction phase. We, fortunately, have only two projects in a construction phase – the redevelopment of our 44 Union Square property in Manhattan and the refurbishment of our Consolidated Theatre at the Kahala Mall in Honolulu. 44 Union Square is in the lease-up phase following completion of construction (except for minor punch list items). We anticipate that our Consolidated Theatre at the Kahala Mall will reopen for business a few weeks after construction is completed, which should follow a few months of work on re-commencement of construction after relaxation of COVID-19 related Hawaiian government restrictions.

 

54


Our pre-COVID-19 business plan with respect to the Real Estate segment of our business was to continue the build-out of our Newmarket Village and Auburn ETCs in Australia; to master-plan and consider the redevelopment of our Courtenay Central site in New Zealand into an urban entertainment center with a focus on cinema exhibition and food & beverage; in Manukau/Wiri, New Zealand, to develop in concert with other major landowners, the infrastructure needed to support the construction of income-producing light industrial improvements; to reassess and master-plan our Cinemas 1,2,3 property for redevelopment as a stand-alone 96,000 square foot mixed use property and in the interim to continue to use it as a cinema; and to continue to be sensitive to opportunities to convert our entertainment assets to higher and better uses, or, where appropriate, to dispose of such assets. Currently, we have determined to postpone further consideration of any redevelopment of our Cinemas 1,2,3 property until we better understand the impact of the COVID-19 pandemic on our assets and the market. However, we continue to advance the planning of our remaining projects.

The success of our Company is naturally dependent on our ongoing ability to execute these business plans effectively through our available resources (both cash and available borrowing facilities), while still addressing our liquidity risk in a timely manner. Liquidity risk is the risk relating to our ability to meet our financial obligations when they come due. Prior to the COVID-19 pandemic, our financial obligations arose mainly from capital expenditure needs, working capital requirements, and debt servicing requirements. We managed the liquidity risk by working to generate adequate cash flows from operating activities, to obtain and maintain appropriate financing or extension of maturity dates under reasonable arrangements, and/or to convert non-performing or non-strategic assets into cash as appropriate under the circumstances. During the pandemic, we have to rely on our ability to control costs, to generate revenue from different sources, and to maintain and obtain adequate and reasonable financing, while at the same time reviewing our options to convert non-strategic assets into cash, if needed. Historically, we have funded our capital expenditures out of operating cash flow. Obviously, with our revenues severely curtailed by the closure and other limitations imposed on our cinema activities, we have needed to look to our lenders for the near term. We, however, remain confident in our cinema industry, and that it will once again be the primary engine through which we fund our liquidity needs.

At September 30, 2020, our consolidated cash and cash equivalents totaled $27.8 million. Of this amount, $8.8 million, $6.2 million, and $12.8 million were held by our U.S., Australian, and New Zealand operations, respectively. Due to the impact of COVID-19, we do not intend to indefinitely reinvest offshore any earnings derived from our Australian and New Zealand operations.

Refer to Note 11 – Debt for additional information.

The changes in cash and cash equivalents for the nine months ended September 30, 2020 and September 30, 2019 are discussed as follows:

Nine Months Ended

September 30,

(Dollars in thousands)

2020

2019

% Change

Net cash provided by (used in) operating activities

$

(28,008)

$

10,797

(>100)

%

Net cash provided by (used in) investing activities

(16,550)

(33,083)

50

%

Net cash provided by (used in) financing activities

57,339

18,261

>100

%

Effect of exchange rate changes on cash and cash equivalents

2,859

(394)

>100

%

Increase (decrease) in cash and cash equivalents

$

15,640

$

(4,419)

>100

%

Operating activities

Cash used in operating activities for the nine months ended September 30, 2020 increased by $38.8 million, to net cash used of $28.0 million driven by $51.3 million lower cash inflows from operating activities as well as a $12.4 million decrease in net operating assets.

Investing activities

Cash used in investing activities during the nine months ended September 30, 2020 decreased by $16.5 million compared to the same period in 2019, to net cash used of $16.6 million. This decrease is primarily attributable to the completion of construction (except for minor punch list items) of our 44 Union Square property along with the suspension of our cinema refurbishment activities due to the COVID-19 shutdown when compared to the same period in 2019.

 

55


Financing activities

The $57.3 million net cash provided by financing activities during the nine months ended September 30, 2020 was related to $87.8 million of new borrowings, offset by $28.9 million of loan repayments. Proceeds from these new borrowings will be used towards working capital provided for ongoing operations in the U.S., Australia, and New Zealand during the COVID-19 pandemic.

On March 10, 2020, the Board increased the stock repurchase program capacity by $25.0 million and extended it to March 2, 2022. At September 30, 2020, there was $26.0 million of capacity remaining in that authorization. During the first nine months of 2020, we repurchased 75,157 shares of our Class A Non-Voting Common Stock, at an average price of $8.92. These purchases occurred in the first quarter of 2020. In view of the need to garner our financial resources, for the foreseeable future our stock repurchase program will likely take a lower capital allocation priority.

Prior to the COVID-19 pandemic, we have used cash generated from operations and other excess cash, to the extent not needed for any capital investment, to pay down our loans and credit facilities providing us some flexibility on our available loan facilities for future use and thereby, reducing interest charges. As a part of our COVID-19 planning, we have determined to maintain significant cash balances, and have accordingly fully drawn-down on all our available operating bank lines. During the third quarter of 2020, we paid down $5.8 million on our U.S. Credit Facility with Bank of America and have the ability to redraw these funds if Management deems necessary.

The table below presents the changes in our total available resources (cash and borrowings), debt-to-equity ratio, working capital, and other relevant information addressing our liquidity for the third quarter ended September 30, 2020 and preceding four years:

As of and

for the

9-Months

Ended

Year Ended December 31

($ in thousands)

September 30, 2020

2019

2018(3)

2017(2)(3)

2016(2)

Total Resources (cash and borrowings)

Cash and cash equivalents (unrestricted)

$

27,775

$

12,135

$

13,127

$

13,668

$

19,017

Unused borrowing facility

15,736

73,920

85,886

137,231

117,599

Restricted for capital projects(1)

9,936

13,952

30,318

62,280

62,024

Unrestricted capacity

5,800

59,968

55,568

74,951

55,575

Total resources at period end

43,511

86,055

99,013

150,899

136,616

Total unrestricted resources at period end

33,575

72,103

68,695

88,619

74,592

Debt-to-Equity Ratio

Total contractual facility

$

289,876

$

283,138

$

252,929

$

271,732

$

266,134

Total debt (gross of deferred financing costs)

274,140

209,218

167,043

134,501

148,535

Current

40,890

37,380

30,393

8,109

567

Non-current

233,250

171,838

136,650

126,392

147,968

Finance lease liabilities

130

209

Total book equity

90,207

139,616

179,979

181,382

146,890

Debt-to-equity ratio

3.04

1.50

0.93

0.74

1.01

Changes in Working Capital

Working capital (deficit)(4)

$

(74,848)

$

(84,138)

$

(56,047)

$

(47,294)

$

6,655

Current ratio

0.36

0.24

0.35

0.41

1.10

Capital Expenditures (including acquisitions)

$

16,310

$

47,722

$

56,827

$

76,708

$

49,166

(1)This relates to the construction facilities specifically negotiated for: 44 Union Square redevelopment project, obtained in December 2016.

(2)Certain 2017 and 2016 balances included the restatement impact as a result of a prior period financial statement correction of immaterial errors (see Note 2 – Summary of Significant Accounting Policies – Prior Period Financial Statement Correction of Immaterial Errors).

(3)See Note 2 – Summary Accounting Policies – Prior Period Financial Statements Correction of Immaterial Errors of the 2019 Form 10-K for the prior period adjustments for accounting for accrued sales tax deemed not material.

(4)Typically, our working capital is reported as a deficit, as we receive revenue from our cinema business ahead of the time that we have to pay our associated liabilities. We use the money we receive to pay down our borrowings in the first instance.

 

56


CONTRACTUAL OBLIGATIONS, COMMITMENTS AND CONTINGENCIES

The following table provides information with respect to the maturities and scheduled principal repayments of our recorded contractual obligations and certain of our commitments and contingencies, either recorded or off-balance sheet, as of September 30, 2020:

(Dollars in thousands)

2020

2021

2022

2023

2024

Thereafter

Total

Debt(1)

$

40,269

$

844

$

24,309

$

169,548

$

293

$

8,081

$

243,344

Operating leases, including imputed interest

7,945

31,963

31,961

31,210

29,368

162,035

294,482

Finance leases, including imputed interest

15

54

43

27

139

Subordinated debt(1)

164

676

711

747

585

27,913 

30,796

Pension liability

171

684 

684 

684 

684 

1,932

4,839

Estimated interest on debt (2)

2,952

7,898

7,157

5,328

1,568

3,683

28,586

Village East purchase option(3)

5,900

5,900 

Total

$

51,516

$

48,019

$

64,865

$

207,544

$

32,498

$

203,644

$

608,086

(1)Information is presented gross of deferred financing costs.

(2)Estimated interest on debt is based on the anticipated loan balances for future periods and current applicable interest rates.

(3)Represents the lease liability of the option associated with the ground lease purchase of the Village East Cinema.

Refer to Note 14 – Commitments and Contingencies for additional information.

Litigation

We are currently involved in certain legal proceedings and, as required, have accrued estimates of probable and estimable losses for the resolution of these claims.

Where we are the plaintiffs, we expense all legal fees on an ongoing basis and make no provision for any potential settlement amounts until received. In Australia, the prevailing party is usually entitled to recover its attorneys’ fees, which recoveries typically work out to be approximately 60% of the amounts actually spent where first-class legal counsel is engaged at customary rates. Where we are a plaintiff, we have likewise made no provision for the liability for the defendant’s attorneys' fees in the event we are determined not to be the prevailing party.

Where we are the defendants, we accrue for probable damages that insurance may not cover as they become known and can be reasonably estimated. In our opinion, any claims and litigation in which we are currently involved are not reasonably likely to have a material adverse effect on our business, results of operations, financial position, or liquidity. It is possible, however, that future results of the operations for any particular quarterly or annual period could be materially affected by the ultimate outcome of the legal proceedings.

Please refer to Item 3 – Legal Proceedings in our 2019 Form 10-K for more information. There have been no material changes to our litigation since our 2019 Form 10-K, except as set forth in Note 14 – Commitments and Contingencies in the accompanying consolidated financial statements included in this Form 10-Q.

Off-Balance Sheet Arrangements

See Note 14 – Commitments and Contingencies to the Consolidated Financial Statements included herein on this report, there are no off-balance sheet arrangements or obligations (including contingent obligations) that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in the financial condition, revenue or expense, results of operations, liquidity, capital expenditures or capital resources.

CRITICAL ACCOUNTING POLICIES

We believe that the application of the following accounting policies requires significant judgments and estimates in the preparation of our Consolidated Financial Statements and hence, are critical to our business operations and the understanding of our financial results:

(i) Impairment of Long-lived Assets (other than Goodwill and Intangible Assets with indefinite lives) – we evaluate our long-lived assets and finite-lived intangible assets using historical and projected data of cash flows as our primary indicator of potential impairment and we take into consideration the seasonality of our business. If the sum of the estimated, undiscounted future cash flows is less than the carrying amount of the asset, then an impairment is recognized for the amount by which the carrying value of the asset exceeds its estimated fair value based on an appraisal or a discounted cash flow calculation. For certain non-income producing properties or for those assets with no consistent historical or projected cash flows, we obtain appraisals or other evidence to evaluate whether there are impairment indicators for these assets.

 

57


No impairment losses were recorded for long-lived and finite-lived intangible assets for the nine months ended September 30, 2020.

(ii) Impairment of Goodwill and Intangible Assets with indefinite lives – goodwill and intangible assets with indefinite useful lives are not amortized, but instead, tested for impairment at least annually on a reporting unit basis. The impairment evaluation is based on the present value of estimated future cash flows of each reporting unit plus the expected terminal value. There are significant assumptions and estimates used in determining the future cash flows and terminal value. The most significant assumptions include our cost of debt and cost of equity assumptions that comprise the weighted average cost of capital for each reporting unit. Accordingly, actual results could vary materially from such estimates.

No impairment losses were recorded for goodwill and indefinite-lived intangible assets for the third quarter ended September 30, 2020.


 

58


FINANCIAL RISK MANAGEMENT

International Business Risks

Our international operations are subject to a variety of risks, including the following:

Currency Risk: while we report our earnings and net assets in U.S. dollars, substantial portions of our revenue and of our obligations are denominated in either Australian or New Zealand dollars. The value of these currencies can vary significantly compared to the U.S. dollar and compared to each other. We do not hedge the currency risk, but rather have relied upon the natural hedges that exist as a result of the fact that our film costs are typically fixed as a percentage of the box office, and our local operating costs and obligations are likewise typically denominated in local currencies. However, we do have intercompany debt and our ability to service this debt could be adversely impacted by declines in the relative value of the Australian and New Zealand dollar compared to the U.S. dollar. Also, our use of local borrowings to mitigate the business risk of currency fluctuations has reduced our flexibility to move cash between jurisdictions. Set forth below is a chart of the exchange ratios between these three currencies since 1996:

Picture 5

In recent periods, we have repaid intercompany debt and used the proceeds to fund capital investment in the United States. Accordingly, our debt levels in Australia are higher than they would have been if funds had not been returned for such purposes. On a company wide basis, this means that a reduction in the relative strength of the U.S. dollar versus the Australian Dollar and/or the New Zealand dollar would effectively raise the overall cost of our borrowing and capital and make it more expensive to return funds from the United States to Australia and New Zealand.

Risk of adverse government regulation: currently, we believe that relations between the United States, Australia, and New Zealand are good. However, no assurances can be given that these relationships will continue, and that Australia and New Zealand will not in the future seek to regulate more highly the business done by U.S. companies in their countries.

Risk of adverse labor relations: deterioration in labor relations could lead to an increased cost of labor (including future government requirements with respect to pension liabilities, disability insurance and health coverage, and vacations and leave).

Our exposure to interest rate risk arises out of our intermediate term floating-rate borrowings. To manage the risk, we utilize interest rate derivative contracts to convert certain floating-rate borrowings into fixed-rate borrowings. It is our Company’s policy to enter into interest rate derivative transactions only to the extent considered necessary to meet its objectives as stated above. Our Company does not enter into these transactions or any other hedging transactions for speculative purposes.

 

59


Inflation

We continually monitor inflation and the effects of changing prices. Inflation increases the cost of goods and services used. Competitive conditions in many of our markets restrict our ability to recover fully the higher costs of acquired goods and services through price increases. We attempt to mitigate the impact of inflation by implementing continuous process improvement solutions to enhance productivity and efficiency and, as a result, lower costs and operating expenses. The effects of inflation have not had a material impact on our operations and the resulting financial position or liquidity.

FORWARD-LOOKING STATEMENTS

Our statements in this quarterly report contain a variety of forward-looking statements as defined by the Securities Litigation Reform Act of 1995, including those related to the expected timing of the reopening of our cinemas and theatres; our belief regarding the attractiveness of the 44 Union Square project to potential tenants; our expectations regarding the commencement of rental income on our office building; our expectations regarding the resiliency of the industrial property sector in New Zealand; our expectations regarding our stock repurchase program; our expectations regarding credit facility covenant compliance and our ability to continue to obtain necessary covenant waivers; and our expectations of our liquidity and capital requirements and the allocation of funds. Forward-looking statements reflect only our expectations regarding future events and operating performance and necessarily speak only as of the date the information was prepared. No guarantees can be given that our expectation will in fact be realized, in whole or in part. You can recognize these statements by our use of words, such as “may,” “will,” “expect,” “believe,” and “anticipate” or other similar terminology.

These forward-looking statements reflect our expectation after having considered a variety of risks and uncertainties. However, they are necessarily the product of internal discussion and do not necessarily completely reflect the views of individual members of our Board of Directors or of our Management team. Individual Board members and individual members of our Management team may have different views as to the risks and uncertainties involved and may have different views as to future events or our operating performance.

Among the risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in or underlying our forward-looking statements are the following:

with respect to our cinema operations:

the adverse impact of the COVID-19 pandemic which resulted in the temporary shutdown of our global theaters beginning in March 2020, and the adverse effects such pandemic may continue to have on our anticipated cinema reopening dates and on the dates that public performances will resume in our live theatres in New York City and Chicago;

the adverse effects of the COVID-19 pandemic on our Company’s results from operations, liquidity, cash flows, financial condition, and access to credit markets;

the adverse impact of the COVID-19 pandemic on short-term and/or long-term entertainment, leisure and discretionary spending habits and practices of our patrons;

the decrease in attendance at our cinemas and theatres after they have reopened due to (i) continued safety and health concerns, (ii) a change in consumer behavior in favor of alternative forms of entertainment, or (iii) additional regulatory requirements limiting our seating capacity;

reduction in operating margins (or negative operating margins) due to the implementation of social distancing and other health and safety protocols;

potentially uninsurable liability exposure to customers and staff should they become (or allege that they have become) infected with COVID-19 while at one of our facilities;

unwillingness of employees to report to work due to the adverse effects of the COVID-19 pandemic or to otherwise conduct work under any revised work environment protocols;

the adverse impact that the COVID-19 pandemic may have on the national and global macroeconomic environment;

competition from cinema operators who have successfully used debtor laws to reduce their debt and/or rent exposure;

the uncertainty as to the scope and extent of government responses to the COVID-19 pandemic;

the disruptions or reductions in the utilization of entertainment, shopping, and hospitality venues, as well as in our operations, due to pandemics, epidemics, widespread health emergencies, or outbreaks of infectious diseases such as the coronavirus, or to changing consumer tastes and habits;

the number and attractiveness to moviegoers of the films released in future periods, and potential changes in release dates for motion pictures;

the lack of availability of films in the short- or long-term as a result of (i) major film distributors releasing scheduled films on alternative channels or (ii) disruptions of film production;

the amount of money spent by film distributors to promote their motion pictures;

the licensing fees and terms required by film distributors from motion picture exhibitors in order to exhibit their films;

 

 

60


 

the comparative attractiveness of motion pictures as a source of entertainment and willingness and/or ability of consumers (i) to spend their dollars on entertainment and (ii) to spend their entertainment dollars on movies in an outside-the-home environment;

the extent to which we encounter competition from other cinema exhibitors, from other sources of outside-the-home entertainment, and from inside-the-home entertainment options, such as “home theaters” and competitive film product distribution technology, such as, streaming, cable, satellite broadcast, Blu-ray/DVD rentals and sales, and so called “movies on demand”;

the impact of major movies being released directly to one of the multitude of streaming services available;

the impact of certain competitors’ subscription or advance pay programs; 

the cost and impact of improvements to our cinemas, such as improved seating, enhanced food and beverage offerings, and other improvements;

the ability to negotiate favorable rent payment terms with our landlords;

disruptions during theater improvements;

the extent to, and the efficiency with, which we are able to integrate acquisitions of cinema circuits with our existing operations;

the risk that California will adopt a split property tax regime resulting in material increases in our liability for pass through property taxes;

in the U.S., the impact of any termination of the so called “Paramount Decree;”

the risk of damage and/or disruption of cinema businesses from earthquakes as certain of our operations are in geologically active areas; and

the impact of protests, demonstrations, and civil unrest on, among other things, government policy, consumer willingness to go to the movies, and the spread of COVID-19.

with respect to our real estate development and operation activities:

the impact of the COVID-19 pandemic may continue to affect many of our tenants at our real estate operations in the United States, Australia, and New Zealand, their ability to pay rent, and to stay in business;

the impact of the COVID-19 pandemic on our construction projects and on our ability to open construction sites and to secure needed labor and materials;

the impact of the COVID-19 pandemic on real estate valuations in major urban centers, such as New York;

uncertainty as to governmental responses to COVID-19;

the potential sale of certain non-core real estate assets;

the rental rates and capitalization rates applicable to the markets in which we operate and the quality of properties that we own;

the ability to negotiate and execute lease agreements with material tenants;

the extent to which we can obtain on a timely basis the various land use approvals and entitlements needed to develop our properties;

the risks and uncertainties associated with real estate development;

the availability and cost of labor and materials;

the ability to obtain all permits to construct improvements;

the ability to finance improvements;

the disruptions to our business from construction and/or renovations;

the possibility of construction delays, work stoppage, and material shortage;

competition for development sites and tenants;

environmental remediation issues;

the extent to which our cinemas can continue to serve as an anchor tenant that will, in turn, be influenced by the same factors as will influence generally the results of our cinema operations;

the increased depreciation and amortization expense as construction projects transition to leased real property;

the ability to negotiate and execute joint venture opportunities and relationships;

the risk of damage and/or disruption of real estate businesses from earthquakes as certain of our operations are in geologically active areas;

the disruptions or reductions in the utilization of entertainment, shopping and hospitality venues, as well as in our operations, due to pandemics, epidemics, widespread health emergencies, or outbreaks of infectious diseases such as the coronavirus, or to changing consumer tastes and habits; and

the impact of protests, demonstrations, and civil unrest on government policy, consumer willingness to visit shopping centers, and the spread of COVID-19, among other things.

with respect to our operations generally as an international company involved in both the development and operation of cinemas and the development and operation of real estate and previously engaged for many years in the railroad business in the United States:

our ability to renew, extend, renegotiate or replace our loans that mature in 2020;

our ability to grow our Company and provide value to our stockholders;

 

61


 

our ongoing access to borrowed funds and capital and the interest that must be paid on that debt and the returns that must be paid on such capital, and our ability to borrow funds to help cover the cessation of cash flows we are experiencing during the COVID-19 pandemic;

our ability to reallocate funds among jurisdictions to meet short-term liquidity needs;

expenses, Management and Board distraction, and other effects of the litigation efforts mounted by James Cotter, Jr. against our Company, including his efforts to cause a sale of voting control of our Company;

the relative values of the currency used in the countries in which we operate;

the impact that any discontinuance, modification or other reform of London Inter-Bank Offered Rate (LIBOR), or the establishment of alternative reference rates, may have on our LIBOR-based debt instruments;

changes in government regulation, including by way of example, the costs resulting from the implementation of the requirements of Sarbanes-Oxley;

our labor relations and costs of labor (including future government requirements with respect to minimum wages, shift scheduling, the use of consultants, pension liabilities, disability insurance and health coverage, and vacations and leave);

our exposure from time to time to legal claims and to uninsurable risks, such as those related to our historic railroad operations, including potential environmental claims and health-related claims relating to alleged exposure to asbestos or other substances now or in the future recognized as being possible causes of cancer or other health related problems, and class actions and private attorney general wage and hour and/or safe work place based claims;

our exposure to cybersecurity risks, including misappropriation of customer information or other breaches of information security;

the impact of major outbreaks of contagious diseases, such as COVID-19;

the availability of employees and/or their ability or willingness to conduct work under any revised work environment protocols;

the increased risks related to employee matters, including increased employment litigation and claims relating to terminations or furloughs caused by theater and ETC closures;

our ability to generate significant cash flow from operations if our theaters and/or ETCs continue to experience demand at levels significantly lower than historical levels, which could lead to a substantial increase in indebtedness and negatively impact our ability to comply with the financial covenants, if applicable, in our debt agreements;

our ability to comply with credit facility covenants and our ability to obtain necessary covenant waivers and necessary credit facility amendments;

changes in future effective tax rates and the results of currently ongoing and future potential audits by taxing authorities having jurisdiction over our various companies; and

changes in applicable accounting policies and practices.

The above list is not necessarily exhaustive, as business is by definition unpredictable and risky, and subject to influence by numerous factors outside of our control, such as changes in government regulation or policy, competition, interest rates, supply, technological innovation, changes in consumer taste and fancy, weather, earthquakes, pandemics, such as COVID-19, and the extent to which consumers in our markets have the economic wherewithal to spend money on beyond-the-home entertainment. Refer to Item 1A - Risk Factors – of our Annual Report on Form 10-K for the year ended December 31, 2019, as well as the risk factors set forth in any other filings made under the Securities Act of 1934, as amended, including any of our Quarterly Reports on Form 10-Q, for more information.

Given the variety and unpredictability of the factors that will ultimately influence our businesses and our results of operation, no guarantees can be given that any of our forward-looking statements will ultimately prove to be correct. Actual results will undoubtedly vary and there is no guarantee as to how our securities will perform either when considered in isolation or when compared to other securities or investment opportunities.

Finally, we undertake no obligation to publicly update or to revise any of our forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law. Accordingly, you should always note the date to which our forward-looking statements speak.

 

62


Item 3 – Quantitative and Qualitative Disclosure about Market Risk

The SEC requires that registrants include information about potential effects of changes in currency exchange and interest rates in their filings. Several alternatives, all with some limitations, have been offered. We base the following discussion on a sensitivity analysis that models the effects of fluctuations in currency exchange rates and interest rates. This analysis is constrained by several factors, including the following:

It is based on a single point in time; and

It does not include the effects of other complex market reactions that would arise from the changes modeled.

Although the results of such an analysis may be useful as a benchmark, they should not be viewed as forecasts.

At September 30, 2020, approximately 36% and 11% of our assets were invested in assets denominated in Australian dollars (Reading Australia) and New Zealand dollars (Reading New Zealand), respectively, including approximately $19.0 million in cash and cash equivalents. At December 31, 2019, approximately 37% and 10% of our assets were invested in assets denominated in Australian dollars (Reading Australia) and New Zealand dollars (Reading New Zealand), including approximately $4.3 million in cash and cash equivalents.

Our policy in Australia and New Zealand is to match revenues and expenses, whenever possible, in local currencies. As a result, we have procured a majority of our expenses in Australia and New Zealand in local currencies. Despite this natural hedge, recent movements in foreign currencies have had an effect on our current earnings. The effect of the translation adjustment on our assets and liabilities noted in our other comprehensive income was a decrease of $1.6 million for the nine months ended September 30, 2020. As we continue to progress our acquisition and development activities in Australia and New Zealand, no assurances can be given that the foreign currency effect on our earnings will not be material in the future.

Historically, our policy has been to borrow in local currencies to finance the development and construction of our long-term assets in Australia and New Zealand. As a result, the borrowings in local currencies have provided somewhat of a natural hedge against the foreign currency exchange exposure. We have also historically paid management fees to the U.S. to cover a portion of our domestic overhead. The fluctuations of the Australian and New Zealand currencies, however, may impact our ability to rely on such funding for ongoing support of our domestic overhead.

In 2007, we issued subordinated Trust Preferred Securities denominated in U.S Dollars, and substantially deployed those funds in our New Zealand subsidiaries, thus exposing approximately 59% of New Zealand assets to currency risk. Those funds were returned to the U.S. parent company permanently and in full during 2019, and the New Zealand subsidiaries were released from liability under the Securities. Presently, we have no plans to make new borrowings in currencies other than the local currency.

We record unrealized foreign currency translation gains or losses that could materially affect our financial position. As of September 30, 2020 and December 31, 2019, the balance of cumulative foreign currency translation adjustments were approximately $6.5 million loss and $8.1 million gain, respectively.

Historically, we maintain most of our cash and cash equivalent balances in short-term money market instruments with original maturities of three months or less. Due to the short-term nature of such investments, a change of 1% in short-term interest rates would not have a material effect on our financial condition. The negative spread between our borrowing costs and earned interest will exacerbate as we hold cash to provide a safety net to meet our expenses while our cinema operations are closed and our tenant income curtailed.

We have a combination of fixed and variable interest rate loans. In connection with our variable interest rate loans, a change of approximately 1% in short-term interest rates would have resulted in approximately $538,000 increase or decrease in our quarterly interest expense.

For further discussion on market risks, please refer to International Business Risks included in Item 2, Part 1 of this Form 10-Q.

 

 

63


Item 4 – Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Company’s reports filed under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our Management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our Management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Under the supervision and with the participation of our Management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such, term is defined under Rule 13a-15(e) promulgated under the Exchange Act. Based upon that evaluation, we concluded that, as of September 30, 2020, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no other changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the third quarter ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


 

64


PART II – Other Information

Item 1 – Legal Proceedings

The information required under Part II, Item 1 (Legal Proceedings) is incorporated by reference to the information contained in Note 14 – Commitments and Contingencies to the Consolidated Financial Statements included herein in Part I, Item 1 (Financial Statements) on this Quarterly Report on Form 10-Q.

For further details on our legal proceedings, please refer to Item 3, Legal Proceedings, contained in our 2019 Form 10-K.

Item 1A – Risk Factors

We are subject to risks related to corporate social responsibility and reputation Many factors influence our reputation and the value of our brands including the perception held by our customers, business partners, other key stakeholders, and the communities in which we do business. Any harm to our reputation could impact employee engagement and retention and the willingness of customers and our partners to do business with us, which could have a material adverse effect on our business, results of operations and cash flows.

 

65


Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

There were no unregistered sales of our equity securities and no repurchases of our common stock during the third quarter ended September 30, 2020.

Item 3 – Defaults upon Senior Securities

None.

Item 4 – Mine Safety Disclosure

Not applicable.

Item 5 – Other Information

Item 1.01 Entry into a Material Definitive Agreement

We incorporate by reference the information contained in Note 11 - Debt of the Notes to Consolidated Financial Statements (Unaudited) in Part I, Item 1 of this quarterly report relating to the respective amendment to our credit agreement with Westpac New Zealand Limited. Such description is only a summary of the material provisions of the respective amendment and does not purport to be complete and is qualified in its entirety by reference to the provisions in such amendment, a copy of which is attached to this report as Exhibits 10.1.

 

66


Item 6 – Exhibits

10.1

Letter of Variation dated September 15, 2020 between Westpac New Zealand Limited and Reading Courtenay Central Limited, filed herewith.

31.1

Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.

31.2

Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.

32

Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished herewith.

101

The following material from our Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Cash Flows, and (v) the Notes to the Consolidated Financial Statements.

104

Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101)

 ____________________

 

67


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

READING INTERNATIONAL, INC.

Date: November 9, 2020

By: /s/ Ellen M. Cotter

Ellen M. Cotter

President and Chief Executive Officer

Date: November 9, 2020

By: /s/ Gilbert Avanes

Gilbert Avanes

Executive Vice President, Chief Financial Officer and Treasurer

 

68

Exhibit 10.1 Westpac Variation Letter Waiver

Exhibit 10.1

 

image1.jpeg



16 September 2020



The Directors

Reading Courtenay Central Limited

C/- Reading International Limited

5995 Sepulveda Blvd

Suite 300

Culver City

California 90230

United States of America



Dear Sirs,



BANKING FACILITIES  READING COURTENAY CENTRAL LIMITED



We confirm that we have approved the following changes to your banking arrangements.



THE CHANGES



1. Westpac NZ waives the 30 September 2020 test of the Interest Cover ratio, applicable to your banking arrangements and detailed in clause 8.2(b) of the MOCL agreement, dated October 2016, as amended from time to time (the Agreement”). Testing of this covenant shall resume on 31 December 2020 and quarterly thereafter.



THE CONDITIONS OF APPROVAL



Nil.



In all other respects your banking arrangements remain unchanged.



If the terms of this letter are acceptable to you, please sign this letter, arrange for all guarantors to sign it, and return it. The changes will take effect from the date we receive the signed copy from you provided any conditions have been satisfied.



This letter may be executed in two or more counterparts, all of which will be deemed  to constitute the same instrument. Westpac NZ may accept as an original a facsimile copy or copies of this letter executed by the parties, which when taken with a counterpart executed by Westpac NZ, will be deemed to  be one original copy of this letter.



This offer is open for acceptance until 5pm on 30 September 2020. 



Yours sincerely,

WESTPAC NEW ZEALAND LIMITED

Picture 2

Melissa Burnett

Senior Manager

Corporate Business




 

ACCEPTANCE



We accept the changes described in this letter.



Signed on behalf of the Borrower, Reading Courtenay Central Limited, by:





 

 

Picture 3

Director

 

Date of acceptance:

16/09/2020

 



GUARANTOR'S CONSENT



We confirm that our guarantee is not affected by the changes referred to in this letter.



Signed on behalf of the Borrower, Reading New Zealand Limited, by:



ncnt

 

 



 

 

Picture 22

Director

 

Date of consent:

16/09/2020

 



Signed on behalf of the Borrower, Reading Cinemas Courtenay Central Limited, by:



ncnt

 

 



 

 

Picture 23

Director

 

Date of consent:

16/09/2020

 



Signed on behalf of the Borrower, Reading New Lynn Limited, by:



ncnt

 

 



 

 

Picture 24

Director

 

Date of consent:

16/09/2020

 



Signed on behalf of the Borrower, Reading Dunedin Limited, by:



ncnt

 

 



 

 

Picture 25

Director

 

Date of consent:

16/09/2020

 



Signed on behalf of the Borrower, Reading Queenstown Limited, by:



ncnt

 

 



 

 

Picture 26

Director

 

Date of consent:

16/09/2020

 

Signed on behalf of the Borrower, Courtenay Car Park Limited, by:

2

 


 



ncnt

 

 



 

 

Picture 27

Director

 

Date of consent:

16/09/2020

 



Signed on behalf of the Borrower, Reading Wellington Properties Limited, by:



ncnt

 

 



 

 

Picture 28

Director

 

Date of consent:

16/09/2020

 



Signed on behalf of the Borrower, Queenstown Land Holdings Limited, by:



ncnt

 

 



 

 

Picture 29

Director

 

Date of consent:

16/09/2020

 



Signed on behalf of the Borrower, Darnelle Enterprises Limited, by:



ncnt

 

 



 

 

Picture 30

Director

 

Date of consent:

16/09/2020

 





Signed on behalf of the Borrower, Movieland Cinemas (NZ) Limited, by:



ncnt

 

 



 

 

Picture 31

Director

 

Date of consent:

16/09/2020

 



Signed on behalf of the Borrower, New Zealand Equipment Supply Limited, by:



ncnt

 

 



 

 

Picture 32

Director

 

Date of consent:

16/09/2020

 



3

 


Exhibit 31.1 CEO Sec 302 Certification

EXHIBIT 31.1



CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a) AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002



I, Ellen M. Cotter, certify that:



1)

I have reviewed this Quarterly Report on Form 10-Q of Reading International, Inc.;



2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3)

Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4)

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and  have:



a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5)

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):



a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





By:         /s/ Ellen M. Cotter 

Ellen M. Cotter

President and Chief Executive Officer

November 9, 2020


Exhibit 31.2 CFO Sec 302 Certification

EXHIBIT 31.2



CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a) AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002



I, Gilbert Avanes, certify that:



1)

I have reviewed this Quarterly Report on Form 10-Q of Reading International, Inc.;



2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 



3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;  



4)

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:



a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5)

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):



a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





By:         /s/ Gilbert Avanes

Gilbert Avanes

Executive Vice President, Chief Financial Officer and Treasurer

November 9, 2020


Exhibit 32 CEO.CFO Sec 906 Certification

EXHIBIT 32



CERTIFICATION PURSUANT TO
18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





Ellen M. Cotter, Chief Executive Officer, and Gilbert Avanes, Chief Financial Officer, of Reading International, Inc. (the “Company”), pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, do each hereby certify, that, to his or her knowledge:



·

The Quarterly Report on Form 10-Q for the period ended September 30, 2020 as filed with the Securities and Exchange Commission (the "Report") of the Company fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

·

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.



DatedNovember 9, 2020



/s/ Ellen M. Cotter

Name:Ellen M. Cotter

Title:President and Chief Executive Officer



/s/ Gilbert Avanes

Name:Gilbert Avanes

Title:Executive Vice President, Chief Financial Officer and Treasurer